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ZUSAMMENFASSUNG	  	  Männliche	   und	   weibliche	   Zellen	   heterogameter	   Organismen	   enthalten	   einen	  unterschiedlichen	   Satz	   von	   Geschlechtschromosomen.	   Die	   daraus	   resultierenden	  Unterschiede	   in	   der	   Genexpression	   werden	   oft	   durch	   epigenetische	   Mechanismen	  ausgeglichen,	  ein	  Phänomen	  bekannt	  als	  Dosiskompensation.	  	  Mittels	  einer	  molekularen	  Maschinerie	   genannt	   MSL	   Komplex	   erhöhen	   männliche	   Zellen	   in	   Drosophila	   die	  Genexpression	   ihres	   einzelnen	   X	   chromosoms	   ungefähr	   um	   den	   Faktor	   zwei.	   Dieser	  enzymatische	   Ribonucleoproteinkomplex,	   spezifisch	   gebildet	   in	   männlichen	   Zellen,	  bindet	   an	   das	   X	   Chromosom,	   ändert	   dessen	   Struktur	   hauptsächlich	   durch	   die	  Acetylierung	   von	   Histon	   H4	   an	   Lysin	   16,	   und	   ermöglicht	   dadurch	   eine	   verstärkte	  Transkription.	   Wie	   genau	   der	   MSL	   Komplex	   das	   X	   chromosom	   erkennt	   und	   die	  Transkription	   reguliert	   ist	   nicht	   im	   Detail	   verstanden.	   Mit	   Hilfe	   von	  röntgenkristallographischen	  Daten	  haben	  wir	  in	  dieser	  Arbeit	  Puntkmutationen	  in	  Msl1	  generiert	   die	   zum	   Verlust	   einzelner	   Faktoren	   aus	   dem	   MSL	   Komplex	   führen,	   um	   so	  deren	  Beiträge	  zur	  X	  Chromosom	  Erkennung,	  RNA	  Integration	  und	  zum	  „spreading“	  des	  MSL	  Komplexes	  entlang	  des	  X	  Chromosoms	  zu	  studieren.	  Der	  Fokus	  des	   ersten	  Teils	   dieser	  Arbeit	   liegt	   auf	  der	  PEHE	   region	  des	  Msl1	  Proteins	  welche	  mit	  Mof	  und	  Msl3	   interagiert.	  Wir	  haben	  Msl1	  Punkmtutante	  erzeugt	  die	  nicht	  mehr	  an	  Mof	  oder	  Msl3	  binden	  können.	  Wir	  zeigen	  dass	  sowohl	  der	  Verlust	  von	  Mof	  als	  auch	  von	  Msl3	  aus	  dem	  MSL	  Komplex	  dessen	  „spreading“	  in	  den	  transkribierten	  Teil	  X	  chromosomaler	   Gene	   verhindert,	   wobei	   die	   Bindung	   von	   Msl1	   an	   die	   Promoteren	  derselben	  Gene	   erhalten	  bleibt.	  Desweiteren	  beobachten	  wir	   qualitative	  Unterschiede	  zwischen	  verschiedenen	  „high	  affinity	  sites“	  (HAS),	  den	   initialen	  Bindestellen	  des	  MSL	  Komplexes,	   insoweit	   dass	   HAS	   an	   Promotoren	   Msl1	   unabhängig	   von	   Mof	   und	   MSl3	  rekrutieren	  können	  während	  die	  optimale	  Bindung	  von	  Msl1	  an	  andere	  HAS	  von	  einer	  intakten	  PEHE	  Domäne	  abhängig	  ist.	  Im	   zweiten	   teil	   dieser	   Arbeit	   haben	   wir	   die	   Interaktion	   zwischen	   MSl1	   und	   Msl2	  untersucht	  und	  zeigen	  dass	  Msl1	  mit	  seiner	  coiled-­‐cloil	  Domäne	  ein	  Homodimer	  bildet	  welches	   als	   Plattform	   für	   die	   Bindung	   an	  Msl2	   dient.	   Diese	   Interaktion	  wird	   in	  Msl2	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SUMMARY	  	  	  In	   heterogametic	   organisms,	   male	   and	   female	   cells	   harbor	   structurally	   different	   sex	  chromosome	   pairs.	   The	   difference	   in	   the	   transcriptional	   output	   of	   these	   sex	  chromosomes	   is	   epigenetically	   balanced,	   a	   phenomenon	   dubbed	   as	   dosage	  compensation.	   In	  Drosophila,	  male	   cells	   up-­‐regulate	   their	   one	  X	   chromosome	   roughly	  two	   times	   by	   the	   help	   of	   a	   molecular	   machine	   called	   MSL	   complex.	   This	  ribonucleoprotein	  enzymatic	  complex,	  specifically	  formed	  in	  male	  cells,	  localizes	  to	  the	  X-­‐chromosome,	  changing	  its	  structure	  mostly	  by	  histone	  H4	  Lysine	  16	  acetylation,	  thus	  enabling	  enhanced	  transcription.	  The	  details	  of	  how	  the	  complex	  finds	  the	  chromosome	  and	  how	   it	   regulates	   transcription	  are	  not	   thoroughly	  understood.	   In	   this	   thesis,	  with	  the	   help	   of	   X-­‐ray	   crystallography,	   we	   derived	   point	   mutations	   on	   the	   scaffold	   Msl1	  protein	   that	   create	   partial	   complexes	   to	   study	   the	   contribution	   of	   each	   subunit	   to	   X	  chromosome	  recognition,	  RNA	  integration	  and	  spreading	  alone	  the	  X	  chromosome.	  	  In	  the	  first	  part	  of	  this	  thesis,	  we	  focused	  on	  the	  PEHE	  region	  of	  Msl1	  protein	  that	  binds	  Mof	  and	  Msl3.	  We	  generated	  point	  mutants	  of	  Msl1	  that	  cannot	  bind	  Mof	  or	  Msl3.	  We	  showed	  that	   loss	  of	  either	  Mof	  or	  Msl3	  prevents	  spreading	  of	  the	  MSL	  complex	  on	  the	  body	  of	   the	  X-­‐linked	   genes	  whereas	  Msl1	  promoter	   binding	   remained	  unaffected.	  We	  observed	   qualitative	   differences	   between	   high	   affinity	   sites	   (HAS),	   initial	   binding	  platforms	   of	   MSL	   complex,	   and	   noticed	   that	   promoter	   located	   HAS	   can	   bind	   Msl1	  independent	   of	   Mof	   and	   Msl3	   whereas	   other	   HAS	   depend	   on	   the	   presence	   of	   intact	  PEHE	  module	  for	  optimal	  binding.	  	  In	   the	   second	   part	   of	   the	   thesis,	   we	   examined	   the	   interaction	   of	   Msl1	   and	  Msl2	   and	  showed	  that	  Msl1	  forms	  a	  homodimer	  through	  its	  coiled	  coil	  region	  and	  this	  homodimer	  creates	  a	  platform	  for	  Msl2	  binding.	  Msl2	  binding	  happens	  through	  helices	  surrounding	  the	  RING	  finger	  domain.	  We	  showed	  that	  Msl2	  RING	  finger	  can	  function	  as	  a	  ubiquitin	  ligase,	   and	   Msl1	   is	   an	   in	   vitro	   substrate	   of	   Msl2	   ubiquitination.	   By	   point	   mutational	  analysis	  on	  Msl1	  we	  showed	  that	  Msl1	  forms	  a	  dimer	  independent	  of	  Msl2	  in	  both	  male	  and	  female	  cells.	  Dimerization	  is	  required	  for	  Msl2	  binding,	  roX2	  RNA	  integration	  to	  the	  complex,	   X	   chromosome	   recognition	   and	   spreading	   along	   the	   body	   of	   X-­‐linked	   genes.	  This	  clearly	  showed	  that	  functionality	  of	  MSL	  complex	  entirely	  depends	  on	  its	  dimeric	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Figure	  1.	  Dosage	  compensation	  in	  Drosophila	  melanogaster.	  	  Female	   cells	   have	   two	   X	   chromosomes,	   whereas	   male	   cells	   has	   one	   X	   and	   one	  degenerated	  Y	  chromosome.	  The	  male	  X	  produces	  the	  same	  dose	  of	  RNA	  as	  the	  female	  to	  compensate	  for	  the	  absence	  of	  homologue.	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Mof	  and	  Msl3	  The	   early	   observations	   of	   polytene	   squashes	   from	   the	   male	   larvae	   salivary	   glands	  revealed	  an	  interesting	  discovery	  that	  male	  X	  chromosome	  was	  enriched	  for	  a	  specific	  acetylation	  mark	  on	  the	  histone	  4	  lysine	  16	  (H4K16)21.	  Co-­‐localization	  of	  this	  mark	  with	  known	   MSL	   members	   and	   its	   absence	   in	   MSL	   mutants	   predicted	   a	   histone	  acetyltransferase	  (HAT)	  enzyme	  in	  the	  complex22.	  Concordantly	  Mof,	  a	  member	  of	  MYST	  family	  of	  HATs	  (named	  for	  members	  MOZ,	  Ybf2/Sas3,	  Sas2,	  and	  Tip60),	  was	  shown	  to	  co-­‐localize	  with	  MSL	  members	  and	  mark	  the	  male	  X	  chromosome	  together	  with	  H4K16	  11,23.	  Mof	  has	  a	  peculiar	  C2HC	  zinc	  finger	  motif,	  which	  mediates	  substrate	  recognition	  24,	  and	   its	   interaction	  with	  Msl115.	  Although	  Mof	  binds	   to	  nucleosomes	  and	   its	  preferred	  substrate	  is	  H425,26,	  it	  can	  also	  acetylate	  Msl3	  and	  Msl127,	  nevertheless	  integration	  into	  the	  complex	  shifts	  the	  substrate	  specificity	  strongly	  to	  H415.	  Both	  Mof	  and	  Msl3	  have	  a	  chromo-­‐related	   domain	   but	   accumulating	   evidence	   indicate	   that	   they	   may	   have	  different	   substrate	   specificities.	   Solution	   structure	   of	   Mof	   chromo-­‐related	   domain	  revealed	  that	  this	  fold	  has	  five	  beta	  strands	  forming	  a	  barrel	  shape,	  therefore	  named	  as	  chromo-­‐barrel	   domain	   (CBD),	   which	   is	   structurally	   similar	   to	   Tudor	   domains28.	   This	  fold	   is	   quite	   different	   from	   chromodomains	   that	   bind	   lysine	  methylated	   histone	   tails	  through	   a	   hydrophobic	   cage	   formed	   by	   three	   conserved	   aromatic	   residues29,30.	   These	  residues	  are	  not	   found	   in	  Mof	   and	   in	   fact	  R387	  of	  CBD	  may	  clash	  with	   superimposed	  methylated	  lysine	  H3	  peptide28.	  Instead	  Mof	  chromo-­‐barrel	  domain	  in	  the	  context	  of	  the	  full-­‐length	   protein	   is	   important	   for	   RNA	   binding	   activity	   in	   vivo	   and	   in	   vitro	   and	  mutation	   of	   a	   conserved	   tyrosine	   disrupts	   this	   interaction	   31.	   Nucleic	   acid	   binding	  activity	  of	   a	   chromodomain	   is	  not	  unique	   to	  Mof	  but	   also	  well	   documented	   for	  dMi-­‐2	  protein	  of	  NuRD	   remodeling-­‐HDAC	  complex	   in	  Drosophila	   32.	   Curiously,	   the	  CBD	  used	  for	  structure	  determination	  was	  not	  able	  to	  bind	  RNA	  by	  itself	  leading	  to	  the	  hypothesis	  that	   the	   fold	  may	  need	  other	  residues	   for	  RNA	  binding	  activity28.	  Supportive	  evidence	  for	  this	  prediction	  came	  from	  the	  structural	  elucidation	  of	  yeast	  homologue	  of	  Mof,	  Esa1	  chromo-­‐domain33.	  Esa1	  chromo-­‐domain	  folds	  similar	  to	  MOF	  CBD	  in	  silico	  and	  does	  not	  show	  nucleotide	   binding	   activity	   in	  vitro	   however	   structure	   of	  N	   terminally	   extended	  domain	  has	  an	  extra	  beta	  sheet	  which	  induces	  a	  loop	  in	  the	  barrel.	  This	  “knotted”	  barrel	  has	  a	  high	  affinity	  for	  RNA	  in	  vitro	  33.	  In	  the	  same	  vein,	  Mof	  chromo-­‐barrel	  domain	  could	  adopt	   a	   slightly	   different	   form	   in	   the	   context	   of	   full	   protein	   such	   that	   it	   has	   a	   high	  affinity	  for	  RNA.	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Msl3	  chromo-­‐related	  domain	  is	  predicted	  to	  fold	  similar	  to	  chromo-­‐barrel	  domain	  but	  unlike	  Mof,	  it	  contains	  the	  typical	  hydrophobic	  residues	  that	  forms	  the	  aromatic	  cage	  28.	  Msl3	  can	  bind	  nucleosomes	  that	  are	  methylated	  on	  H3K36	  and	  mutation	  of	  hydrophobic	  residues	  causes	  the	  loss	  of	  this	  interaction34,35.	  Besides,	  the	  chromodomain	  by	  itself	  can	  bind	  to	  a	  nucleosomal	  template36.	  Chromodomain	  structures	  of	  Eaf3	  and	  MRG15,	  yeast	  and	   human	   homologue	   of	   drosophila	   Msl3	   respectively,	   were	   solved	   and	   showed	   to	  bind	  methylated	  H3K3637,38.	  Nevertheless,	  Eaf3	  interaction	  with	  this	  histone	  mark	  is	  a	  rather	  weak	  one	  and	  was	  suggested	  to	  take	  assistance	  from	  PhD	  finger	  for	  the	  optimal	  binding	  39,40.	  MRG15	  binding	  to	  H3K36me3	  is	  predicted	  to	  be	  different	   from	  canonical	  chromodomains	   because	   a	   beta	   strand	   in	   chromo-­‐barrel	   preoccupies	   the	   histone	  peptide-­‐binding	  groove37.	   Interestingly,	  Msl3	  chromo-­‐related	  domain	  can	  bind	  DNA	   in	  
vitro	   suggesting	   that	   nucleosome	   interaction	   may	   occur	   partly	   through	   DNA41.	  Additionally,	  Msl3	  localization	  to	  X-­‐chromosome	  is	  lost	  upon	  RNAse	  treatment	  and	  Msl3	  can	  bind	  roX	  RNA	  both	   in	  vivo	  and	   in	  vitro19,27,	   therefore	  nucleic	  acid	  binding	  surfaces	  can	   be	   used	   to	   bind	   both	   RNA	   and	   DNA.	   Acetylated	   Msl3	   cannot	   immunoprecipitate	  significant	  amounts	  of	  roX2	  RNA;	  hence	  this	  posttranslational	  modification	  may	  be	  used	  as	   a	   regulatory	   switch	   for	   the	   substrate	   specificity	   of	   Msl3.	   Recently	   two	   groups	  independently	  solved	  the	  crystal	  structure	  drosophila	  Msl3	  chromodomain	  and	  showed	  that	   it	   binds	   rather	   to	  H4K20	  methyl	  marks	   (preferentially	   lower	  methylation	   status:	  mono	   and	   di)42,43.	   Interestingly	   H4K16	   acetylation	   antagonizes	   with	   H4K20	   methyl	  mark	  indicating	  a	  dynamic	  display	  of	  H4	  peptide	  in	  the	  complex42,43.	  	  
Mle	  The	  third	  enzyme	  associated	  with	  the	  MSL	  complex	  is	  Mle.	  Mle	  bears	  a	  modified	  DEAD	  box	  motif,	  DEIH,	  which	  is	  one	  of	  the	  key	  signatures	  for	  RNA	  helicases10.	  Mutations	  in	  the	  DEAD	  box	  and	  the	  ATP	  binding	  pocket	  are	  lethal	  for	  flies	  44,45.	  Mle	  fulfills	  single	  stranded	  nucleic	  acid	  binding,	  double	  stranded	  nucleic	  acid	  binding,	  ATPase	  activity	  and	  homo-­‐hetero	  duplex	  unwinding	  activities	  in	  vitro	  45.	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Figure	  2.	  MSL	  complex	  and	  known	  interactions.	  	  
(A)	  MSL	  complex	  binds	  specifically	  to	  X	  chromosome	  in	  male	  cells.	  This	  is	  clearly	  seen	  in	   polytene	   squashes	   of	   salivary	   glands	   from	   third	   instar	  male	   larvae.	  DNA	   is	   stained	  with	  Hoechst	  and	  Msl1	  is	  detected	  by	  specific	  antibody.	  (B)	  The	  MSL	  complex.	  Msl1	  and	  Msl2	  interact	  through	  RING	  domain	  of	  Msl2	  and	  N	  terminus	  of	  Msl1.	  Mof	  chromobarrel	  (CHB)	   domain	   interacts	  with	  RNA.	  HAT	   (histone	   acetylase)	   domain	   acetylates	  H4K16	  residue	   (represented	   by	   a	   red	   ball)	   and	   Zinc	   finger	   (ZnF)	   is	   important	   for	   the	   H4	  specificity.	   Msl3	   chromo-­‐related	   domain	   (CRD)	   has	   been	   shown	   to	   bind	   to	   DNA	   and	  nucleosomes	   and	   been	   suggested	   to	   interact	   with	   tri-­‐methylated	   H3	   on	   K36	  (H3K36me3	  represented	  by	  red	  Flag).	  Msl3	  and	  Mof	  bind	  Msl1	   through	  ZnF	  and	  MRG	  domain,	   respectively.	   PEHE	   domain	   of	   Msl1	   was	   shown	   to	   be	   crucial	   for	   Msl3	  interaction.	  Mle	  has	   two	  RNA	  binding	  domains	   (RB1	  and	  RB2)	  but	  only	  RB1	  can	  bind	  RNA.	   Glycine	   rich	   region	   on	   the	   C	   terminus	   has	   a	   high	   affinity	   for	   RNAs.	   	  MLE	   could	  associate	   with	   the	   rest	   of	   the	   complex	   though	   RNA.	   The	   stoichiometry	   of	   the	  components	  and	  the	  mutual	  presence	  of	  roX	  RNAs	  are	  not	  known.	  The	  complex	   is	  not	  drawn	  to	  scale	  due	  to	  absence	  of	  any	  structural	  data	  therefore	  the	  figure	  must	  be	  seen	  as	  an	  artistic	  rendering	  of	  what	  is	  known	  so	  far.	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It	   has	   two	   RNA	   binding	   domains	   in	   the	  N	   terminal	   region	   but	   only	   RB2	   domain	  was	  shown	   to	   bind	   RNA46.	   RNA	   binding	   and	   deletion	   of	   C	   terminal	   glycine	   rich	   region	  increases	  the	  ATPase	  activity46.	  Therefore	  Mle	  may	  undergo	  continuous	  self-­‐regulation	  through	  its	  own	  domains.	  Mle	  X	  chromosome	  localization	  is	  RNAse	  sensitive	  and	  it	  has	  a	  very	  salt	  susceptible,	  weak	   interaction	  with	   the	  rest	  of	   the	  complex,	  suggesting	   that	   it	  may	  bind	  MSL	  proteins	   through	  an	  RNA	   intermediate,	  presumably	   the	   roX	  RNAs	   16,44.	  However	  till	  today,	  direct	  Mle	  interaction	  with	  roX	  RNAs	  have	  not	  been	  shown.	  	  
roX	  RNAs	  RoX	  RNAs	  were	  discovered	  in	  two	  different	  enhancer	  trap	  screens;	  one	  to	  look	  for	  sex	  specific	  expression	   in	  mushroom	  bodies	  of	   fly	  brains	   that	   causes	  dimorphic	   courtship	  behavior47	  and	  the	  other	  to	  look	  for	  differential	  expression	  of	  a	  reporter	  in	  mushroom	  bodies48.	  These	  RNAs	  are	  nuclear,	  male	  specific,	  expressed	  in	  all	  tissues	  of	  flies	  and	  co-­‐localize	  with	  MSL	   proteins	   along	   the	   X	   chromosome	   in	  males47-­‐49.	   Although	   their	   big	  difference	  in	  size	  and	  sequence,	  they	  are	  functionally	  redundant49,50.	  The	  only	  sequence	  similarity	   is	   a	   30	   bp	   sequence	   identity	   however	   deletion	   of	   this	   sequence	   has	   no	  phenotypic	   output51.	   Many	   evidence	   suggest	   that	   roX	   RNAs	   exert	   their	   functions	  through	   a	   yet	   unpredictable	   tertiary	   structure	   or	   at	   least	   not	   in	   a	   strict	   sequence	  dependent	  manner.	  Additional	  to	  the	  inter-­‐redundancy	  of	  roXs,	  there	  is	  also	  high	  intra-­‐redundancy	   in	   each	   roX	   52,53.	   Successive	   ten	   percent	   deletions	   of	   roX1	   and	   series	   of	  small	  deletions	  in	  roX2	  do	  not	  change	  the	  male	  viability	  except	  for	  a	  region	  near	  3’	  end	  of	  roX1	  that	  contains	  a	  predicted	  stem	  loop	  structure52.	  Moreover,	  roX	  RNAs	  from	  other	  
Drosophila	   species	   can	  be	   integrated	   into	  D.melonagester	  MSL	   complex	   in	   spite	  of	   the	  low	   sequence	   homology;	   31%	   in	   the	   example	   of	  D.willistoni	   roX253.	   	   Recent	   findings	  suggest	   that	   there	   are	   evolutionary	   conserved	   “roX	   boxes”	   that	   may	   be	   the	  exchangeable	   functional	   units	   of	   roX	   RNAs	   53.	   Inarguably	   roX	   RNAs	   have	   physical	  contacts	  to	  the	  complex;	  they	  can	  be	  immunoprecipitated	  with	  MSL	  proteins	  and	  female	  expression	   of	  Msl2	   causes	   stabilization	   of	   roX	   RNAs	   26,31,47,54.	   Although,	  Mle,	  Mof	   and	  Msl3	   have	   the	   domains	   to	   bind	   roX	   RNAs,	   direct	   targets	   of	   roXs	   have	   not	   been	  determined	  but	  considering	  their	  size	  (roX1	  3.7	  kb	  and	  roX2	  0.6	  kb),	  it	  is	  plausible	  that	  they	  have	  several	  contact	  points.	  Interestingly,	  there	  is	  a	  time	  frame	  in	  the	  early	  hours	  of	  embryogenesis,	  where	  roX1	   is	   transcribed	   in	   the	  absence	  of	  any	  detectable	   level	  of	  MSL	  components,	  but	  the	  rapid	  turnover	  of	  roX	  RNAs	  in	  the	  absence	  of	  the	  MSL	  complex	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led	   to	   the	  question	  how	   this	   stability	   is	   achieved.	   It	  was	   found	   that	   in	   the	   absence	  of	  maternal	   Mle,	   roX1	   RNA	   is	   hardly	   detectable,	   therefore	   maternal	   stores	   of	   Mle	   can	  contribute	  to	  early	  stabilization	  of	  roX1	  55.	  
EARLY	  EVENTS	  of	  MSL	  ASSEMBLY	  
What	  do	  females	  do?	  The	  MSL	  complex	  formation	  is	  strictly	  inhibited	  in	  female	  cells,	  which	  is	  achieved	  by	  the	  master	   sex	   regulator,	   Sxl	   protein.	   Sxl	   is	   expressed	   only	   in	   females.	   In	  males,	   Sxl	   pre-­‐mRNA	   is	   spliced	   in	   a	  way	   that	   a	   premature	   stop	   codon	   is	   retained	   and	   the	  mRNA	   is	  degraded56.	  Many	  observations	   clearly	   showed	  msl2	  mRNA	  as	   the	  direct	   target	  of	   Sxl.	  
Msl2	   mRNA	   has	   poly	   U	   stretches,	   binding	   sequences	   of	   Sxl,	   in	   both	   of	   its	   UTRs.	   In	  females	   these	   binding	   sites	   are	   retained	   however	   in	  males	   a	   133	   bp	   intron	   in	   5’UTR,	  containing	   two	   of	   are	   spliced	   out57.	   Additionally	   transgenic	   constructs	   lacking	   poly	  U	  stretches	  enabled	  expression	  of	  Msl2	  protein	  in	  females6.	  Sxl	  modulates	  female	  specific	  intron	  retention	  by	   interfering	  with	  U2AF65	  and	  U2AF35	  snRNP	   interaction	  on	   the	  3’	  splice	  site	  58	  and	  U1	  recognition	  of	  the	  5’	  splice	  site	  59.	  Msl2	  mRNA	  translation	  inhibition	  occurs	  a	  by	  a	  dual	  mechanism,	  one	  conducted	  through	  3’UTR	  binding	  and	  inhibition	  of	  43S	  recruitment	  and	  the	  second	  one	  through	  5’	  UTR	  binding	  and	  prevention	  of	  43S	  pre-­‐initiation	   complex	   scanning	   12,60-­‐62.	   3’UTR	   control	   of	   Sxl	   requires	   a	   co	   repressor,	   Unr,	  which	  is	  present	  in	  both	  male	  and	  female	  cytoplasm	  but	  is	  specifically	  recruited	  to	  the	  
msl2	   mRNA	   3’UTR	   by	   Sxl	   in	   females60,63,64.	   Interestingly,	   Unr	   was	   found	   to	   have	   an	  important	   role	   in	   male	   dosage	   compensation65.	   Overexpression	   of	   Unr	   causes	   a	  preferential	  male	   lethality	  and	   loss	  of	   the	  MSL	  complex	   from	  X	  chromosome.	  Unr	  also	  immnoprecipitates	  roX1	  and	  roX2	  however	  if	  this	  is	  a	  direct	  or	  indirect	  interaction	  has	  not	  been	  shown	  65.	  	  	  	  	  
Somatic	  versus	  germ	  line	  Most	  of	  the	  available	  data	  on	  dosage	  compensation	  comes	  from	  observations	  of	  somatic	  cells,	   therefore	   much	   less	   is	   known	   how	   the	   male	   germ	   line	   deals	   with	   the	   dose	  problem.	  Mle	  had	  been	  known	  to	  function	  in	  spermatogenesis	  and	  consistently	  can	  be	  detected	  in	  male	  germ	  line	  cells66.	  Interestingly	  Msl1,	  Msl2	  and	  Msl3	  are	  not	  observed	  in	  these	  cells	  and	  Mle,	  along	  with	  H4K16	  acetylation,	  is	  not	  concentrated	  on	  X	  but	  rather	  scattered	   throughout	   the	   genome66,67.	   Nevertheless,	   expression	   microarray	   analysis	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showed	  that	  male	  germ	  line	  do	  compensate	  for	  the	  imbalance	  despite	  the	  absence	  of	  the	  MSL	   complex	   although	   the	   number	   of	   escaping	   genes	   are	   higher	   than	   those	   on	   the	  somatic	  cells68.	  The	  possibility	  of	  an	  MSL	  independent	  dosage	  compensation	  mechanism	  was	  pointed	  out	  before	  because	  msl	  mutant	  males	  can	  complete	  embryogenesis,	  survive	  up	  to	  third	  instar	  larvae	  -­‐	  early	  pupae	  and	  additionally	  some	  genes	  are	  compensated	  in	  the	   absence	   of	   MSL,	   like	   runt69.	   This	   mechanism	   could	   be	   the	   result	   of	   a	   complex	  buffering	   system	   inherent	   in	   genetic	   networks	   or	   another	   uncharacterized	   protein	  complex	  may	  function	  in	  the	  early	  dosage	  compensation70.	  Although	  the	  nature	  and	  the	  timing	   of	   an	   MSL	   independent	   mechanism	   is	   elusive,	   it	   appears	   that	   MSL	   mediated	  activation	   begins	   at	   blastoderm,	   coinciding	   with	   zygotic	   transcription	   start	   in	  embryos55,71,72.	  In	  males	  with	  homozygous	  msl1,	  mle	  or	  msl3	  mutant	  mothers,	  the	  onset	  of	   MSL	   detection	   on	   X	   chromosome	   is	   delayed;	   supporting	   the	   idea	   that	   maternal	  contribution	  may	  help	  balancing	  the	   low	  level	  of	  zygotic	  expression	  in	   initial	  stages	  of	  the	   MSL	   complex	   establishment67,71.	   Initiation	   of	   dosage	   compensation	   relies	   on	   the	  expression	  of	  one	  of	  the	  roX	  RNAs55.	  In	  males,	  roX1	  RNA	  transcription	  starts	  in	  the	  early	  stages	  of	  blastoderm	   	   (2	  hours	  After	  Egg	  Laying,	  AEL)	  and	  Msl2	   localization	   to	  nuclei	  foci	  follows	  after.	  When	  roX1	  is	  absent,	  Msl2	  localization	  to	  the	  nuclear	  foci	  can	  only	  be	  seen	   after	   roX2	   expression,	   which	   is	   nearly	   6	   hours	   AEL.	   This	  may	   indicate	   that	   roX	  transcription	  may	  guide	  the	  MSL	  complex	  to	  the	  X	  chromosome.	  	  
TARGETING	  THE	  MALE	  X	  CHROMOSOME	  
Single	  gene	  versus	  high	  throughput	  analyses	  The	   advances	   of	   new	   technologies	   such	   as	   expression-­‐arrays,	   high	   resolution	   tiling	  arrays	  and	  new	  generation	  sequencing	  technologies	  coupled	  with	  biochemical	  methods	  gave	   a	   totally	   new	   pace	   in	   understanding	   the	  mechanism	   of	   dosage	   compensation	   in	  
Drosophila.	   MSL-­‐chromatin	   interactions	   had	   often	   been	   carried	   out	   in	   polytene	  squashes	  of	  salivary	  glands	  by	  immunofluoresence	  but	  the	  resolution	  of	  this	  technique	  is	   very	   low,	   therefore	  one	  big	   leap	   in	   the	   field	  occurred	  when	  MSL	   components	  were	  mapped	   in	   high	   resolution	   throughout	   the	   Drosophila	   genome	   by	   ChIP	   on	   chip	  method73-­‐78.	  Although	  the	  immunoprecipitated	  proteins,	  cell	  type	  and	  embryonic	  stage	  are	  different	  in	  each	  case,	  common	  themes	  arose.	  First,	  not	  all	  genes	  on	  X	  are	  bound	  by	  MSL	  complex	  and	  also	  there	  are	  a	  few	  autosomal	  sites	  that	  are	  clearly	  bound.	  The	  MSL	  complex	   members	   are	   mostly	   found	   on	   genes	   rather	   than	   intergenic	   sequences	   and	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when	  the	  binding	  profiles	  are	  averaged,	  a	  clear	  enrichment	  in	  the	  body	  and	  towards	  the	  end	   of	   the	   genes	   are	   observed	   74,76	   (Figure	   3).	  Most	   target	   genes	   seem	   to	   be	   actively	  expressed	   however	   there	   is	   no	   correlation	   between	   the	   expression	   level	   and	   MSL	  abundance	  75,76.	  Although	  most	  MSL	  target	  genes	  are	  actively	  transcribed,	  transcription	  
per	  se	   is	  not	   sufficient	   to	  explain	  MSL	  binding	  because	  many	  genes	   that	  are	  bound	  by	  elongating	   form	   of	   RNAPII	   and	   canonical	   elongation	   factors	   are	   devoid	   of	   the	   MSL	  complex	   74,75.	  Also,	  Msl1	  binding	  profiles	   of	   4-­‐6	  hour	   embryos	   and	   third	   instar	   larvae	  salivary	  gland	  are	  fairly	  similar75,	  supporting	  the	  notion	  that	  most	  compensated	  genes	  are	   selected	   early	   during	   development	   and	   bind	   irrespective	   of	   developmental	  changes79.	  	  
	  
Figure	   3.	   Global	   profiles	   of	   MSL	   components	   and	   associated	   histone	   marks	  
averaged	   on	   a	   single	   transcriptional	   unit.	   In	   male	   cells,	   MSL	   components	   are	  enriched	  in	  the	  body	  of	  the	  genes	  peaking	  at	  the	  end	  along	  with	  the	  H3K36me3	  mark.	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Mof	  shows	  a	  bimodal	  distribution	  peaking	  at	  promoters	  and	  at	  the	  3’end	  of	  the	  genes.	  Mof	  peak	  at	   the	  promoters	  are	   independent	  of	  MSL	  complex	  and	  also	   found	   in	   female	  cells	  and	  autosomal	  genes	  in	  males.	  H4K16	  acetylation	  is	  on	  the	  whole	  body	  of	  the	  gene	  in	   Mof	   bound	   genes.	   Red	   balls	   indicate	   histone	   acetylation	   and	   transcriptional	   unit	  nucleosomes	  are	  depicted	  in	  blue.	  	  
	  Realization	  of	  3’	  enrichment	  of	   the	  MSL	  complex	  members	  stimulated	   investigation	  of	  associations	   to	  other	  well-­‐known	  3’	   enriched	  epigenetic	  marks.	  Genome-­‐wide	  histone	  modifications	   from	   yeast	   and	   humans	   showed	   that	   Set2	   dependent	   H3K36me3	   is	   a	  conserved	   3’	   bias	   epigenetic	   mark	   associated	   with	   active	   genes80,81.	   Mapping	   of	  H3K36me3	   on	   X	   chromosome	   revealed	   that	   more	   than	   90%	   of	   MSL	   targets	   are	   also	  enriched	  with	  this	  mark	  and	  there	  is	  a	  high	  correlation	  of	  MSL	  and	  H3K36me3	  position	  on	  the	  gene35,82.	  Interestingly,	  there	  seems	  to	  be	  a	  context	  dependent	  crosstalk	  between	  H3K36me3	   and	   H4K16ac	   because	   reduction	   of	   Hypb,	   the	   enzyme	   required	   for	   final	  methylation	   state	   of	   H3K36	   in	   Drosophila,	   causes	   a	   reduction	   of	   H4K16	   acetylation	  mark	  on	  X-­‐linked	  genes	  but	  not	  on	  autosomes82.	  Although	  H3K36me3	  enrichment	  near	  the	  end	  of	  the	  genes	  and	  its	  interaction	  with	  Msl3	  chromodomain	  is	  the	  current	  dogma,	  recently	   found	   H4K20me	   interaction	  with	  Msl3	   chromodomain	  may	   yet	   reveal	   other	  epigenetic	  marks	  for	  the	  3’	  enrichment	  of	  MSL	  complex.	  Mof	   seems	   to	   have	   a	   unique	   status	   in	   the	   complex.	   Promoter	   binding	   of	   Mof	   is	  distributed	   throughout	   the	   whole	   genome	   in	   both	   males	   and	   females	   in	   an	   MSL	  independent	  manner	  whereas	  3’	  enrichment	  is	  restricted	  to	  the	  X	  chromosome	  in	  males	  and	  is	  MSL	  dependent	  73.	  This	  led	  to	  the	  hypothesis	  that	  Mof	  plays	  an	  important	  role	  on	  the	  promoters	  of	  both	  sexes,	  and	  the	  MSL	  complex	  members	  binds	  this	  HAT	  to	  skew	  its	  location	  towards	  the	  end	  of	  the	  genes	  for	  specific	  acetylation	  and	  up-­‐regulation	  of	  male	  X	   chromosome73.	   Morever,	   purifications	   of	   Mof	   led	   to	   the	   discovery	   of	   a	   novel	  transcriptional	  regulator	  complex,	  called	  NSL	  complex,	  which	   is	  partly	  responsible	   for	  the	  promoter	  targeting	  of	  Mof	  83,84.	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High	  affinity	  sites	  One	   of	   the	  most	   obvious	   questions	   of	   dosage	   compensation	   is	   how	   the	  MSL	   complex	  recognizes	  the	  X	  chromosome	  specifically.	  An	  intriguing	  feature	  of	  the	  MSL	  complex	  is	  that	  Msl1	  and	  Msl2	  are	  able	  to	  bind	  30-­‐40	  bands	  in	  polytene	  squashes	  in	  the	  absence	  of	  Msl3,	  Mof	  or	  Mle,	  which	  have	  been	  named	  as	  Chromatin	  Entry	  Sites	  (CES)85,86.	  Msl1	  and	  Msl2	   behave	   as	   the	   core	   of	   the	   complex	   because	   they	   are	   strictly	   dependent	   on	   each	  other	   for	   stability	   and	   they	   can	   localize	   to	   X	   without	   the	   other	   partners6,7,86	   .	  Surprisingly,	  roX1	  and	  roX2	  sites	  were	  the	  first	  CES	  to	  be	  mapped,	  due	  to	  their	  ability	  to	  recruit	  MSL	  components	  upon	  translocation	  to	  an	  autosomal	  site54,87.	  This	  feature	  of	  roX	  genes	  does	  not	  depend	  on	  their	  transcription	  but	  on	  a	  DNAse	  hypersensitive	  site	  (DHS)	  that	  can	  bind	  the	  MSL	  complex51,88.	   Initially,	  CES	  were	  thought	  to	  be	  the	  only	  sites	   for	  early	  MSL	  binding	  however,	  investigation	  of	  large	  X	  to	  autosome	  translocations	  showed	  that	  any	  segment	  of	  X	  was	  able	  to	  recruit	  MSL	  complexes	  even	  if	  they	  do	  not	  possess	  a	  previously	  mapped	  CES89,90.	  Moreover,	  translocated	  genomic	  segments	  from	  autosomes	  to	  X	  were	  devoid	  of	  MSL	  complexes90.	  Identification	  of	  other	  Msl1	  binding	  fragments	  by	  ChIP	   showed	   that	   only	   a	   subset	   of	   these	   fragments	   are	   able	   to	   recruit	   Msl1/2	  when	  moved	   to	   autosomes,	   and	   the	   rest	   can	   do	   so	   only	   in	   the	   presence	   of	   over	   expressed	  Msl1/2	  91.	  Therefore,	  X	  chromosome	  seems	  to	  have	  a	  gradient	  of	  potential	  to	  recruit	  the	  MSL	  complex,	  named	  as	  the	  “affinity	  model”89.	  Some	  sequences	  can	  recruit	  MSL	  complex	  independent	  of	  any	  apparent	  targeting	  determinant,	  called	  High	  Affinity	  Sites	  (HAS)	  and	  other	   sequences,	   Low	   Affinity	   Sites	   (LAS),	   can	   only	   do	   so	   by	   the	   help	   of	   other	  mechanisms.	  The	  cipher	  of	  high	  affinity	  sites	  had	  remained	  a	  mystery	  due	  to	  absence	  of	  advance	   sequence	   algorithms	   and	   low	   number	   of	  mapped	   sites.	   But	   high	   throughput	  experiments	   discovered	   important	   clues	   about	   this	   phenomenon.	   High-­‐resolution	  binding	   profiles	   of	  Msl1	   and	  Msl2	   in	   the	   absence	   of	   other	  MSL	   components	   revealed	  more	  than	  130	  Chromatin	  Entry	  sites	  (CES)	  or	  High	  Affinity	  sites	  (HAS)	  and	  a	  GA	  rich	  motif	   named	  as	  MRE	  motif	   (MSL	  Recognition)	   in	   these	   sites77,78.	   This	  motif	   is	   slightly	  enriched	  on	  X	  chromosome	  and	  autosomal	   transposition	  of	  a	  minimal	  CES,	  containing	  as	   few	  as	   three	  MRE	  elements	  was	  able	   to	  recruit	  MSL,	  and	  up-­‐regulate	   the	  upstream	  reporter	   gene	   77.	   Since	   there	   are	   thousands	   of	   similar	   motifs	   scattered	   around	   the	  
Drosophila	   genome,	   the	   choice	   of	   X	   chromosome	   still	   remains	   an	   unsolved	   issue.	  However,	   H3	   depletion	   around	   the	   CES	   site	   indicates	   that	   accessibility	   could	   be	   an	  important	  player77,78.	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The	   importance	  of	  roX	  RNAs	   for	   the	   initial	   targeting	  have	  been	  shown	  in	  a	  number	  of	  cases92.	  MSL	  protein	  complex	  per	  se	  have	  a	  weak	  affinity	  towards	  the	  chromatin	  but	  this	  is	   greatly	   enhanced	   with	   the	   presence	   and/or	   integration	   of	   roX	   RNAs50,93,94.	   In	   the	  absence	  of	  both	  roX	  RNAs,	  partial	  MSL	  complex	  can	  be	  located	  on	  a	  few	  X	  chromosome	  loci,	   autosomal	   loci	   and	   chromocenter50,93-­‐95.	   These	   sites	   have	   the	   intact	   complexes	  because	   all	  MSL	  proteins	   and	  H4K16	   acetylation	   are	   seen	   coincidently50,94.	  Moreover,	  overexpression	   of	   Msl1	   and	   Msl2	   can	   rescue	   male	   lethality	   to	   some	   extent94.	  Nevertheless,	  there	  are	  opposing	  reports	  claiming	  that	  even	  though	  roX	  mutants	  are	  so	  severe	  that	  allows	  no	  detection	  by	  any	  means,	  they	  may	  still	  contribute	  to	  targeting	  and	  dosage	   compensation96,97.	  Therefore	   the	   role	  of	   roX	  RNAs	   in	   targeting	   is	   still	   an	  open	  issue.	  	  Are	   the	   presences	   of	   entry	   sites	   on	   roX	   genes	   a	   coincidence?	   Compelling	   evidence	  suggest	   that	   the	  complex	   forms	  on	  the	  site	  of	  roX	  transcription	   in	  a	  co-­‐transcriptional	  manner94,98.	   It	   is	  plausible	   that	   roX	  genes	  have	  acquired	  an	  entry	   site	   to	  establish	   the	  complex	  formation	  more	  efficiently	  and	  fast.	  On	  the	  other	  hand,	  roX1	  DHS	  was	  shown	  to	  play	   a	   role	   in	   roX1	   transcription	   activation	   in	   males	   and	   Msl2	   was	   shown	   to	   be	  important	   for	   this	   role	   as	   an	   independent	   task	   from	   the	  MSL	   complex99,100.	   Similarly	  
roX2	  gene	  was	  found	  to	  have	  elements	  that	  bind	  Mle	  and	  regulates	  its	  transcription101.	  Therefore,	  a	  complex	  regulatory	  network	  that	  contains	  components	  of	  the	  MSL	  complex	  may	  fine	  tune	  roX	  transcription	  and	  eventually	  formation	  of	  the	  MSL	  complex.	  	  
Beyond	  the	  high	  affinity	  sites	  	  How	   is	   the	   complex	   located	   further	   from	   the	   high	   affinity	   sites?	   An	   intriguing	  observation	   upon	   roX	   gene	   translocation	   to	   autosomes	   was	   the	   spreading	   of	   the	  complex	   from	   the	   site	   of	   insertion	   in	   cis54,87.	   This	   spreading	   depends	   on	   the	   site	   of	  insertion,	  amount	  of	  the	  MSL	  complex,	  and	  presence	  of	  the	  competing	  roX	  transgene95.	  Because	  other	   large	  X	  to	  autosome	  translocations	  did	  not	  show	  any	  cis	  spreading,	  roX	  situation	  was	  pointed	  to	  be	  a	  unique	   feature	  of	  roX	  genes	  due	  to	   their	   function	  as	   the	  site	  of	   complex	   formation89.	  Mof	   enzymatic	   activity	   is	   required	   for	   localization	   to	   low	  affinity	  sites	  but	  it	  is	  not	  known	  if	  this	  is	  due	  to	  its	  canonical	  histone	  acetylation	  activity	  or	  another	  protein	  acetylation	  event	  that	  may	  help	  maturation	  of	  the	  MSL	  complex27,102.	  Mle	  helicase	  activity	   is	  also	   found	  to	  be	   important	   for	  LAS	   localization103.	  Since	  Mle	   is	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required	  for	  the	  roX	  association	  into	  the	  complex54,	  the	  phenotype	  can	  be	  a	  downstream	  result	  of	  an	  incomplete	  complex	  that	  is	  not	  able	  to	  spread	  further.	  	  Enrichment	   of	   H3K36	   methylation	   on	   actively	   transcribed	   genes	   prompted	  investigation	   of	   Msl3	   as	   it	   contains	   a	   chromo-­‐related	   domain	   that	   could	   be	   a	   good	  candidate	   that	   can	   bind	   to	   this	   mark.	   By	   ChIP-­‐chip	   analysis,	   it	   was	   seen	   that	   Msl3	  chromodomain	  mutants,	   including	  the	  deletion	  mutant	  were	  enriched	  around	  the	  high	  affinity	   sites	   suggesting	   the	   requirement	   of	   intact	   chromodomain	   for	   spreading34.	   In	  view	   of	   these	   results,	   Sural	   et	   al,	   proposes	   a	   two-­‐step	   model,	   in	   which	   sequence	  dependent	   initial	   targeting	   to	   X	   chromosome	   is	   established	   on	   MRE	   containing	  chromatin	   entry	   sites	   and	   is	   followed	   by	   H3K36me3/chromodomain	   mediated	  spreading,	   analogous	   to	   heterochromatin	   spreading.	   Surprisingly,	   transgenic	   flies	  carrying	   the	   chromodomain	   mutants	   have	   a	   range	   of	   phenotypes	   ranging	   from	   fully	  viable,	   developmental	   delay	   and	   severe	   affect	   on	  male34,36.	   This	   already	   suggests	   that	  chromodomain	   mediated	   spreading	   from	   high	   affinity	   sites	   cannot	   be	   the	   sole	  mechanism	   for	   the	  MSL	  binding	  pattern	   throughout	   the	  X	  chromosome.	  Transcription	  was	   noticed	   as	   a	   good	   candidate	   inferred	   from	   the	   high	   correlation	   between	   active	  transcriptional	   state	   and	   MSL	   binding.	   Indeed	   when	  mof	   gene,	   a	   low	   affinity	   site,	   is	  translocated	   to	   an	   autosomal	   site,	   it	   can	   recruit	   Msl1	   only	   in	   the	   presence	   of	  endogenous	   or	   exogenous	   promoter104.When	   the	   promoter	   is	   absent,	   blocked	   or	  reversed,	   Msl1	   cannot	   bind.	   Effect	   of	   transcription	   extends	   beyond	   the	   mof	   gene	  because	  blocking	  of	  RNA	  polymerase	  II	  by	  alpha	  amanitin	  decreases	  the	  occupancy	  MSL	  components	  on	  X-­‐linked	  genes104.	  Binding	  of	  Msl1	  after	  a	  strong	  activation	  of	  X	   linked	  genes	   by	   a	   Gal4	   induced	   promoter	   had	   also	   been	   observed	   before105.	   The	   passage	   of	  RNA	  Polymerase	  II	  may	  either	  expose	  targeting	  sequences	  that	  are	  normally	  hidden	  or	  it	  can	  change	  the	  chromatin	  marks	  such	  that	   the	  gene	  becomes	  a	  better	   target	   for	   the	  MSL	  complex.	  All	  these	  models	  are	  not	  mutually	  exclusive	  and	  genes	  may	  have	  evolved	  different	   strategies	   to	   recruit	   MSL	   depending	   on	   their	   need	   to	   compensate,	   their	  inherent	  affinity	  towards	  MSL	  or	  their	  plasticity	  during	  the	  development.	  One	  attractive	  possibility	  could	  be	  that	  transcription	  in	  combination	  with	  MSL	  proteins	  that	  recognize	  chromatin	  marks	  on	  active	  genes	  could	  facilitate	  spreading	  along	  the	  X	  chromosome.	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EVOLUTIONARY	  CONSIDERATIONS	  	  Dosage	   compensation	   arises	   as	   an	   inevitable	   consequence	   of	   sex	   chromosome	  evolution.	   In	   Drosophila	   species,	   the	   dose	   problem	   begins	   with	   the	   evolution	   of	   Y	  chromosome106.	   Although	   the	   exact	   nature	   of	   Y	   chromosome	   formation	   is	   under	  debate106,	   the	   current	   model	   predicts	   the	   random	   acquisition	   of	   a	   male	   determining	  gene	  on	  an	  autosome	  and	  prevention	  of	  recombination	  of	  that	  locus107.	  This	  leads	  to	  a	  strong	   tendency	   to	   accumulate	   degenerative	  mutations	   like	   transposition,	   duplication	  and	   finally	   the	   heterochromatinization	   of	   the	   whole	   chromosome	   107.	   	   Therefore	   the	  male	  cell	  nucleus	  is	  forced	  to	  balance	  this	  hemizygocity	  by	  formation	  of	  a	  novel	  complex	  acting	  on	  the	  X	  chromosome.	  There	  are	  plethora	  of	  evidence	  that	  once	  the	  MSL	  complex	  evolved,	   it	   was	   co-­‐opted	   in	   other	   Drosophila	   species,	   which	   have	   a	   different	   sex	  chromosome	   history	   108.	   In	   D.	   pseudoobscura,	   a	   fusion	   event	   between	   an	   autosomal	  chromosome	  (Muller	  D	  element)	  and	  original	  X	  chromosome	  (Muller	  A	  element)	  led	  to	  formation	   of	   a	  metacentric	   X	   chromosome	   and	   the	   similarization	   of	   the	   both	   arms	   in	  terms	  of	  sequence	  identity109.	  Interestingly,	  the	  autosomal	  homolog	  of	  D	  element	  is	  lost	  in	  males	   and	   the	   newly	   translocated	   hemizygous	   arm	   is	   bound	   by	  MSL	   complex	   and	  acetylated	  on	  H4K16	   110.	  On	   the	   contrary,	   in	  D.	  americana	  americana,	   a	   similar	   fusion	  event	  occurred	  but	   the	  males	  kept	   the	  autosomal	  homologue	  (Neo-­‐Y)	  chromosome111.	  	  Since	  the	  two	  homologues	  can	  still	  recombine,	   there	   is	  no	  sign	  of	  degeneration	  on	  the	  neo-­‐Y	  and	  no	  MSL	  binding	  on	  the	  X	  chromosome	  110.	  	  	  Perhaps	   the	   best	   tool	   to	   study	   the	   evolution	   of	   sex	   chromosomes	   and	   dosage	  compensation	  is	  the	  neo-­‐sex	  chromosomes	  of	  D.miranda.	  D.miranda	  is	  closely	  related	  to	  
D.	  Pseudoobscura	  and	  has	   the	   same	  metacentric	  X	   chromosome,	  which	   is	   fully	  dosage	  compensated.	  But	   in	   addition,	   a	  Robertsonian	   translocation	  of	   an	  autosome	   (Muller	  C	  element)	  to	  the	  Y	  chromosome	  generated	  a	  neo-­‐Y	  chromosome	  112.	  The	  fusion	  event	  is	  thought	  to	  occur	  about	  2	  million	  years	  ago	  and the homologue pair is kept in the male cells 
(neo-X chromosome)	   113. After the fusion event, neo-Y chromosome had undergone 
extensive random degeneration, including retrotransposition, duplication and nonsense 
mutations but most loci are still intact 114. Amazingly, the neo-X chromosome recruits MSL 
complex and acetylates H4K16 to the loci that are degenerating in the neo-Y homologue 108,110 (Figure 4).  
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Figure	  4.	  Dosage	  compensation	  in	  Drosophila	  miranda.	  	  	  In	  male	   cells	   the	   proto	   X	   chromosome,	   (which	   is	   indicated	   by	  Muller	   A+Muller	   D)	   is	  compensated	  normally	  as	  in	  D.melanogaster.	  A	  translocation	  event	  of	  an	  autosomal	  arm	  onto	  the	  proto-­‐Y	  chromosome	  created	  a	  neo-­‐Y	  chromosome,	  which	  is	  in	  the	  process	  of	  degeneration.	  The	  degenerated	   loci	  are	   indicated	  as	   light	  colored	  bars.	  The	  autosomal	  homolog	  of	  neo-­‐Y,	  also	  called	  neo-­‐X	  or	  X2,	  shows	  upregulation	  at	  the	  loci	  in	  which	  there	  is	  degeneration	  on	  neo-­‐Y.	  The	  upregulated	   loci	  are	   indicated	   in	  orange	  color	  and	  they	  correspond	  to	  similar	  loci	  as	  in	  the	  neo-­‐Y.	  A	  hypothetical	  magnifier	  to	  one	  of	  these	  loci	  is	  shown.	   The	   degenerated	   loci	   on	   the	   neo-­‐Y	   go	   under	   heterochromatinization	   due	   to	  retrotransposition	  and/or	  other	  means	  of	  molecular	  events	  leading	  to	  hemizygosity.	  In	  the	   homologous	   region	   on	   neo-­‐X	   chromosome,	   the	  MSL	   complexes	   are	   recruited	   and	  upregulate	  the	  genes	  for	  dosage	  compensation.	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Interestingly,	  the	  core	  promoters of	  the	  lcp1-­‐4	  genes	  that	  are	  upregulated	  in	  the	  neo-­‐X	  in	  response	  to	  degeneration	  in	  neo-­‐Y	  show	  no	  apparent	  significant	  sequence	  alteration	  that	  could	  lead	  to	  two-­‐fold	  upregulation	  115.	  Moreover,	  significant	  sequence	  variation	  of	  the	  neo-­‐X	  chromosome	  from	  the	  old	  X	  shows	  that	  multiple	  selective	  sweeps	  of	  cis-­‐acting	  regulatory	  regions	  did	  not	  occur	  116.	  These	  results	  show	  that	  MSL	  complex	  recruitment	  does	  not	  require	  a	  strict	  gene-­‐by-­‐gene	  basis	  cis-­‐acting	  sequence	  evolution.	  	  Since	  dosage	  compensation	  in	  Drosophila	  is	  an	  old	  problem	  and	  various	  subgroups	  use	  the	   same	   complex	   to	   cover	   up	   hemizygousity,	   MSL	   components	   are	   expected	   to	   be	  under	   stabilizing	   (purifying)	   selection.	   But	   recent	   experiments	   show	   that	   even	   two	  closely	   related	  Drosophila	   species,	  D.	  melanogaster	   and	  D.	   simulans	   that	   diverged	   2.5	  million	  years	  ago	  have	  highly	  asymmetric	  rapid	  evolution	  of	  MSL	  genes	  117.	  For	  instance	  the	  Mof	  acetylation	  site	  on	  Msl3	   in	  D.melanogaster	   is	  unique	   in	  the	  Drosophila	   species	  118.	  It	  is	  possible	  that	  there	  are	  other	  selective	  forces	  that	  are	  acting	  on	  the	  MSL	  complex	  of	  D.melanogaster	   like	   the	  male	   killing	   bacteria	   S.poulsonii	   119.	  MSL	   proteins	   could	   be	  evolving	   away	   from	   recognition	   by	   these	   bacteria.	   Nevertheless	   since	   the	   protein	  complexes	  tend	  to	  co-­‐evolve;	  the	  whole	  complex	  could	  be	  trying	  to	  fine	  tune	  to	  escape	  from	  selection	  while	  also	  trying	  to	  keep	  its	  essential	   function.	  Curiously,	  Mof	  has	  been	  shown	   to	   bind	   LTR	   retrotransposons	   in	   D.melanogaster	   and	   inhibit	   their	  transposition120.	   Inhibition	  of	   retrotransposition	  could	  also	  be	  a	  strong	  selective	   force	  on	  this	  subgroup.	  These	  recent	  findings	  can	  provide	  an	  explanation	  why	  it	  is	  difficult	  to	  find	  a	  consensus	  sequence	  for	  the	  MSL	  binding	  among	  other	  species.	  
MSL-­‐LIKE	  PROTEINS	  IN	  OTHER	  ORGANISMS	  The	  protein	  components	  of	  the	  MSL	  complex	  of	  D.	  melanogaster	  have	  clear	  homologues	  from	  yeast	  to	  mammals,	  except	  that	  Msl1	  and	  Msl2	  are	  not	  found	  in	  yeast17.	  Yeast	  NuA4	  HAT	   complex	   contains	   Esa1	   and	   Eaf3,	   homologues	   of	   Mof	   and	   Msl3	   respectively121.	  However,	  stringent	  sequence	  analysis	  showed	  that	  yeast	  NuA4	  complex	  is	  not	  the	  direct	  ancestor	   of	   compensasome	   in	   Drosophila,	   rather	   a	   novel	   complex	   arose	   with	   the	  concomitant	   evolution	   of	   Msl1	   and	   Msl217.	   Although	   humans	   have	   entirely	   different	  strategy	  for	  the	  dosage	  compensation	  problem,	  the	  MSL	  complex	  is	  kept	  in	  mammals	  as	  well83,122,123.	  However	  it	  seems	  that	  human	  MSL	  complex	  has	  evolved	  other	  functions	  in	  DNA	  damage	  response	  pathway	  and	   inhibition	  of	   tumor	  genesis122,123.	  Recently	   it	  was	  shown	   that	   human	   MSL2	   is	   responsible	   for	   the	   mono-­‐ubiquitination	   of	   p53	   and	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subsequent	  extra	  nuclear	  localization124.	  Even	  though	  mammals	  shows	  X-­‐inactivation	  in	  female	   nucleus,	   the	   active	   homologue	   of	   X	   is	   two-­‐fold	   up	   regulated	   to	   reach	   the	  stoichiometry	  of	  autosomal	  gene	  expression	  level3,4,125,126.	  The	  role	  of	  the	  MSL	  complex	  in	  this	  upregulation	  is	  a	  tempting	  hypothesis.	  	  
HOW	  GENERAL	  FACTORS	  MAY	  IMPINGE	  ON	  THE	  MECHANISM	  	  One	   of	   the	   first	   issues	   addressed	   by	   high	   throughput	   experiments	   was	   the	   global	  regulation	  of	  expression	  on	  X	  by	  the	  MSL	  complex.	  A	  significant	  amount	  of	  earlier	  data	  proposed	   an	   alternative	   mechanism	   named	   inverse	   dose	   model	   for	   the	   X	   versus	  autosome	  balance127-­‐129.	  This	  model	  suggests	  that	  X	  chromosome	  inherently	  possesses	  sequences	  that	  recruit	  transcription	  factors	  for	  a	  roughly	  two	  fold	  up-­‐regulation	  and	  the	  MSL	  complex	  functions	  to	  titrate	  Mof	  from	  autosomes	  to	  X	  to	  inhibit	  over-­‐expression	  of	  autosomes	   by	   overriding	   the	   effects	   of	   hyper-­‐upregulation	   of	   X130.	   RNAi	   against	   the	  components	   of	   the	   MSL	   complex	   and	   stringent	   normalization	   analysis	   of	   expression	  arrays	  showed	  that	  the	  MSL	  complex	  was	  indeed	  acting	  to	  up-­‐regulate	  X-­‐linked	  genes	  to	  the	  autosomal	  levels	  arguing	  against	  the	  inverse	  dosage	  model131,132.	  Moreover	  artificial	  recruitment	  of	  the	  MSL	  complex	  upstream	  of	  a	  reporter	  gene	  can	  cause	  its	  up	  regulation	  and	  roX	  autosomal	  transgenes	  can	  overcome	  silent	  heterochromatin133,134.	  	  Specific	  enrichment	  of	  X	   chromosome	  by	  H4K16	  acetylation	   led	   to	   the	  belief	   that	   this	  canonical	  activation	  mark	  could	  be	  largely	  responsible	  for	  the	  up	  regulation.	  Indeed	  Mof	  can	   activate	   transcription	   in	   vivo	   and	   in	   vitro25.	   	   Moreover	   H4K16	   acetylation	   can	  decondense	  30	  nm	  chromatin	  fiber	  in	  vitro135.	  A	  simple	  prediction	  was	  that	  opening	  the	  chromatin	   might	   enable	   loading	   more	   polymerase	   RNA	   Polymerase	   II	   onto	  compensated	   genes.	   However,	   polymerase	   profiles	   show	   that	   there	   are	   not	   more	  polymerases	  on	   compensated	  genes	   than	  non-­‐compensated	  ones74.	  Recent	   findings	  of	  new	   components	   related	   to	   dosage	   compensation	   tell	   us	   that	   the	   story	  may	   be	  much	  more	  complicated.	  	  Identification	  of	  nuclear	  pore	  components,	  Nup153	  and	  Mtor,	  in	  MSL	  purifications,	  and	  their	   effect	  on	  X	   linked	  gene	  expression	   suggest	   a	   link	  between	  dosage	   compensation	  and	   nuclear	   architecture83.	   Numerous	   findings	   indicate	   that	   position	   of	   a	   gene	   in	   the	  nuclear	  volume	  could	  affect	  its	  transcriptional	  status	  136-­‐138.	  Although	  nuclear	  periphery	  was	  long	  known	  accepted	  as	  a	  repressive	  zone	  and	  a	  host	  for	  heterochromatin,	  nuclear	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pore	   complexes	   (NPC)	   can	   be	   a	   docking	   site	   for	   an	   induced	   gene	   139,140.	   Close	  approximation	   of	   the	   X-­‐linked	   genes	   to	   NPC	   may	   create	   a	   transcription	   competent	  domain/environment	  and	  may	  even	  provide	  up	  regulation	  of	  genes	  that	  are	  not	  bound	  by	  MSL	   but	   still	   dosage	   compensated.	   Interestingly,	   human	   interphase	   chromosomes	  are	   found	   to	   be	   associated	   with	   lamins	   in	   domains	   that	   are	   clearly	   demarcated	   by	  insulators	   showing	   that	   the	   genome	   can	   indeed	   be	   organized	   in	   discrete	   structures	  under	  the	  nuclear	  envelope141.	  	  	  	  Another	  protein	  found	  to	  be	  associated	  with	  MSL	  complex	  is	  the	  Jil-­‐1	  kinase.	  Jil-­‐1	  can	  co-­‐immunoprecipitate	  with	  MSL	   components	   and	   it	   is	   enriched	   on	  male	   X	   chromosome,	  although	  it	  is	  also	  distributed	  on	  other	  chromosomes142.	  Jil-­‐1	  is	  the	  main	  kinase	  that	  is	  responsible	   for	   H3S10	   phosphorylation143.	   Although	   this	   mark	   was	   known	   to	   be	   a	  mitotic	   marker,	   it	   is	   also	   enriched	   in	   euchromatic	   regions	   and	   can	   antagonize	  heterochromatin	  spreading143,144.	  Recently	  Jil-­‐1	  was	  shown	  to	  be	  an	  important	  activator	  in	  many	  genes	  in	  Drosophila	  and	  can	  relieve	  the	  promoter	  proximal	  pausing	  of	  RNAPII,	  which	   is	   thought	   to	   be	   a	   checkpoint	   after	   the	   initiation	   of	   transcription145,146.	  Conceptually,	   selective	   recruitment	   of	   Jil-­‐1	   kinase	   by	  MSL	   to	   the	   X-­‐linked	   genes	  may	  relieve	   this	   pausing	   more	   than	   autosomes	   and	   female	   X;	   helping	   twice	   as	   much	  transcription	   on	   male	   X.	   	   Albeit	   this	   attractive	   hypothesis,	   an	   opposing	   experiment	  demonstrated	  that	  RNA	  Polymerase	  II	  mediated	  transcription	  is	  independent	  of	  H3S10	  phosphorylation	   and	   Jil-­‐1	   kinase	   affects	   transcription	   through	   maintaining	   the	  structural	  integrity	  of	  the	  chromosomes147.	  	  	  It	   seems	   that	   the	   male	   X	   chromosome	   is	   generally	   more	   sensitive	   to	   perturbations	  related	  to	  proteins	  that	  are	  responsible	  for	  general	  chromatin	  morphology.	  Two	  of	  these	  proteins	   are	  NURF,	   a	   chromatin	   remodeler,	   and	   Su(var)3-­‐7,	   a	   protein	   responsible	   for	  heterochromatin	  formation	  by	  the	  help	  of	  Hp1148,149.	  NURF	  is	  the	  founding	  member	  of	  ISWI	   family	   of	   remodelers	   and	   it	   contains	   ISWI	   protein	   as	   the	   catalytic	   subunit	   that	  enables	   sliding	   of	   nucleosomes150.	   Normally	   ISWI	   is	   not	   enriched	   on	   the	   male	   X	  chromosome	  or	   its	  mutations	  do	  not	  cause	  mislocalization	  of	   the	  MSL	  proteins,	  or	  the	  acetylation.	   Nevertheless,	   the	   male	   X	   chromosome	   looks	   much	   decondensed	   and	  broader	   in	   its	  absence	  and	  a	   functional	  MSL	  is	  required	  for	  this	  phenotype149,151.	   ISWI	  protein	   is	   also	   found	   in	   other	   complexes	   however	   this	   effect	   is	   related	   to	   NURF	  remodeler	  because	  aberrant	  phenotype	  of	  male	  X	  is	  repeated	  in	  Nurf301	  mutations,	  the	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main	  scaffold	  in	  NURF	  complex152.	   	  Recently	  it	  was	  found	  that	  roX	  null	  mutation	  could	  suppress	   the	   puffy	   appearance	   coming	   from	   the	  NURF	  mutations.	   Additionally,	  NURF	  can	   repress	   roX2	   transcription	   in	   females153.	   Similar	   to	   ISWI,	   Su(var)3-­‐7	   mutation	  causes	   male	   X	   chromosome	   decondensation,	   which	   can	   be	   suppressed	   by	   null	   mle	  mutation148,154.	   These	   antagonistic	   relations	   suggest	   that	   chromatin	   opening	   is	   not	  unchecked	   but	   actually	   scrutinized	   by	   various	   complexes	   to	   maintain	   a	   sufficiently	  open-­‐	  not	  more	   than	  necessary-­‐	  state	  of	  chromatin.	  Actually,	  an	  analog	  system	  can	  be	  seen	  in	  a	  smaller	  scale	  on	  actively	  transcribing	  genes.	  Active	  genes	  have	  an	  increasing	  H3K36	  di	  and	  trimethylation	  on	  the	  body	  of	  their	  genes	  and	  this	  mark	  is	  recognized	  by	  an	  HDAC	   complex,	   Rpd3S,	  which	   inhibits	   spurious	   transcription	   that	  may	   come	   from	  cryptic	   promoters155.	   Interestingly,	   Rpd3S,	   the	   histone	   deacetylase	   and	   Set2,	   the	  enzyme	   required	   for	   H3K36	   methylation	   play	   a	   role	   in	   dosage	   compensation27,34,82.	  Curiously,	   the	   components	   of	   the	   exosome,	   Dis3	   and	   Rrp6,	   also	   copurify	   with	   MSL	  proteins83	   suggesting	   that	  RNA	  degradation	  may	  be	   also	  be	   coupled	   to	   the	   system.	   In	  this	  sense	  exosome	  may	  degrade,	  antisense	  or	  cryptic	  transcripts	  that	  were	  generated	  uncontrolled	   due	   to	   open	   chromatin	   structure.	   Another	   fail-­‐safe	  mechanism	   could	   be	  mediated	  by	  Supercoiling	   factor	  (Scf),	  of	  which	  genetic	   interaction	  with	  MSL	  has	  been	  shown156.	   Scf	   was	   hypothesized	   to	   help	   decreasing	   the	   helical	   torsion	   that	  may	   have	  generated	  during	  chromatin	  remodeling	  however	  its	  role	  in	  dosage	  compensation	  is	  not	  determined	  yet	  156.	  	  	  	  All	  these	  observations	  suggest	  that	  capabilities	  of	  MSL	  reach	  far	  beyond	  than	  expected	  before.	  Not	  only	  it	  behaves	  as	  a	  HAT	  complex	  but	  also	  acts	  as	  a	  mediator	  that	  fine	  tunes	  two	   fold	   upregulation	   by	   approaching	   to	   nuclear	   pore,	   cross	   talking	   with	   chromatin	  remodelers,	   heterochromatin	   proteins,	   and	   RNA	   degradation	  machines.	   Although	   the	  dazzling	  discoveries	  brought	  by	  powerful	   genetics,	   biochemistry	   and	  high	   throughput	  approaches,	   the	   new	   findings	   bring	   about	   their	   own	   mysteries,	   which	   eventually	  motivated	  us	  to	  find	  the	  results	  presented	  in	  this	  thesis.	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RESULTS	  
Structure	  of	  the	  mammalian	  MSL1-­‐MSL3	  complex	  The	  MSL3	  construct	  we	  used	  corresponds	  to	  the	  hMSL3	  isoform	  c	  (residues	  167-­‐517).	  It	  contains	   the	   predicted	   MRG	   domain	   but	   lacks	   the	   upstream	   chromo-­‐barrel	   domain	  (Figure	  5A).	  Compared	  to	   the	  sequence	  of	   the	  known	  structure	  of	   the	  MRG	  domain	  of	  MRG15	  (PDB	  entry	  2AQL),	  the	  human	  and	  Drosophila	  MSL3	  domains	  contain	  two	  poorly	  conserved	   insertions	  with	   no	   predicted	   secondary	   structure	   elements	   (residues	   223-­‐250	  and	  290-­‐441	  in	  hMSL3).	  In	  order	  to	  obtain	  diffracting	  crystals,	  the	  longer	  insertion	  was	  removed	  and	  replaced	  with	  an	  8-­‐residue	  linker.	  MSL3	  (167-­‐289,442-­‐517)	  was	  co-­‐expressed	  with	   the	   C-­‐terminal	   fragment	   of	   the	  mammalian	  MSL1	   PEHE	   region	   (545-­‐597)	  in	  bacteria	  and	  the	  structure	  of	  the	  complex	  was	  determined	  at	  3Å	  resolution.	  	  The	  MSL3	  MRG	  domain	  structure	  consists	  essentially	  of	  a	  compact	  bundle	  of	  six	  helices	  (Figure	   5B).	   The	   core	  made	   of	   two	  helical	   hairpins	   that	   are	   orthogonal	   to	   each	   other	  (α2/α3	  and	  α5/α6)	  is	  flanked	  by	  the	  N-­‐	  and	  C-­‐terminal	  loops	  and	  helices	  α1	  and	  α4.	  The	  151-­‐residue	   region	   deleted	   from	   the	  MSL3	   construct	   links	   helices	   α4	   and	   α5	   (Figure	  5B).	  	  The	  MSL1	  region	  interacting	  with	  MSL3	  wraps	  around	  its	  MRG	  domain	  as	  an	  extended	  chain	  (Figures	  5B),	  which	  is	  probably	  intrinsically	  unstructured	  in	  the	  absence	  of	  MSL3.	  MSL1	  forms	  numerous	  hydrophobic	  as	  well	  as	  several	  charged	  contacts	  with	  MSL3.	  The	  crucial	  interacting	  residues	  of	  MSL1	  are	  four	  highly	  conserved	  phenylalanines	  (Phe556,	  557,	  577	  and	  589)	  that	  insert	  into	  different	  hydrophobic	  pockets	  on	  MSL3	  (Figure	  6A).	  Essentially	  all	  MSL3	  and	  MSL1	  residues	  involved	  in	  the	  interaction	  are	  well	  conserved	  among	  species	  (Figures	  6A).	  	  
Structure	  of	  the	  mammalian	  MSL1-­‐MOF	  complex	  The	  HAT	  domain	   of	   human	  MOF	   (174-­‐458)	  was	   co-­‐expressed	   in	   bacteria	  with	   the	  N-­‐terminal	   part	   of	   the	   MSL1	   PEHE	   region	   (470-­‐540).	   The	   complex	   was	   co-­‐crystallized	  with	   acetyl-­‐CoA,	   and	   its	   structure	   was	   determined	   by	   X-­‐ray	   crystallography	   at	   2.8	   Å	  resolution	  (Figure	  5C).	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Figure	  5.	  Crystal	  structures	  of	  the	  mammalian	  MSL1-­‐MSL3	  and	  MSL1-­‐MOF	  sub-­‐complexes.	  
(A)	  Schematic	  representation	  of	  the	  domain	  structure	  of	  mouse	  MSL1	  (which	  is	  essentially	  
identical	  to	  hMSL1),	  hMSL3	  and	  hMOF.	  Domain	  colors	  correspond	  to	  the	  ribbon	  diagram	  in	  
B	  and	  C.	  The	   red,	  blue	  and	  green	  bars	   indicate	  MSL1,	  MOF	  and	  MSL3	   interacting	   regions,	  
respectively,	  as	  defined	   in	   this	  work	  and	   in	  Scott	  et	  al.,	  2000.	  CC,	  coiled	  coil;	  CD,	  chromo-­‐
barrel	   domain.	   (B)	   Ribbon	   representation	   of	   the	   complex	   between	  MSL1	   and	  MSL3.	   The	  
MSL3	   MRG	   domain	   (residues	   167-­‐288,	   442-­‐517)	   is	   shown	   in	   green	   and	   its	   secondary	  
structures	  are	   labeled.	  The	  disordered	   regions	   in	  MSL1	  and	  MSL3	  are	   shown	  as	  dots.	   The	  
arrow	  indicates	  the	  place	  where	  residues	  289-­‐441	  were	  deleted	  and	  replaced	  by	  an	  8	  amino	  
acid	   linker.	   	   (C)	   Ribbon	   diagram	   of	   the	  mammalian	  MSL1/MOF/AcCoA	   complex.	   The	   HAT	  
domain	   of	   MOF	   (residues	   174-­‐458)	   is	   shown	   in	   blue.	   The	   MOF	   secondary	   structures	  
interacting	  with	  MSL1	  are	  labeled.	  This	  figure	  is	  provided	  by	  Jan	  Kadlec.	  	  This	   and	   the	   MSL1-­‐MSL3	   structure	   (Figure	   5B)	   clearly	   show	   that	   the	   MOF/MSL3	  interacting	   region	   of	   MSL1	   is	   not	   a	   genuine	   pre-­‐folded	   domain	   and	   thus	   rather	   than	  PEHE	  domain	  we	  will	  refer	  to	  it	  as	  PEHE	  region.	  Next,	  we	  analyzed	   the	   interaction	   interface	  between	   the	  MOF	  HAT	  domain	  and	  MSL1.	  The	   MSL1	   fragment	   forms	   a	   loop	   (residues	   494-­‐501)	   followed	   by	   a	   52Å	   long	   helix	  (residues	  502-­‐533).	  Both	  elements	  interact	  extensively	  with	  the	  N-­‐terminal	  part	  of	  the	  MOF	  HAT	  domain	  with	  numerous,	  mainly	  charged	  contacts	  between	  the	  two	  molecules.	  In	  MSL1	  the	  key	  interacting	  residues	  include	  Glu498,	  Asp502,	  Arg508,	  His509,	  Glu513	  and	  Glu516	  which	  form	  multiple	  hydrogen	  bonds	  and	  salt	  bridge	  interactions	  with	  MOF	  (Figure	   7A).	   Additionally,	   Leu500,	   Phe505	   and	   Leu512	   are	   inserted	   in	   hydrophobic	  pockets	   in	   the	   center	  of	   the	   interface.	  All	   the	  MSL1	   interacting	   residues	  are	  very	  well	  conserved	  among	  species,	  reflecting	  the	  importance	  of	  this	  interaction	  for	  the	  functional	  integrity	  of	  the	  MSL	  complex	  (Figure	  7A).	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Msl3	   can	   be	   removed	   from	   the	   complex	   without	   any	   overall	   effect	   on	   other	  
protein-­‐protein	  interactions	  To	  study	  the	  incorporation	  of	  MOF	  and	  MSL3	  into	  the	  MSL	  complex	  in	  vivo	  we	  designed	  mutations	  in	  the	  full-­‐length	  MSL1	  based	  on	  predictions	  from	  the	  crystal	  structure.	  Since	  MSL	  proteins	  and	   their	  key	   interacting	   residues	  are	  evolutionary	   conserved	  and	   their	  role	  is	  better	  understood	  in	  Drosophila,	  we	  studied	  the	  effect	  of	  these	  mutations	  using	  Drosophila	  Msl1.	   The	  mutations	   are	   indicated	   in	   Figure	   6B.	   Msl1	  mutants	   were	   sub-­‐cloned	   in	   pAc5.1	   vector	   under	   the	   strong	   actin	   promoter	   and	   they	   all	   contain	   a	   C-­‐terminal	   Flag	   epitope	   tag.	   Msl1	   mutants	   were	   expressed	   in	   SL-­‐2	   cells	   by	   transient	  transfection	  and	  the	  corresponding	  MSL	  complexes	  were	  immunopreciptated	  using	  an	  anti-­‐Flag	  resin.	  All	  tested	  Msl1	  mutations	  in	  the	  C-­‐terminal	  part	  of	  the	  PEHE	  region	  were	  unable	   to	   co-­‐purify	   endogenous	  Msl3,	  while	   they	  had	  no	  effect	  on	   the	   remaining	  MSL	  components,	  Mof,	  Msl2	  and	  Mle	  (Figure	  6C).	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Figure	  6.	  Msl1	  mutagenesis	  for	  disruption	  of	  Msl3	  interaction	  
(A)	  Sequence	  alignment	  of	   the	  MSL1	   fragment	   that	   is	   involved	   in	   the	   interaction	  with	  MSL3.	   Identical	   residues	  are	   in	   red	  boxes.	  The	   interacting	  residues	  are	   indicated	  with	  green	  triangles.	  The	  five	  residues	  targeted	  for	  point	  mutations	  are	  shown	  for	  Drosophila	  melanogaster	   species.	   (B)	   Msl1	  wild	   type	  with	   Flag	   epitope	   (mut.1)	   and	   three	   PEHE	  mutants	  predicted	   to	  disrupt	  Msl3	   interactions.	  (C)	  Flag	   immunoprecipitation	  of	  Msl1	  mutants	   in	   SL-­‐2	   cells.	   Wild	   type	   and	   indicated	   Msl1	   mutants	   were	   transiently	  transfected	   in	   SL-­‐2	   cells.	   After	   48	   hours,	   the	   cells	   were	   harvested	   and	  immunoprecipitations	   using	   Flag-­‐Agarose	   resin	   were	   carried	   out	   from	   whole	   cell	  extracts.	  Mock	   lane	  represents	   the	  empty	  vector.	  Asterisk	   in	  MLE	  blot	   is	  an	  unspecific	  cross-­‐reacting	  band.	  The	  slight	  running	  difference	  between	  INPUT	  and	  IP	  lanes	  is	  due	  to	  different	   denaturing	   buffers.	   Anti-­‐Flag	   antibody	   was	   used	   to	   detect	   exogenous	   Msl1	  proteins.	   Transient	   transfections	  were	   always	   below	   the	   limit	   of	   detection	   for	   INPUT	  lanes.	  
	  
Mof	  interaction	  with	  MSL	  complex	  can	  be	  disrupted	  by	  point	  mutations	  on	  Msl1	  After	   the	   observation	   that	  Msl3	   can	   be	   successfully	   dislocated	   from	   the	   complex,	   we	  tried	  to	  achieve	  the	  same	  effect	  for	  Mof.	  Therefore	  we	  designed	  point	  mutations	  on	  Msl1	  based	  on	  the	  structure.	  The	  Msl1	  mutants	  for	  Mof	  interaction	  are	  shown	  in	  Figure	  7B.	  In	  this	  case	  a	  reduced	  binding	  of	  Mof	  was	  obtained	   for	   the	  single	  F893R	  mutation	  (Msl1	  mut.6)	  in	  the	  N-­‐terminal	  portion	  of	  the	  Msl1	  PEHE	  region	  but	  not	  for	  single	  mutations	  E886R	  and	  H897R	  (Msl1	  mut.5	  and	  7	  respectively)	  (Figure	  7C).	  Further	  reduction	  was	  observed	  for	  the	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Figure	  7.	  Msl1	  mutagenesis	  for	  disruption	  of	  Mof	  interaction	  
(A)	  Sequence	  alignment	  of	   the	  MSL1	   fragment	   that	   is	   involved	   in	   the	   interaction	  with	  MOF.	   Identical	   residues	   are	   in	   red	   boxes.	   The	   interacting	   residues	   are	   indicated	  with	  blue	   triangles.	   The	   three	   residues	   targeted	   for	   point	   mutations	   are	   shown	   for	  Drosophila	  melanogaster	  species.	  (B)	  Msl1	  wild	  type	  with	  Flag	  epitope	  (mut.1)	  and	  five	  PEHE	   mutants	   predicted	   to	   disrupt	   Mof	   interactions.	   (C)	   Flag	   immunoprecipitations	  from	  whole	  cell	  extracts	  of	  SL-­‐2	  cells	  transiently	  transfected	  with	  Msl1	  mut.1,5,6	  and	  7.	  Western	  blots	  are	  shown	   for	   the	   indicated	  antibodies.	  Flag	   INPUT	  signals	  were	  below	  detection	  limit.	  	  (D)	  Same	  experiment	  as	  in	  C,	  including	  Msl1	  mut.8.	  	  
	  E886R/F893R	   double	   mutant	   (Msl1	   mut.8)	   (Figure	   7D).	   	   A	   partial	   reduction	   was	  observed	  also	  for	  Msl3	  and	  Msl2	  incorporation,	  suggesting	  that	  the	  presence	  of	  Mof	  in	  the	   complexmight	   be	   important	   for	  Msl1	   stability	   (Figure	   7D).	   These	   results	   indicate	  that	  Msl3	   and	  Mof	   are	   incorporated	   into	   the	  MSL	   complex	   via	   the	  Msl1	   scaffold	   and	  show	   that	   at	   least	  Msl3	   can	   be	   disassembled	   from	   the	   complex	  without	   an	   apparent	  effect	  on	  the	  molecular	  interactions	  of	  other	  members	  of	  MSL	  complex.	  
PEHE	  region	  of	  Nsl1	  utilizes	  similar	  interaction	  network	  for	  MOF	  as	  in	  Msl1	  MOF	  resides	  in	  two	  functionally	  distinct	  complexes	  in	  Drosophila	  as	  well	  as	  in	  mammals	  namely	   the	   MSL	   complex	   and	   the	   novel	   NSL	   complex83.	   There	   is	   a	   high	   degree	   of	  conservation	   between	   MSL1	   and	   NSL1	   in	   the	   N-­‐terminal	   part	   of	   the	   PEHE	   region	  (Figure	   8A).	   To	   investigate	   whether	   Nsl1	   uses	   the	   same	   interaction	   surface	   for	   Mof	  contact	   in	  vivo,	  amino-­‐acids	  predicted	  to	  interact	  with	  Mof	  were	  mutated	  in	  full	   length	  
Drosophila	  Nsl1	  and	  the	  mutant	  proteins	  were	  expressed	  in	  SL-­‐2	  cells.	  Remarkably,	  the	  Nsl1	   mutant	   E1264R/F1271R	   showed	   a	   strong	   loss	   of	   Mof	   interaction	   (Figure	   8B)	  whereas	  keeping	  MBDR-­‐2	  and	  Nsl3	  still	  interacting.	  This	  indicates	  that	  Mof	  uses	  similar	  surfaces	  for	  the	  integration	  into	  either	  NSL	  or	  MSL	  complexes	  in	  Drosophila	  cells.	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Figure	  8.	  	  Nsl1	  PEHE	  region	  interacts	  with	  Mof	  similar	  to	  Msl1	  	  
(A)	  Alignment	  of	  PEHE	  regions	  of	  MSL1	  proteins	  together	  with	  Drosophila	  and	  human	  NSL1.	  Identical	  residues	  are	  indicated	  with	  green	  boxes.	  Green	  triangles	  indicate	  contact	  points	   with	   MOF.	   Provisional	   point	   mutations	   are	   shown	   on	   Drosophila	   Nsl1	   and	  corresponding	  residues	  of	  Msl1	  are	  shown	  in	  red.	  (B)	  Flag	  immunoprecipitations	  from	  whole	  cell	  extracts	  of	  SL-­‐2	  cells	  transiently	  transfected	  with	  wild	  type	  Flag	  tagged	  Nsl1	  and	   Flag	   tagged	   E1264R/F1271R	   double	   mutant.	   Mock	   represents	   empty	   vector	  transfection.	  Western	  blots	  are	  shown	  for	  the	  indicated	  antibodies.	  Flag	  INPUT	  signals	  were	  below	  detection	  limit.	  	  Anti-­‐Flag	  signal	  corresponds	  to	  Nsl1.	  	  
	  
Mof	  and	  Msl3	  interaction	  is	  mostly	  mediated	  by	  Msl1	  The	  observation	  that	  Msl3	  and	  Mof	  can	  be	  removed	  from	  the	  complex	  without	  affecting	  each	   other	   considerably	   raises	   the	   question	   as	   to	   the	   significance	   of	   the	   interaction	  between	  Mof	  and	  Msl3,	  reported	  by	  Buscaino	  et	  al27.	  To	  further	  investigate	  this	  putative	  interaction,	  which	  was	  not	  confirmed	  by	  Morales	  et	  al.	  15,	  we	  performed	  MSL	  complex	  reconstitution	  assays	  with	  the	  full-­‐length	  proteins	  expressed	  in	  Sf21	  insect	  cells.	  In	  the	  presence	  of	  Msl1,	  Mof	  clearly	  co-­‐purifies	  with	  Msl3	  (Figure	  9),	  however	  in	  the	  absence	  of	  Msl1,	   this	   interaction	   could	   be	   seen	   only	   using	  western	   blot	   detection	   (Figures	   9),	  suggesting	   that	   the	   Msl3-­‐Mof	   interaction	   does	   occur	   marginally	   in	   vitro,	   albeit	  significantly	  weaker	  than	  in	  a	  trimeric	  complex.	  	  
Msl1	  can	  be	  localized	  to	  chromatin	  and	  X	  chromosome	  without	  Mof	  or	  Msl3	  In	   order	   to	   observe	   the	   consequences	   of	   taking	   Mof	   or	   Msl3	   from	   the	   complex,	   and	  whether	  the	  transiently	  expressed	  proteins	  are	  incorporated/targeted	  to	  chromatin,	  we	  performed	   chromatin	   fractionation	   assays,	   where	   first	   nuclei	   were	   separated	   from	  cytoplasm	  and	  the	  nucleoplasm	  was	  extracted	  at	  physiological	  salt	  concentration	  (150	  mM	   NaCl)	   with	   detergent	   perforation	   of	   the	   membrane.	   The	   remaining	   chromatin	  fraction	  was	  solubilized	  by	  nucleases	  and	  all	  pools	  were	  analyzed	  by	  immunodetection.	  In	   wild	   type	   cells,	   all	   MSL	   members	   have	   both	   nucleoplasmic	   and	   chromatin	  distributions	   with	   an	   enrichment	   in	   the	   chromatin	   bound	   pool	   (Figure	   10B).	  Interestingly,	  Mof	  can	  also	  be	  observed	  in	  the	  cytoplasm.	  Upon	  increase	  of	  salt	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Figure	   9.	   Mof	   interaction	   with	   Msl3	   is	   largely	  
mediated	  by	  Msl1	  (A)	   Msl3-­‐Flag,	   Mof-­‐HA	   and	   non-­‐tagged	   Msl1	  proteins	  were	  expressed	  individually	  in	  Sf21	  insect	  cells.	   Equal	   amounts	   of	   whole	   cells	   extracts	   were	  mixed	   and	   anti-­‐Flag	   resin	  was	   used	   to	   pull	   down	  the	  Msl3.	   After	  washing,	   the	   proteins	  were	   eluted	  by	   Flag	   peptides	   and	   TCA	   precipitated.	   Elutions	  were	   analyzed	   on	   a	   gradient	   gel	   by	   Coomasie	  staining.	  Western	   blot	   analysis	   of	   HA	   antibody	   to	  detect	  Mof	  is	  shown	  below.	  	  	  	  	  	  	  concentration,	  most	  members	  detach	   from	  chromatin	  pool	  and	  remain	  nucleoplasmic,	  however	  even	   in	  the	  stringent	  condition,	  a	  slight	  pool	  of	  MSL	  members	  remain	  on	  the	  chromatin.	  (Figure	  10B).	  For	  chromatin	  localization,	  we	  chose	  one	  mutant	  for	  the	  loss	  of	  Msl3	   (Msl1	  mut.2)	   and	  one	   for	  Mof	   (Msl1	  mut.8)	   and	   repeated	   the	   experiment	  under	  physiological	  conditions.	  When	  Msl1-­‐Flag	  and	  the	  mutants	  were	  transiently	  expressed,	  they	   were	   mostly	   detected	   in	   the	   chromatin	   fractions	   indicating	   that	   our	   constructs	  were	  incorporated	  into	  chromatin	  similar	  to	  endogenous	  MSL	  complexes	  (Figure	  10C).	  	  Next,	  we	  wanted	  to	  see	  if	  X	  chromosomal	  targeting	  is	  affected	  by	  the	  disruption	  of	  Msl1	  interaction	  with	  either	  Mof	  or	  Msl3.	  In	  order	  not	  to	  exceed	  physiological	  protein	  levels,	  we	   expressed	   the	   constructs	   under	   the	   cupper	   inducible	   MtnB	   promoter	   under	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uninduced	  conditions	  and	  used	  an	  anti-­‐Flag	  antibody	  to	  visualize	  the	  exogenous	  Msl1-­‐Flag	  and	  mutant	  derivatives	  by	  immunofluorescence	  (IF)	  microscopy.	  MSL	  members	  are	  known	   to	   show	   a	   crescent	   shape	   in	   the	   nucleus	   in	   SL-­‐2	   IF	   cells,	   named	   as	   nuclear	  periphery83.	   All	   constructs	   were	   able	   to	   target	   to	   the	   X	   chromosome	   showing	   co-­‐localization	  with	  endogenous	  MOF	  (Figure	  11).	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Figure	  10.	  Fractionation	  assay	  in	  SL-­‐2	  cells	  
(A)	   Schematic	   representation	   of	   the	   flow	   of	   the	   experiment.	   (B)	   Fractionation	  experiment	  to	  monitor	  endogenous	  MSL	  proteins	  under	  increasing	  salt	  concentrations.	  Equal	   amounts	   of	   each	   fraction	   is	   resolved	   on	   SDS-­‐PAGE	   and	   blotted	   with	   indicated	  antibodies.	   Histone	   3	   was	   used	   as	   a	   positive	   control	   for	   the	   chromatin	   pool.	   (C)	  Fractionation	   assay	   for	  Msl1	  mut.1	   (wt),	  mut.2	   (Msl3	   losing	  mutant)	   and	  mut.8	   (Mof	  losing	  mutant)	  under	  150	  mM	  salt	  concentration.	  Flag	  antibody	  was	  used	  to	  detect	  the	  exogenously	   expressed	  Msl1	   proteins.	   Only	   nucleoplasmic	   (NP)	   and	   chromatin	   pools	  (Chr)	  are	  shown.	  Endogenous	  proteins	  were	  detected	  by	  their	  respective	  antibodies.	  
	  
	  
Figure	  11.	  X	  chromosome	  localization	  can	  be	  seen	  for	  Msl1	  mut.2	  and	  mut.8	  Immunofluorescence	  of	  SL-­‐2	  cells	  expressing	  Msl1-­‐Flag	  and	  its	  derivatives	  under	  leaky	  MtnB	  promoter.	  Transiently	  transfected	  cells	  were	  spun	  in	  a	  cytospin	  machine	  to	  poly-­‐Lysine	   coated	   slides.	  Msl1-­‐Flag	   and	   endogenous	  MOF	  were	   detected	   by	   the	   indicated	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antibodies	  and	  DNA	  was	  detected	  by	  DAPI	  staining.	  Due	  to	  transient	  transfection,	  only	  some	  of	  the	  cells	  express	  the	  Msl1	  and	  its	  mutants.	  
	  
Consequence	  of	  loss	  of	  Msl3	  or	  Mof	  on	  the	  localization	  of	  Msl1	  on	  X	  chromosome	  Since	  immunofluoresence	  microscopy	  does	  not	  provide	  sufficient	  resolution	  to	  observe	  targeting	   to	   individual	   loci,	  we	  decided	   to	  perform	  chromatin	   immunoprecipitation	  of	  the	  Msl1	  derivatives	  on	  X-­‐linked	  genes	  using	  an	  anti-­‐Flag	  antibody	   to	   specifically	  pull	  down	   the	   exogenous	   proteins.	   Our	   first	   trials	   to	   perform	   ChIP	   with	   transiently	  transfected	   cells	   were	   not	   successful,	   possibly	   due	   to	   low	   efficiency	   of	   transient	  transfection.	   To	   generate	   a	   stable	   line,	   it	   is	   required	   to	   co-­‐transfect	   the	   selection	  cassette	  together	  with	  the	  plasmid	  of	   interest	  and	  the	  ratio	  between	  these	  plasmids	  is	  crucial	  and	  requires	  optimization.	  In	  order	  to	  overcome	  this	  optimization,	  we	  generated	  a	   new	   vector	   that	   expresses	   Neomycin	   cassette	   under	   Actin	   promoter	   and	   SV40	  terminator.	   Another	   multiple	   cloning	   site	   also	   exists	   under	   MtnA	   promoter,	   which	  enables	   us	   to	   induce	   expression	  with	   CuSO4.	  We	   call	   this	   plasmid	   pIBU1	   and	   all	   our	  stable	  cell	   lines	  were	  generated	  with	   this	  plasmid.	  We	  also	  replaced	  Flag	  epitope	  at	  C	  terminal	  of	  Msl1	  constructs	  with	  3x	  Flag-­‐6His	  to	  enhance	  the	  recovery	  with	  flag	  epitope.	  3xFlag	  6	  His	  epitopes	  would	  also	  enable	  us	  to	  perform	  tandem	  affinity	  purifications.	  We	  first	   confirmed	   that	   the	   3xFlag	   epitope	   containing	   Msl1	   and	   the	   mutant	   cognates	  showed	   identical	   co-­‐immunoprecipitation	   behaviours	   as	   their	   single	   Flag	   carrying	  counterparts	   (data	  not	   shown).	  MSL	  proteins	  have	  been	  shown	   to	  enrich	   towards	   the	  3’UTR	  of	  ORFs	  on	  X-­‐	  linked	  genes	  (See	  introduction).	  After	  establishing	  ChIP	  protocol	  in	  Sl-­‐2	   cells	   with	   endogenous	  Msl1	   (Figure	   12A),	   we	  made	   a	  minor	  modification	   in	   the	  protocol	   including	   a	   bridge	   antibody	   amplification	   step	   for	   enhancing	   the	   Flag	   signal	  (See	   Methods).	   Upon	   these	   modifications,	   we	   were	   able	   to	   show	   that	   Msl1-­‐3xFlag	  showed	  similar	  binding	  profiles	  as	   the	  endogenous	  MSL1	  (Figure	  12B),	  displaying	   the	  quality	  of	  the	  Flag	  ChIP.	  	  When	  this	  method	  applied	  to	  all	  mutants,	  we	  observed	  that	  in	  contrast	   to	   the	   wild-­‐type	   Msl1,	   Msl1	   E886R/F893R	   (mut.8)	   and	   MSL1	  F945E/A965E/F979E	  (mut.2)	  showed	  significantly	   reduced	  binding	  on	   the	  body	  of	  X-­‐linked	  genes	  (Figure	  13A).	  We	  also	  observed	  a	  low	  but	  consistent	  Msl1	  signal	  towards	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promoters	  of	  the	  X	  linked	  genes.	  Interestingly,	  this	  signal	  remained	  largely	  unaffected	  in	  MSL1	  derivatives	  (Figure	  13A).	  We	  will	  examine	  the	  importance	  of	  this	  binding	  further.	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Figure	  12.	  	  ChIP	  from	  wild	  type	  SL-­‐2	  cells.	  	  
(A)	   Anti-­‐Msl1	   antibody	   was	   used	   to	   show	   the	   binding	   profile	   of	   endogeneous	   Msl1.	  Rox2	  and	  CES11D1	  are	  High	  Affinity	  sites	  and	  represent	  high	  recovery	  of	  Msl	  complexes	  and	  serve	  as	  positive	  controls.	  Four	  X-­‐	  linked	  genes	  were	  tested	  as	  dosage	  compensated	  genes	   and	  ODSH	  downstream	   intergenic	   region	  was	   used	   as	   a	   negative	   control.	   Each	  gene	   was	   probed	   with	   three	   different	   primer	   pairs	   targeted	   to	   the	   promoter	   (Pro),	  middle	  (Mid)	  and	  3’UTR	  (End).	  Each	  bar	  represents	   the	  average	  of	   three	   independent	  IPs	   and	   the	   error	   bars	   are	   standard	   deviations.	   (B)	   ChIP	   from	   SL-­‐2	   cells	   stably	  expressing	   Msl1-­‐Flag.	   The	   cells	   were	   induced	   with	   0.5	   µM	   CuSO4	   for	   12	   hours	   and	  immunoprecipitation	   was	   performed	   by	   using	   anti-­‐Flag	   mouse	   monoclonal	   antibody.	  The	   immunocomplexes	   were	   collected	   with	   blocked	   Protein	   A-­‐Sepharose	   beads.	   To	  enhance	   the	   recovery,	   a	   bridging	   anti-­‐mouse	   antibody	   produced	   in	   rabbit	   had	   been	  coupled	  to	  the	  beads.	  Same	  primer	  pairs	  were	  used	  as	  in	  (A)	  to	  show	  the	  similar	  binding	  profile	  of	  endogenous	  Msl1	  and	  Msl1-­‐Flag.	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Figure	   13.	   Effect	   of	   loss	   of	   Msl3	   and	   Mof	   on	   MSL	   complex	   targeting	   on	   X	  
chromosome	  
(A)	  ChIP	  of	  Msl1-­‐Flag	  and	  derivatives.	  Stable	  cell	  lines	  expressing	  wild	  type	  Msl1-­‐3xFlag	  or	   derivatives,	   under	   cupper	   inducible	   promoters,	   were	   grown	   to	   same	   density	   and	  induced	  with	  0.5	  µM	  CuSO4.	  The	  ChIP	  was	  performed	  as	  in	  Figure	  12B.	  Quantitative	  real	  time	  PCR	  was	  performed	  to	  the	  regions	  corresponding	  to	  promoters	  (P),	  middle	  (Mid)	  and	  3’UTR	  of	  the	  genes	  (End).	  All	  tested	  genes	  are	  dosage	  compensated	  and	  located	  on	  
A 
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the	   X	   chromosome.	   ODSH	   upstream	   region	   was	   used	   as	   a	   negative	   control	   for	   the	  binding	  of	   the	  MSL	  complex.	  Each	  bar	  represents	   the	  average	  of	   four	   independent	   IPs	  and	  error	  bars	  indicate	  the	  standard	  deviation.	  	  Mock	  sample	  corresponds	  to	  wild-­‐type	  cells.	   (B)	   ChIP	   of	  Msl1-­‐3xFlag	   and	   derivatives	   on	  High	   Affinity	   Sites.	   The	   experiment	  was	  performed	  as	  explained	  in	  (A).	  13	  High	  Affinity	  Sites	  were	  chosen	  from77.	  The	  sites	  were	   grouped	   according	   to	   their	   genomic	   positions.	   Note	   that	   two	   2B14	   sites	   are	  different.	  
	  
MSL1	  and	  MSL2	  form	  a	  heterotetrameric	  core	  of	  the	  MSL	  complex	  The	   complex	  between	   the	  predicted	   coiled-­‐coil	   region	  of	  human	  MSL1	   (residues	  213-­‐310)	  and	  the	  N-­‐terminal	  portion	  of	  MSL2	  (residues	  1-­‐116)	  was	  formed	  by	  co-­‐expression	  in	   bacteria.	   Using	   trypsin	   limited	   proteolysis	   we	   identified	   a	   shorter	   MSL1	   fragment	  spanning	  residues	  213-­‐267	  that	  was	  sufficient	  for	  the	  MSL2	  binding	  (Figure	  14A).	  The	  structure	   of	   this	   complex	  was	   determined	   by	   X-­‐ray	   crystallography	   at	   a	   resolution	   of	  3.5Å	   (Figure	   1).	   MSL1	   and	   MSL2	   proteins	   were	   originally	   suggested	   to	   dimerize	   via	  their	   putative	   coiled	   coil	   regions13,14.	   However	   unexpectedly,	   both	   of	   our	   structures	  show	  that	  instead,	  these	  two	  proteins	  form	  a	  heterotetrameric	  core	  of	  the	  MSL	  complex,	  where	  two	  MSL1	  subunits	  form	  a	  dimeric	  coiled-­‐coil	  which	  serves	  as	  a	  binding	  platform	  for	  two	  molecules	  of	  MSL2	  (Figure	  14B,C).	  	  	  The	  crystallized	  fragment	  of	  MSL1	  (residues	  213-­‐267)	  forms	  a	  75Å	  long	  parallel	  dimeric	  coiled	   coil,	  where	  10	  hydrophobic	   and	  4	  polar	   residues	   (Gln229,	  Gln236,	   Lys243	   and	  Arg254),	  that	  were	  originally	  thought	  to	  be	  involved	  in	  the	  interaction	  with	  MSL2	  14,14,	  pack	   in	   layers	  with	   a	   regular	   heptad	   (3-­‐4)	   periodicity	   (Figure	   14D,E).	   The	   coiled	   coil	  also	   contains	   other	   stabilizing	   interactions	   between	   Gln236	   and	   Gln237,	   Lys243	   and	  Glu244	   or	   Glu253	   and	   Arg254.	   The	   dimer’s	   two	   Glu229	   and	   Glu236	   residues	   form	  respectively	  interhelical	  hydrogen	  bonds	  at	  its	  core	  	  (Figure	  14E).	  Most	  of	  the	  residues	  involved	   in	   the	  MSL1	  dimerization	   are	  highly	   conserved	   across	   species,	   reflecting	   the	  importance	  of	   this	   interaction	   for	   the	   functional	   integrity	  of	   the	  MSL	  complex	   (Figure	  15A).	   Upon	   dimerization,	   the	   MSL1	   coiled	   coil	   forms	   two	   composite,	   mostly	  hydrophobic	  binding	  sites	  for	  two	  molecules	  of	  MSL2.	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Figure	  14.	  Crystal	  structures	  of	  the	  MSL1-­‐MSL2	  complex.	  
(A)	  Schematic	  representation	  of	  the	  domain	  structures	  of	  human	  MSL1	  and	  MSL2.	  The	  binding	   partners	   are	   indicated	   above	   individual	   domains.	   (B)	   Ribbon	   diagram	   of	   the	  human	   MSL1213-­‐267/MSL21-­‐116	   complex.	   Two	   molecules	   of	   MSL1	   form	   the	   central	  dimeric	  coiled	  coil	  (shown	  in	  brown	  and	  green).	  The	  N-­‐terminal	  RING	  finger	  containing	  domains	  of	  MSL2	  are	  shown	  in	  blue	  and	  gray.	  (C)	  The	  MSL1213-­‐252/MSL21-­‐116	  structure	  rotated	  by	  90°	  along	  the	  horizontal	  axis	  relative	  to	  (B).	  (D)	  Ribbon	  diagram	  of	  the	  MSL1	  dimeric	  coiled	  coil.	  Residues	  at	  the	  a	  and	  d	  heptad	  positions	  are	  labeled.	  (E)	  Details	  of	  the	  MSL1	  dimerization	  contacts.	  This	  figure	  is	  provided	  by	  Jan	  Kadlec.	  
	  It	  is	  important	  to	  note	  that	  Drosophila	  Msl1	  was	  originally	  proposed	  to	  self-­‐associate	  via	  a	   so	   called	   glycine-­‐rich	   region	   between	   residues	   26-­‐84,	   possibly	   mediating	  oligomerization	   of	  MSL	   complexes	   on	  male	   X-­‐chromosome14.	   However,	  we	   show	   that	  MSL1	   forms	  dimers	   (rather	   than	  higher	  oligomers)	  via	   its	   coiled	  coil	   region	  while	   the	  upstream	  glycine	  rich	  region	  is	  not	  required	  for	  the	  dimerization.	  MSL2	   was	   suggested	   to	   interact	   with	   MSL1	   via	   its	   RING	   finger16.	   In	   contrast,	   our	  structure	   shows	   that	   its	   interaction	  with	   the	  MSL1	   dimer	   is	   exclusively	  mediated	   by	  helices	  α1	  and	  α3,	  while	   the	  RING	   finger	  has	  no	  contact	  with	  MSL1.	   Interestingly,	   the	  putative	   role	   of	   the	   Drosophila	   Msl2	   RING	   finger	   in	   the	   interaction	   with	   Msl1	   was	  established	   by	   identification	   of	   13	  mutations,	   which	   in	   light	   of	   the	   present	   structure	  would	  nearly	  all	  destabilize	  the	  RING	  finger	  and	  thus	  probably	  also	  the	  entire	  Msl2	  16.	  Only	  2	  of	  these	  mutations	  (M14K	  and	  C107R)	  would	  probably	  directly	  affect	  the	  binding	  of	  helix	  α1	  and	  α3	  to	  Msl1.	  The	  helices	  of	  the	  two	  MSL2	  molecules	  bind	  to	  MSL1	  in	  an	  anti-­‐parallel	   fashion	   forming	   an	   eight-­‐helical	   bundle	   (Figure	   14B,C)	   with	   multiple	  contacts	   within	   several	   hydrophobic	   and	   polar	   layers	   along	   the	   first	   three	   heptad	  repeats	  of	  MSL1.	  The	  key	   interacting	   residues	  of	  MSL1	   form	  a	   short	  highly	  conserved	  cluster	  between	  Ser117	  and	  Gln239	  (Figure	  15A).	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MSL1	  dimerization	  is	  independent	  of	  and	  prerequisite	  to	  MSL2	  binding	  	  Since	   the	   role	   of	   the	   MSL	   complex	   is	   better	   understood	   in	   Drosophila	   and	   the	   key	  residues	  in	  all	  interaction	  interfaces	  MSL1	  makes	  with	  MSL1,	  MSL2,	  MSL3	  and	  MOF	  are	  evolutionary	   conserved,	   we	   performed	   all	   our	   functional	   studies	   with	   Drosophila	  proteins	  in	  cell	  lines	  as	  well	  as	  transgenic	  flies.	  All	  the	  Drosophila	  Msl1	  mutants	  used	  for	  dimerization	   studies	   and	   the	   corresponding	   mutations	   to	   human	   counterparts	   are	  summarized	  in	  Figure	  15	  and	  they	  all	  have	  a	  C-­‐terminal	  3xFlag	  epitope	  unless	  indicated	  otherwise.	  	  
	  






	  	   53	  
	  
Figure	  15.	  Generation	  of	  Drosophila	  Msl1	  dimerization	  mutants	  
(A)	   Sequence	   alignment	   of	   MSL1	   proteins	   comparing	   vertebrates	   and	   Drosophila	  species.	  Only	   the	  sequence	  of	   the	  coiled	  coil	  region	   is	  shown.	   Identical	  residues	  are	   in	  green	   boxes	   and	   conserved	   residues	   are	   shown	   in	   green.	   Blue	   triangles	   indicate	  residues	   involved	   in	   the	   MSL1	   dimerization	   while	   red	   triangle	   show	   residues	  interacting	   with	   MSL2.	   (B)	   Mutated	   residues	   in	   Drosophila	   and	   their	   human	  homologoues	  are	  represented	  on	  the	  human	  MSL	  protein	  scheme.	  (C)	  Drosophila	  Msl1	  mutants	   used	   in	   this	   study.	   All	   Msl1	  mutants,	   including	  wild	   type,	   have	   a	   C-­‐terminal	  3xFlag	  tag.	  (D)	  Flag	  IP	  from	  whole	  cell	  extract	  of	  SL-­‐2	  cells	  transiently	  expressing	  Msl1	  mut.1	  and	  mut.10.	  	  
	  Previously	  we	  showed	  that	   the	  Msl3	  and	  Mof	   interactions	  with	  Msl1	  can	  be	  disrupted	  without	   any	   apparent	   influence	   on	   the	   other	   protein-­‐protein	   interactions	   within	   the	  complex.	   To	   further	   support	   this	   finding	   and	   functionally	   separate	   the	   N-­‐terminal	  interactions	   of	   Msl1	   with	   Msl2	   and	   the	   C-­‐terminal	   interactions	   with	   Mof	   and	   Msl3	  (through	   the	   PEHE	   region),	   we	   generated	   an	   Msl1	   mutant	   (Msl1	   mut.10)	   that	   binds	  neither	  Msl3	  nor	  Mof	  (Figure	  15D).	  Using	  co-­‐immunoprecipitation	  we	  could	  show	  that	  the	  Msl1	   interaction	  with	  Msl2	  remains	  unaffected	  even	  when	  both	  Msl3	  and	  Mof	  are	  eliminated	  from	  the	  complex.	  	  	  To	  test	  the	  dimerization	  of	  the	  full-­‐length	  Msl1	  in	  vivo,	  we	  transiently	  co-­‐expressed	  the	  wt	   Msl1-­‐Flag	   and	   Msl1-­‐myc	   proteins	   and	   immunoprecipitated	   Msl1-­‐Flag	   bound	  proteins	   using	   a	   Flag	   antibody-­‐coupled	   resin.	   Indeed,	   we	   could	   show	   that	   the	   Flag	  tagged	   Msl1	   co-­‐immunoprecipitated	   with	   Msl1-­‐myc	   as	   well	   as	   Msl2,	   Msl3	   and	   Mof	  (Figure	   16A	   lane	   1).	   Furthermore,	   we	   observed	   that	   Msl1	   can	   dimerize	   even	   in	   the	  absence	  of	  Msl3	  and	  Mof	   (Figure	  16A	   lane	  2).	  Next,	  we	  were	   interested	   in	   identifying	  Msl1	   mutations	   that	   would	   disrupt	   its	   dimerization,	   without	   directly	   affecting	   the	  residues	  interacting	  with	  Msl2.	  Thus,	  we	  mutated	  either	  4	  or	  5	  residues	  at	  a	  or	  d	  heptad	  positions	   along	   the	   coiled	   coil	   to	   aspartates	   (Msl1	   mut.11	   and	   12).	   Both	   mutants,	  although	   they	  were	   expressed	  more,	   failed	   to	   co-­‐purify	  Msl1-­‐myc	   and	  Msl2	  while	   the	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interaction	   with	   Msl3	   and	   Mof	   was	   unaffected	   (Figure	   16A	   lane	   3	   and	   4).	   This	  experiment	  confirms	  that	  the	  interaction	  with	  Msl2	  requires	  the	  entire	  composite	  Msl2	  binding	  site	   formed	  by	  the	  Msl1	  dimer	  (Figure	  14B)	  while	   the	  monomeric	  Msl1	   is	  not	  sufficient.	  It	  is	  important	  to	  note	  that,	  neither	  the	  Msl1	  dimerization	  nor	  Msl2	  binding	  is	  required	   for	   the	   interaction	  with	  Msl3	  and	  Mof.	  These	  results	  emphasize	   the	  modular	  nature	  of	  Msl1	  interactions	  with	  different	  members	  of	  the	  MSL	  complex.	  	  Next	  we	  designed	  a	  mutant	  that	  would	  not	   interact	  with	  Msl2	  but	  would	  preserve	  the	  integrity	  of	  the	  Msl1	  dimer.	  Thus,	  we	  mutated	  three	  residues	  in	  the	  Msl1/Msl2	  interface	  that	   do	   not	   lie	   at	   a	   or	   d	   heptad	   positions	   to	   arginines	   (M113R,	   L118R,	   L120R:	   Msl1	  mut.13).	  The	  Msl1	  mut.13	  was	  still	  able	  to	  dimerize	  with	  Msl1-­‐myc,	  bind	  Msl3	  and	  Mof,	  while	   the	   interaction	   with	   Msl2	   was	   lost	   (Figure	   16A,	   lane	   5)	   indicating	   that	   the	  presence	  of	  Msl2	   is	  not	   required	   for	   the	  Msl1	  dimerization.	  Finally,	  we	  showed	   that	  a	  single	   additional	   mutation	   in	   a	   heptad	   position	   (V114E)	   was	   sufficient	   to	   disrupt	  directly	  both	  Msl1	  dimerization	  and	  Msl2	  binding	  (Figure	  16A,	   lane	  6).	  Similar	  results	  were	  obtained	  when	  we	  repeated	   the	  co-­‐IP	  experiments	  with	  an	  HA	   tagged	  wild	   type	  Msl1	  (Figure	  16B).	  To	  further	  support	  the	  hypothesis	  that	  Msl1	  dimer	  can	  exist	  without	  Msl2,	   we	   performed	   the	   co-­‐IP	   experiments	   in	   Kc	   cells,	   a	   cell	   culture	   model	   for	  
Drosophila	  female	  cells,	  where	  Msl2	  translation	  is	  inhibited	  (Figure	  16C).	  In	  these	  cells,	  wt	  Msl1	  forms	  a	  dimer	  (Figure	  16C,	  lane	  1)	  and	  loss	  of	  Msl3	  and	  Mof	  does	  not	  affect	  the	  dimerization	   (Figure	  16C,	   lane	  2).	  Msl1	  mut.11	  and	  12,	  which	   shows	  abolished	  dimer	  formation	  in	  SL-­‐2	  cells	  also	  show	  compromised	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Figure	  16.	  Msl1	  dimerization	  is	  independent	  of	  and	  prerequisite	  to	  Msl2	  binding	  
(A)	  Flag	  immunoprecipitation	  of	  Msl1	  mutants	  in	  SL-­‐2	  cells.	  Msl1-­‐Flag	  mutants	  are	  co-­‐transfected	  with	  wild	  type	  myc-­‐tagged	  Msl1	  and	  Flag	  beads	  were	  used	  for	  IP.	  Western	  blots	   were	   performed	   with	   the	   indicated	   antibodies.	   Flag	   and	   myc	   tag	   indicates	   C-­‐terminal	  3xFlag	  and	  3xMyc	  tag,	  respectively.	  (B)	  Experiment	  repeated	  with	  HA	  tagged	  wilt	  type	  Msl1	  as	  in	  (A)	  (C)	  Same	  experiment	  in	  (A)	  performed	  in	  Kc	  cells.	   	  Asterisk	  in	  anti-­‐myc	  blot	  indicates	  a	  contamination	  band.	  Msl2	  absence	  is	  a	  marker	  for	  Kc	  cells.	  	  
	  dimer	  formation	  in	  Kc	  cells	  while	  mut.13	  still	  dimerizes	  as	  predicted.	  Interestingly,	  Msl1	  mutants	  that	  lose	  the	  Msl2	  interaction	  were	  consistently	  observed	  to	  be	  more	  abundant	  than	  the	  wild	  type	  and	  mut.10,	  indicating	  a	  possible	  effect	  of	  Msl2	  on	  Msl1	  turnover.	  The	  schematic	  summary	  of	  the	  all	  the	  mutant	  Msl1	  containing	  complexes	  is	  represented	  in	  Figure	  17.	  Taken	  together,	  these	  results	  conclusively	  show	  that	  Msl1	  dimeric	  coiled	  coil	  is	   a	   platform	   for	   Msl2	   interaction	   in	   vivo	   and	   PEHE	   domain	   interactions	   are	   rather	  independent	  from	  MSL2	  interaction,	  furthermore	  supporting	  the	  modular	  nature	  of	  the	  MSL	  complex.	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Msl2	  is	  an	  E3	  ligase	  Our	  structure	  revealed	  that	  RING	  finger	  of	  Msl2	  is	  not	  involved	  in	  Msl1	  interaction	  but	  rather	  solvent	  exposed,	   indicating	   that	   this	   fold	  can	  act	  as	  an	  enzyme.	  We	   thus	   tested	  the	   ubiquitination	   activity	   of	   Drosophila	   Msl2	   using	   purified	   full-­‐length	   protein	  expressed	   in	   Sf21	   insect	   cells	   in	   an	   in	  vitro	   ubiquitination	   assay.	  We	   could	   show	   that	  Msl2	  can	  auto-­‐ubiquitinate	  itself,	  which	  is	  a	  hallmark	  of	  E3	  ligase	  proteins	  (Figure	  18).	  Msl1,	   which	   served	   as	   a	   negative	   control,	   did	   not	   exhibit	   any	   ubiquitination	   activity.	  Surprisingly,	   in	   the	   presence	   of	   Msl2,	   Msl1	   also	   showed	   higher	   molecular	   species	  indicating	  that	  Msl1	  is	  a	  substrate	  of	  Msl2	  in	  vitro	  (Figure	  18,	  lanes	  9-­‐10).	  	  
Figure	  18.	  Msl2	  is	  an	  E3	  ligase	  In	   vitro	   ubiquitination	   assay	   with	   recombinant	   Flag	   tagged	   Msl1	   and	   Msl2.	   Equal	  amounts	  of	  proteins	  were	  assayed	  in	  10	  minutes	  time	  interval.	  Flag	  antibody	  was	  used	  to	  determine	  ubiquitinated	  pools	  of	  Msl1	  and	  Msl2.	  Coomassie	  gel	  of	  purified	  Msl1	  and	  Msl2	  is	  shown	  in	  the	  right	  panel.	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Figure	  19.	  Msl2-­‐E2	  interaction	  surface	  disruption	  trials	  
(A)	   Purification	   of	   Msl2	   mutants	   in	   Sf21	   cells	   by	   Baculovirus	   mediated	   expression	  system.	  All	  mutants	   are	   purified	   by	   Flag	   agarose	   beads	   and	   eluted	  with	   Flag	   peptide.	  Coomasie	   gel	   is	   shown	   for	   Flag	   elutions.	   Major	   degradation	   bands	   are	   indicated	  according	   to	   their	   recognition	   by	   Flag	   antibody	   upon	   western	   blotting.	   (B)	   In	   vitro	  
B 
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ubiquitination	  assay	  of	  Msl2-­‐Flag	  mutants.	  Assay	  is	  performed	  as	  in	  Figure	  18.	  “0”	  time	  represents	  no-­‐ATP	  control.	  HA	  antibody	  is	  used	  to	  assay	  HA-­‐Ubiquitin.	  Flag	  blot	  shows	  the	  loading	  control	  for	  the	  amounts	  of	  purified	  Msl2	  proteins.	  (C)	  Transient	  expression	  of	  Msl2	  mutants	   in	  Kc	  cells.	   In	  order	   to	  avoid	   the	  effects	  of	  endogenous	  Msl2,	  Kc	  cells	  were	   transfected	  with	   indicated	  mutant	  constructs	  and	   immunoprecipitated	  with	  Flag	  agarose	  beads.	  Msl2	  mutants	   differ	   in	   their	   levels	   of	   expression.	  Asterisks	   in	   the	   Flag	  and	  Msl3	  blot	  indicate	  nonspecific	  bands.	  
	  
roX2	  RNA	  integration	  requires	  the	  full	  complex	  The	   MSL	   complex	   is	   a	   ribonucleoprotein	   complex,	   containing	   two	   functionally	  redundant	  long	  non-­‐coding	  RNAs,	  roX2	  and/or	  roX149.	  In	  the	  absence	  of	  both	  of	  the	  roX	  RNAs,	  the	  MSL	  complex	  binds	  to	  several	  sites	  along	  the	  X	  chromosome,	  some	  autosomal	  sites	   and	   chromocenter50,	   indicating	   a	   role	   of	   roX	   RNAs	   in	   spreading	   of	   the	   complex	  from	   a	   relatively	   few	   sites	   along	   the	   X-­‐chromosome.	   Although	   essentially	   all	   the	  proteins	  of	  the	  MSL	  complex	  have	  a	  potential	  of	  interacting	  with	  nucleic	  acids,	  the	  actual	  mode	  by	  which	   the	  complex	  binds	  RNA	  remains	  unknown19,31,45,159.	  We	  used	  the	  Msl1	  mutants	  to	  study	  roX	  integration	  into	  the	  complex	  in	  vivo	  by	  RNA	  immunoprecipitation	  (RIP)	   method,	   where	   fixed	   complexes	   are	   pulled	   down	   and	   RNAs	   are	   quantitatively	  measured	   by	   quantitative	   PCR	   158.	   First,	   we	   optimized	   the	   RIP	   protocol	   in	   SL-­‐2	   cells,	  where	   roX2	   but	   not	   roX1	   is	   expressed,	   using	   the	  Mle	   subunit	   as	   a	   bait	   protein	   as	   its	  interaction	  with	  roX2	  is	  well	  established	  45.	  Mle	  bound	  roX2	   in	  vivo,	  as	  verified	  by	  two	  different	  primer	  pairs,	  and	  did	  not	  bind	  a	  non-­‐specific	  nuclear	  RNA,	  7SK	  (Figure	  20A).	  RIP	   by	   Flag	   antibody	   gave	   only	   background	   levels	   of	   signal	   from	  wild	   type	   SL-­‐2	   cells	  (Figure	   20A),	   ensuring	   the	   specificity	   of	   signals	   obtained	   from	   RIP	   of	   Msl1	   mutants	  (Figure	   20C).	   In	   order	   to	   capture	   partial	   complexes	   more	   efficiently,	   we	   generated	  stable	  SL-­‐2	  cell	  lines	  for	  all	  the	  Msl1	  mutants	  except	  for	  Msl1	  mut.11	  because	  it	  behaves	  very	  similar	  to	  mut.12	  (Figure	  16).	  Since	  the	  level	  of	  expression	  can	  affect	  the	  recoveries	  of	   RIP,	   we	   optimized	   induction	   with	   Cu+2	   concentrations	   to	   achieve	   similar	   levels	   of	  expression	  for	  each	  mutant	  (Figure	  20B).	  Rox2	  binding	  to	  the	  exogenous	  wt	  Flag-­‐tagged	  Msl1	  was	  recapitulated	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Figure	  20.	  RoX2	  interaction	  with	  partial	  MSL	  complexes	  (A)	  RNA	  immunoprecipitation	  (RIP)	  in	  SL-­‐2	  cells	  with	  Mle	  and	  Flag	  antibody.	  RIP	  on	  Mle	  protein	  is	  used	  as	  a	  positive	  control	  for	  roX2	  RNA	  binding.	  Two	  different	  roX2	  sites	  are	  quantitatively	  amplified	  (roX2	  a,	  roX2	  b).	  7SK	  is	  used	  as	  a	  nuclear	  RNA	  negative	  control.	  RIP	   with	   Flag	   antibody	   is	   repeated	   on	   same	   targets	   in	   wild	   type	   SL-­‐2	   cells	   to	   show	  background	  levels	  of	  RNA	  recovery.	  The	  error	  bars	  represent	  the	  standard	  deviation	  of	  3	   independent	   experiments.	   (B)	   Equal	   levels	   of	   Msl1	   mutants	   used	   in	   ChIP	   and	   RIP	  experiments	  were	  achieved	  by	  differential	   induction	  of	  MtnA	  promoter	  with	   indicated	  
A B 
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CuSO4	  amounts	  in	  SL-­‐2	  stable	  lines.	  MtnA	  promoter	  has	  a	  leaky	  expression	  without	  any	  induction.	   Each	   line	   contains	   Msl1	   construct	   with	   3xFlag	   tag	   in	   C	   terminus.	   Flag	  antibody	  was	  used	  to	  determine	  the	  levels	  of	  Msl1	  proteins.	  (C)	  Flag	  RIP	  experiment	  in	  SL-­‐2	  stable	  cell	  lines	  that	  express	  Msl1	  mutants.	  2	  rox2	  RNA	  target	  sites	  and	  a	  negative	  control	  RNA	  target	  (7SK)	  are	  amplified.	  	  
	  from	   the	   stable	   cell	   line.	   While	   Msl1	   mut.10	   showed	   a	   significant	   reduction	   of	   RNA	  recovery,	   mut.12	   and	   mut.13	   completely	   lost	   the	   binding	   despite	   their	   equivalent	  expression	  levels	  (Supplementary	  Figure	  5A).	  The	  lack	  of	  roX2	  signal	  in	  these	  assays	  is	  a	  direct	  indication	  of	  RNA	  loss	  of	  incorporation	  to	  the	  partial	  complexes,	  since	  roX2	  RNAs	  are	  stabilized	  by	  the	  presence	  of	  endogenous	  proteins.	  These	  results	  indicate	  that	  Msl1-­‐Msl3-­‐Mof	   trimeric	   complex	   (Msl1	   mut.12)	   and	   hexameric	   complex	   (Msl1	   mut.13)	  cannot	  bind	  roX2	  in	  the	  absence	  of	  Msl2.	  The	  Msl3	  or	  Mof	  proteins	  are	  also	  required	  for	  complete	   incorporation	   of	   the	   RNA	   but	   their	   contribution	   is	   not	   detectable	   by	   this	  method	  when	  Msl2	  is	  not	  present	  in	  the	  complex.	  Msl2	  thus	  appears	  to	  be	  a	  key	  subunit	  for	  stable	  roX2	  integration	  into	  the	  MSL	  complex.	  
Msl1	  dimer	  platform	  and	   its	  association	  with	  Msl2	   is	   required	   for	  X	  chromosome	  
recognition	  In	   order	   to	   understand	   the	   importance	   of	   the	   Msl1	   dimerization	   in	   X	   chromosome	  targeting,	  we	  tested	  our	  mutants	  for	  their	  interactions	  with	  chromatin	  by	  ChIP	  analysis	  in	   stable	   SL-­‐2	   cell	   lines	   where	   each	   Msl1	   mutant	   is	   under	   a	   Cu+2	   inducible	  metallothionein	   A	   (MtnA)	   promoter.	   Expression	   levels	   were	   equilibrated	   as	   in	   figure	  20B.	   We	   used	   the	   Flag	   epitope	   for	   IP	   to	   selectively	   pull	   down	   mutant	   derivatives,	  avoiding	   endogenous	   Msl1.	   First	   we	   analyzed	   Msl1	   binding	   to	   two	   high-­‐affinity	   site	  (HAS)	   targets	   (roX2	   and	   su(wa))	   and	   several	   low	   affinity	   sites	   within	   four	   X-­‐linked	  genes	  (Figure	  21A).	  Msl1	  mut.10	  ChIP	  shows	  that	  roX2	  HAS	  binding	  is	   independent	  of	  both	   Msl3	   and	   Mof	   and	   su(wa)	   showed	   a	   reduced	   binding	   of	   the	   partial	   complex	  whereas	   spreading	   across	   the	   body	   of	   the	   X-­‐linked	   genes	   was	   completely	   lost.	   This	  result	   further	   supports	   our	   previous	   hypothesis	   that	   not	   all	   high	   affinity	   sites	   are	  identical	  and	  show	  differential	  affinities	  towards	  various	  surfaces	  of	  the	  MSL	  complex.	  Strikingly	  all	  the	  other	  mutants	  (Msl1	  mut.12,	  13,	  14)	  did	  neither	  bind	  either	  to	  HAS	  nor	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Figure	  21.Chromatin	  interactions	  of	  partial	  MSL	  complexes	  
(A)	  ChIP	  of	  Msl1	  mutants	  with	  Flag	  antibody	  in	  SL-­‐2	  stable	  cell	   lines.	  Transcription	  of	  Msl1	  
mutants	   is	   induced	   by	   different	   Cu+2	   concentrations	   for	   similar	   level	   of	   expression	   (See	  
Supplementary	   Figure	   5A).	   2	   High	   Affinity	   sites	   and	   4	   X-­‐linked	   genes	   were	   chosen	   as	   X-­‐
chromosomal	   targets.	   OdsH	   target	   is	   used	   as	   a	   negative	   control.	   P,	   M	   and	   E	   indicate	  
promoter,	  middle	  and	  end	  of	  the	  genes	  respectively.	  The	  error	  bars	  represent	  the	  standard	  
deviation	   of	   3	   independent	   experiments.	   (B)	   Same	   experiment	   as	   in	   (A)	   is	   performed	   on	  
selected	  twelve	  High	  Affinity	  Sites.	  
	  
Msl1	  binds	  to	  promoters	  in	  male	  and	  female	  cells	  	  Reproducible	   Msl1	   binding	   to	   the	   promoters	   of	   X-­‐chromosomal	   genes	   and	   its	  independent	   nature	   from	   Msl3,	   Mof,	   Msl2	   and	   dimerization	   (Figure	   13	   and	   21)	  prompted	   us	   to	   hypothesize	   that	   this	   binding	   could	   be	   independent	   from	   its	   role	   in	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dosage	   compensation.	   In	   such	   a	   scenario,	   Msl1	   might	   also	   be	   detectable	   at	   the	  promoters	  of	  autosomal	  genes,	  where	  dosage	  compensation	  does	  not	  occur.	  Indeed,	  by	  ChIP	   we	   detected	   strong	   enrichments	   at	   the	   promoters	   of	   eight	   random	   autosomal	  targets,	  while	  ORF	  binding	  was	  at	  the	  background	  level	  (Figure	  22A,	  black	  bars).	  Given	  the	  tight	  interaction	  between	  Msl1	  and	  Msl2	  and	  its	  role	  in	  transcriptional	  regulation	  at	  the	   promoters	   in	   mammalian	   cells18,	   we	   analyzed	   also	   the	   Msl2	   binding	   to	   the	  promoters	  of	  autosomal	  and	  X-­‐chromosomal	  genes.	   Interestingly,	  Msl2	   follows	  similar	  binding	   patterns	   as	   Msl1,	   occupying	   promoters	   on	   the	   autosomal	   genes	   while	   on	   X-­‐linked	  genes	  enrichment	  peaks	  towards	  the	  end	  of	  the	  genes	  in	  male	  cells	  (Figure	  23A).	  We	  were	  next	  interested	  in	  identifying	  the	  distinguishing	  factor	  between	  autosomal	  and	  X-­‐linked	  genes.	  Since	  MOF	  is	  also	  present	  in	  autosomal	  promoters	  73,	  we	  checked	  Msl3	  systematically	   on	   the	   same	   autosomal	   and	   X-­‐linked	   genes	   in	   males	   and	   females.	  Surprisingly,	  Msl3	  was	  absent	  on	  autosomal	  promoters	   in	  male	  cells	  (Figure	  23B)	  and	  on	   female	   promoters	   (data	   not	   shown)	   compared	   to	   X	   chromosomal	   targets.	   Msl3	  occupancy	   at	   X-­‐linked	   promoters	  was	   either	   absent	   or	   very	   low	   relative	   to	  Msl1	   and	  Msl2.	   Taken	   together;	   these	   results	   suggest	   that	   Msl1	   binding	   at	   the	   promoters	   is	  independent	   from	   its	   role	   in	   dosage	   compensation.	   The	   exclusive	   presence	   of	   Msl3	  provides	   a	   distinguishing	   feature	   for	   the	   X-­‐chromosomal	   genes	   versus	   autosomal	  targets	  with	  concomitant	  spreading	  of	  the	  MSL	  complex.	  
	  
Msl1	  dimerization	  is	  essential	  for	  male	  viability	  	  In	  order	  to	  assess	  the	  functional	  relevance	  of	  these	  msl1	  mutations	  in	  Drosophila	  in	  vivo,	  we	  generated	   transgenic	   flies	  expressing	   the	  mutant	  variants	  of	  msl1	   (wt	  Flag-­‐tagged,	  mut.10,	  12,	  13,	  14)	  in	  a	  spatiotemporally	  regulated	  manner	  using	  the	  UAS/Gal4	  binary	  system.	  All	   transgenes	  were	   inserted	   in	   the	   same	  genomic	   location	   (65B2)	  by	  phiC31	  integrase-­‐mediated	   transformation	   to	   avoid	   the	   influence	   of	   position	   effects	   on	   gene	  expression	  and	  facilitate	  direct	  comparison	  upon	  phenotypic	  analysis160.	  Furthermore,	  using	  the	  fly	  system	  also	  enabled	  us	  to	  directly	  compare	  sex-­‐specific	  effects	  of	  different	  mutations.	  	  	  




Figure	   22.	   Msl1	   binds	   to	   promoters	   of	   X	   and	   autosomes	   in	   a	   sex-­‐independent	  
manner.	  	  	  
(A)	   ChIP	   of	   endogenous	   Msl1	   in	   SL-­‐2	   cells.	   5	   X-­‐linked	   genes	   and	   2	   HAS	   are	   chosen	   for	  
canonical	  X	  chromosome	  enrichment	  (Red	  bars).	  Cg3473	  is	  a	  negative	  control	  target	  site.	  8	  
autosomal	   target	   sites	   are	   shown	  with	   black	   bars.	   The	   error	   bars	   represent	   the	   standard	  
deviation	  of	  3	  independent	  experiments.	  (B)	  Same	  experiment	  is	  performed	  for	  endogenous	  
Msl1	  in	  Kc	  cells	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  Figure	  23.	  Msl2	  binds	  to	  the	  promoters	  but	  not	  Msl3	  	  Standard	  ChIP	  with	  Msl2	  (A)	  and	  Msl3	  (B)	  antibodies	  as	  performed	  in	  Figure	  22	  with	  same	  target	  sites.	  	  
	  We	   first	   induced	   ectopic	   expression	   of	   these	   mutants	   in	   a	   wild	   type	   background	  ubiquitously	  with	  a	  strong	  tubulin-­‐Gal4	  driver	  at	  25°C	  161.	  Strikingly,	  expression	  of	  Msl1	  mut.	  12,	  13,	  14	  caused	  both	  male	  and	  female	  lethality,	  whereas	  Msl1	  mut.10	  caused	  only	  male-­‐specific	   lethality	   and	   wild	   type	   Msl1	   expression	   did	   not	   have	   any	   observable	  effects	  on	  viability	  (Figure	  24B).	  Western	  blot	  analysis	  showed	  that	  Msl1	  mut.	  12,13	  and	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Figure	  24.	  Overexpression	  of	  Msl1	  mutants	  in	  wild	  type	  background	  at	  25°C	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transgene	  expression	  are	  shown	  in	  grey	  and	  females	  in	  pink.	  Viability	  of	  adult	  flies	  for	  each	   genotype	   is	   represented	   as	  %	   from	   the	   total	   number	   of	   offspring	   for	   each	  UAS-­‐
msl1*	  mutant	   set	  of	   crosses	   shown	   in	  methods.	  Total	  number	  of	   flies	   counted	   for	   this	  assay	   was	   n=	   3489.	   (C)	  Western	   blots	   from	   protein	   extracts	   prepared	   from	   second	  instar	  larvae	  carrying	  different	  UAS-­‐msl1*	  transgenes,	  all	  C-­‐terminal	  3xFlag	  tagged.	  Flag	  antibody	  was	  used	  to	  probe	  exogenous	  Msl1;	  Mof	  and	  Msl3	  protein	  levels	  are	  shown	  for	  comparison.	  Tubulin	  levels	  were	  used	  as	  a	  loading	  control.	  
	  14,	  which	   lose	  Msl2	   interaction,	  are	  more	  abundant	   than	  wt	  Msl1	  and	  mut.10	   (Figure	  24C),	  suggesting	  a	  down-­‐regulating	  effect	  of	  Msl2	  on	  Msl1,	  which	  is	  consistent	  with	  our	  cell	   culture	   observations	   and	   in	   vitro	   ubiquitination	   assays	   that	   Msl1	   is	   an	   Msl2	  ubiquitination	  substrate.	  	  In	  order	  to	  ensure	  that	  lethality	  is	  not	  due	  to	  indirect	  effects	  of	  over-­‐expression	  of	  the	  mutant	  proteins,	  especially	  for	  the	  coiled-­‐coil	  Msl1	  mut.	  12,	  13	  and	  14,	  we	  repeated	  the	  experiment	   at	   18°C,	   where	   tubulin-­‐Gal4	   induced	   transgene	   expression	   can	   be	  significantly	  decreased	  relative	  to	  25°C162	  and	  (Figure	  25A).	  Under	  these	  conditions,	  we	  observed	  that	  female	  viability	  is	  restored	  for	  Msl1	  mut.12,	  13	  and	  partially	  for	  mut.14,	  whereas	  male-­‐specific	   lethality	  was	   still	   observed	   for	   all	  mutants	   (albeit	   escapers	   for	  Msl1	  mut.10	  and	  mut.	  13).	  Ectopic	  expression	  of	  wild	  type	  Msl1	  in	  these	  conditions	  had	  no	   effects	   on	   viability.	   These	   results	   show	   that	   dominant	   negative	   effects	   of	   all	  mutations	  can	  be	  observed	  exclusively	  in	  males	  at	  both	  temperatures,	  whereas	  females	  become	  sensitive	  to	  the	  levels	  of	  Msl1	  mut.	  12,	  13	  and	  14	  at	  25˚C.	  To	  assess	  the	  direct	  effect	  of	  the	  mutations,	  we	  expressed	  the	  Msl1	  mutant	  variants	  in	  
msl1L60/msl1γ269	   null	   mutant	   flies	   to	   reconstitute	   Msl1	   function.	   As	   expected,	   in	   the	  absence	  of	  Msl1,	  females	  are	  viable	  whereas	  males	  die	  as	  third	  instar	  larvae	  or	  at	  early	  pupal	  stages	  (Figure	  26B).	  At	  25°C,	  tubulin-­‐Gal4-­‐induced	  ectopic	  expression	  of	  wild	  type	  Msl1	  rescued	  completely	  the	  msl1	   loss-­‐of-­‐function	  male-­‐specific	   lethality	  (Figure	  26B).	  Noticeably,	   none	   of	   the	   msl1	   mutants	   rescued	   male	   lethality	   (Figure	   26B).	   Female	  viability	  dropped	  significantly	  in	  Msl1	  mut.12,	  13	  and	  14,	  similar	  to	  the	  dominant	  effect	  observed	   upon	   over-­‐expression	   in	   a	   wild	   type	   background	   (Figure	   26B).	   At	   18°C,	  
tubulin-­‐Gal4-­‐induced	   ectopic	   expression	   of	   wild	   type	   Msl1	   rescued	   the	  msl1	   loss-­‐of-­‐	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function	  male-­‐specific	  lethality	  only	  partially	  and	  other	  mutants	  failed	  to	  do	  so	  (data	  not	  shown).	  These	  results	  clearly	  show	  that	  all	  of	  the	  residues	  that	  are	  determined	  from	  the	  crystal	  structure	  are	  absolutely	  essential	  for	  male	  viability.	   	  
	   	  
Figure	  25.	  Overexpression	  of	  Msl1	  mutants	  in	  wild	  type	  background	  at	  18°C	  (A)	   Temperature	   dependence	   of	   tub-­‐Gal4	   driven	   expression.	   Protein	   samples	   were	  prepared	  from	  larvae	  grown	  at	  25˚C	  and	  18˚C	  expressing	  UAS-­‐msl1	  genes	  with	  tub-­‐Gal4	  driver	   in	   msl1L60/	  msl1γ269	   null	   background.	   Tubulin	   expression	   was	   assayed	   as	   a	  loading	   control	   and	   endogenous	   Msl3	   protein	   was	   shown	   for	   temperature	  independence	  of	  endogenous	  proteins.	  (B)	  Western	  blots	  were	  done	  as	  in	  (Figure	  24C).	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(C)	  Recovery	  of	  female	  but	  not	  male	  viability	  upon	  weaker/lower	  ectopic	  expression	  of	  Msl1	  mut.12,	  13	  and	  14	  in	  a	  wild	  type	  background	  at	  18˚C.	  Crosses	  were	  performed	  as	  in	  (Figure	  24A)	  but	  the	  flies	  had	  been	  kept	  at	  18˚C.	  Total	  number	  of	  flies	  counted	  for	  this	  assay	  was	  n=	  2376.	  	  
	  
	  	  	  	  	  	  




Figure	   26.	   Rescue	   of	   the	  msl1	   loss-­‐of-­‐function	  male-­‐specific	   lethality	   phenotype	  
by	  ectopic	  expression	  of	  Msl1	  mutants	  in	  msl1L60/msl1γ269	  null	  mutant	  background	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(A)	  The	  cross	  was	  performed	  as	  indicated	  in	  Methods	  and	  schematically	  respresented.	  
(B)	   Transgene	   expressing	  msl1L60/msl1γ269;	   tubGal4/UAS-­‐msl1*	   males	   are	   represented	  with	   black	   and	   corresponding	   females	   with	   red	   bars.	   The	   non-­‐expressing	  
msl1L60/msl1γ269;	  TM6Tb/UAS-­‐msl1*	   internal	   controls	   are	   shown	   in	   grey	   for	  males	   and	  pink	  for	  females.	  Total	  number	  of	  flies	  counted	  was	  n=2428.	  (C)	  Tubulin	  antibody	  was	  used	  for	  loading	  control	  and	  Msl3	  and	  Flag	  antibodies	  were	  probed	  to	  show	  the	  levels	  of	  expression	  of	  transgenic	  Msl1	  and	  endogenous	  Msl3.	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DISCUSSION	  Dosage	   compensation	   is	   an	   excellent	   example	   of	   how	   cells	   can	   fine-­‐tune	   a	   whole	  chromosome	   in	   an	   epigenetic	   manner.	   At	   the	   heart	   of	   the	   dosage	   problem	   lies	   the	  imbalance	  resulting	  from	  the	  structure	  of	  sex	  chromosomes,	  where	  one	  of	  the	  homolog	  bears	  the	  sex	  determining	  region	  and	  structurally	   inert,	  as	   in	  Y	  chromosome	  in	  males.	  	  Although	  recently	  the	  “universality”	  of	  dose	  problem	  have	  been	  questioned163,	  it	  is	  clear	  that,	  at	  least	  in	  model	  organisms	  ranging	  from	  C.	  elegans	  to	  mammals,	  there	  are	  micro-­‐molecular	  machines	   that	   structure	  a	  whole	   chromosome.	   In	  Drosophila	  melanogaster,	  this	   machine	   is	   the	   MSL	   complex	   or	   DCC	   complex	   (Dosage	   compensation	   complex)	  which	   tries	   to	   transcriptionally	   up-­‐regulate	   the	   single	   X	   chromosome	   two	   fold	   in	   a	  surprisingly	  accurate	  manner.	  It	  is	  difficult	  to	  comprehend	  how	  more	  than	  2200	  genes,	  all	   having	   unique	   promoter-­‐distal	   elements	   evolution,	   can	   be	   elevated	   with	   a	   single	  machine.	  Therefore	  it	  is	  not	  unexpected	  to	  witness	  the	  complexity	  and	  the	  diversity	  of	  the	  elements	  MSL	  complex	  brings	  together.	  It	  has	  at	  least	  three	  enzymes,	  Msl2	  and	  Mof	  having	   the	   potential	   to	   post-­‐translationally	   modify	   histones,	   Mle	   being	   an	   RNA	  helicase/chaperone.	   It	   contains	   two	   functionally	   redundant	   long	   non-­‐coding	   RNAs,	  which	  on	  the	  sequence	  level	  have	  minor	  similarity.	  It	  harbors	  a	  histone	  marker	  reader	  (Msl3)	  that	  can	  recognize	  methylation	  of	  histones	  1.	  Furthermore,	  the	  X	  chromosome	  in	  males	   seems	   to	   be	   positionally	   restrained	   to	   nuclear	   periphery138.	   Nevertheless,	   the	  complexity	  could	  be	  broken	  down	  to	  three	  different	  categories;	  	  a)	  Assembly	  problem:	  How	  do	  the	  male	  cells	  promote	  the	  complex	  formation	  whereas	  females	   avoid	   it?	   	   Where	   in	   the	   cell	   does	   the	   complex	   form	   and	   how	   it	   chooses	   the	  integrate	   either	   of	   the	   non-­‐coding	   RNAs?	   Is	   the	   chromatin	   needed	   to	   structurally	  support	  the	  complex	  formation?	  When	  in	  the	  developmental	  stage	  the	  complex	  starts	  to	  function	  and	  how	  is	  this	  coordinated	  with	  developmental	  clues?	  	  	  b)	  Targeting	  problem:	  How	  does	  the	  complex	  recognize	  the	  X	  chromosome?	  What	  are	  the	  genetic	  and	  epigenetic	  marks	  that	  confine	  the	  complex	  to	  one	  single	  chromosome?	  What	  are	  the	  features	  of	  autosomal	  MSL	  binding	  sites?	  	  c)	   Function	   problem:	   How	   does	   the	   MSL	   complex	   regulate	   the	   transcriptional	   up-­‐regulation?	  How	  is	  actually	  two	  fold	  calculated?	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Although	   these	   problems	   seem	   to	   ask	   different	   questions,	   their	   answers	   are	   usually	  entangled	  and	  give	  clues	  to	  one	  another.	  In	  this	  thesis,	  we	  tried	  to	  obtain	  the	  structure	  of	   the	  MSL	   complex	  with	   the	   hope	   that	  we	   could	   contribute	   to	   the	   above-­‐mentioned	  problems.	  As	  expected,	  we	  gained	  considerable	  insight	  from	  the	  structural	  data.	  
Advantages	  of	  having	  point	  mutations	  To	   understand	   the	   contribution	   of	   a	   single	   compartment	   of	   a	   system,	   in	   this	   case,	   a	  protein	  inside	  a	  complex,	  it	  is	  a	  general	  practice	  to	  knock	  down	  or	  knock	  out	  the	  gene	  of	  interest.	  However	  growing	  number	  of	  evidence	  show	  that	  proteins	  are	  not	  usually	  part	  of	  single	  complexes	  with	  single	   functions,	  but	  rather	  have	  multiple	   functions	  that	  may	  reside	   in	  more	  than	  one	  complex.	  A	  relevant	  example	   is	  MOF	  acetyltransferase.	  Mof	   is	  part	  of	  at	   least	  two	  complexes,	  NSL	  and	  MSL83.	  NSL	  is	  a	  major	  regulator	  of	  Drosophila	  genome	   in	   both	   sexes84.	   Furthermore	   mammalian	   MOF	   is	   indicated	   in	   DNA	   damage	  pathway	  acetylating	  p53164,	  acetylation	  of	  TIP5,	  a	  part	  of	  the	  NORC	  complex	  responsible	  for	   regulation	   of	   rRNA	   genes165.	   Therefore,	   RNAi	   against	  Mof	  will	   not	   yield	   a	   dosage	  complex	   phenotype	   but	   rather	   a	   complex	   one.	   Our	   point	   mutation	   analysis	   on	   Msl1	  scaffold	   yields	   surgical	   removal	   of	   proteins,	   creating	   genuine	   partial	   complexes	   and	  enabling	   us	   to	   monitor	   the	   absence	   of	   individual	   proteins	   in	   the	   context	   of	   dosage	  compensation.	   By	   using	   this	  method	  we	   gained	   important	   insights	   into	   targeting	   and	  spreading	  of	  the	  complex.	  	  
Dimerization	  of	  Msl1	  enables	  spreading	  of	  the	  complex	  along	  gene	  bodies	  The	   fact	   that	   Msl1	   dimerizes	   through	   such	   an	   extended	   interface	   and	   the	   dimer	  formation	   is	   required	   for	  Msl2	   binding	   dramatically	   changes	   our	   view	   on	   the	   dosage	  compensation	   complex	   structure	   and	   assembly.	   As	   it	   is	   possible	   to	   co-­‐purify	   the	  recombinant	   human	   MSL1/MSL2/MSL3/MOF	   complex	   from	   insect	   cells	   using	   Flag-­‐tagged	  MSL2	  that	  can	  presumably	  only	  bind	  dimeric	  MSL1,	  it	  is	  very	  likely	  that	  the	  MSL	  complex	  contains	  all	  the	  subunits	  in	  pairs,	  including	  also	  MSL3	  and	  MOF	  18	  (Figure	  26).	  We	  therefore	  propose	  that	  MSL	  complex	  binding	  to	   the	  open	  reading	   frames	  of	   the	  X-­‐linked	   genes	   in	   Drosophila	   happens	   through	   a	   dimer	   dependent	   nucleosome	  engagement.	   The	   presence	   of	   two	   copies	   of	   each	   of	   the	   chromatin	   modifying	   or	  modification	  binding	  domains	  of	   the	   complex	  would	   increase	   the	  number	  of	  possible,	  probably	  transient	  contacts	  with	  nucleosome(s),	  containing	  histones	  also	  in	  pairs.	  The	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Drosophila	   Msl1	   scaffold	   is	   a	   large,	   mostly	   disordered	   protein	   (1039	   residues)	   that	  provides	   the	  MSL	  complex	  with	  high	  degree	  of	   flexibility.	  Msl2	  and	  Mof/Msl3	  binding	  regions	  of	  Msl1	  are	  separated	  by	  720	  poorly	  conserved	  probably	  unstructured	  residues.	  It	  is	  thus	  possible	  that	  while	  some	  subunits	  are	  	  	  	  	  
Figure	  26.	  Summary	  of	  the	  structural	  information	  on	  the	  human	  MSL	  complex.	  	  A	   schematic	   model	   showing	   all	   existing	   structures	   of	   the	   MSL	   sub-­‐complexes	   and	  domains	   including	   the	   MSL1/MSL2	   tetramer	   structure,	   the	   structures	   of	   MSL1	   in	  complex	  with	  the	  MRG	  domain	  of	  MSL3	  and	  the	  HAT	  domain	  of	  MOF	  (PDB	  codes	  2Y0N,	  2Y0M)	   the	   chromo	   barrel	   domain	   of	   MSL3	   (PDB	   code	   3OB9,	   42)	   and	   chromo	   barrel	  domain	  of	  MOF	  (PDB	  code	  1WGS).	  These	  structures,	  together	  with	  sequence	  alignments	  and	   secondary	   structure	   and	   disorder	   predictions	   suggest	   that	   the	   MSL	   complex	   is	  characterized	   by	   ordered	   functional	   domains	   separated	   by	   extensive	   natively	  disordered	   and	   flexible	   regions.	   In	   particular	   MSL1	   contains	   short	   helical	   (or	  unstructured)	   interaction	  peptides	   that	   interact	  with	  MSL2,	  MSL3	  and	  MOF	  separated	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by	   a	   very	   long,	   disordered	   region	   (shown	   as	   red	   dotted	   line).	   Similarly	   the	   chromo	  barrel	  domains	  are	  separated	  from	  the	  MRG	  and	  HAT	  domains	  by	  rather	  long,	  probably	  unstructured	  linkers	  (green	  and	  blue	  dotted	  line).	  The	  only	  defined	  domain	  of	  unknown	  structure	  remains	   the	  CXC	  DNA	  binding	  domain	  of	  MSL2,	  which	   is	  again	  separated	  by	  long	   linker	   from	   the	   N-­‐terminal	   RING	   finger	   (dotted	   line	   in	   cyan).	   As	   it	   is	   currently	  unknown	  whether	  any	  additional	   interactions	  exist	  among	  the	  individual	  proteins	  and	  their	  domains,	  this	  model	  should	  be	  regarded	  only	  as	  schematic	  and	  is	  not	  intended	  to	  imply	   any	   particular	   three-­‐dimensional	   arrangement	   of	   the	   MSL	   complex.	   Putative	  nucleosome	  and	  RNA	  binding	  sites	  are	  labeled.	  
	  attached	   to	   chromatin,	   others,	   connected	   by	   the	   flexible	   Msl1	   linker	   can	   browse	   the	  surrounding	  nucleosomes	   for	  new	  attracting	  histone	  marks.	   It	   is	  well	  established	   that	  MSL	  complex	  can	  spread	  in	  cis	  from	  a	  HAS	  translocated	  to	  autosomes	  depending	  on	  the	  transcription	  status	  of	  the	  nearby	  genes	  35.	  Since	  transcription	  machinery	  will	  generate	  a	  linear	  gradient	  of	  active	  marks	  along	  the	  genes,	  which	  will	  be	  also	  linearly	  erased,	  MSL	  complex	   ‘walking’	   could	   be	   unidirectional	   along	   the	   gene.	   The	   dimer	   dependent	  spreading	   can	   also	   be	   deduced	   from	   the	   ChIP	   analysis	   of	   Msl3/Mof	   deficient	   Msl1	  mutant	  in	  the	  endogenous	  Msl1	  background	  (Figure	  21).	  Msl1	  mut.10	  can	  still	  dimerize	  with	  the	  endogenous	  intact	  Msl1,	  albeit	  low	  levels	  observed	  from	  our	  IP	  analysis	  (Figure	  16),	   however	   it	   cannot	   spread	   to	   the	   open	   reading	   frames,	  which	   indicates	   that	   both	  copies	  of	  Msl3	  and	  Mof	  are	  required	  spreading.	  
Msl1	  and	  X	  chromosome	  recognition	  MSL	  complex	  has	  to	  differentiate	  X	  chromosome	  from	  autosomal	  ones.	  One	  of	   the	  key	  concepts	   in	   this	   manner	   is	   the	   High	   Affinity	   sites	   (HAS)	   already	   suggested	   in	  199485.High	   affinity	   sites	   were	   suggested	   to	   be	   initial	   recruitment	   sites	   to	   the	   X	  chromosome	   but	   only	   years	   later	   their	   sequence	   identity	   is	   discovered	   through	   high	  throughput	  sequencing77.	  Nevertheless,	  it	  is	  not	  clear	  what	  exactly	  these	  ‘landing	  sites’	  are	  and	  if	  there	  are	  other	  clues	  than	  the	  mere	  DNA	  sequence.	  In	  our	  study	  we	  were	  able	  to	   distinguish	   HAS	   qualitatively.	   Our	   work	   strongly	   suggests	   that	  Msl1	   per	   se	   cannot	  recognize	   other	   X-­‐chromosomal	   features	   but	   promoters.	  However,	   binding	   of	  Msl2	   to	  the	   Msl1	   dimer	   has	   two	   important	   consequences:	   rudimentary	   recognition	   of	   X	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chromosome	  and	  roX2	  RNA	  integration	  into	  the	  complex.	  Msl1	  mut.10	  ChIP	  experiment	  shows	  that	  roX2	  HAS	  only	  requires	  Msl1-­‐Msl2	  while	  all	  other	  tested	  HAS	  show	  reduced	  level	  of	  the	  complex	  (Figure	  13	  and	  21).	  We	  propose	  that	  chromatin	  regions	  like	  roX2	  HAS	   are	   the	   “elementary	   high	   affinity	   sites”	  where	   initial	   enrichment	   of	  Msl1	   on	  X	  chromosome	  was	  mediated	  by	  a	  composite	  surface	  of	  Msl1-­‐Msl2.	  We	  currently	  do	  not	  know	   how	  many	   such	   elementary	   sites	   exist	   on	   the	   X	   chromosome.	  High	   throughput	  analysis	   with	   different	   Msl1	   mutants	   is	   required	   to	   understand	   the	   qualitative	  differences	  between	  these	  sites	  and	  other	  high	  affinity	  sites.	   	  Furthermore	  Msl1	  mut.2	  and	  mut.8	  CHIP	   showed	   that	  non-­‐elemenatary	   HAS	   requires	  Mof	   and	  Msl3	   for	   their	  optimal	   binding	   (Figure	   13).	   Grouping	   these	   sites	   according	   to	   their	   location	   in	   a	  transcription	  unit	  revealed	  that	  non-­‐elementary	  HAS	  behave	  very	  similar	   to	   typical	  X-­‐linked	   genes,	  meaning	   that	   their	   ChIP	   recoveries	   drop	   significantly	   in	   the	   absence	   of	  Msl3	  and	  Mof	  however	  unaffected	  if	  they	  are	  at	  the	  promoters.	  	  	  This	  can	  easily	  be	  explained	  with	  the	  hypothesis	  that	  ORF	  spreading	  is	  merely	  mediated	  by	   nucleosome	   engagement,	   most	   probably	   Mof/Msl3	   head	   of	   the	   machine	   but	   the	  promoter	  bindings	  are	  independent	  of	  it	  (Figure	  27).	  	  
MSL	  complex	  and	  roX2	  RNA	  Our	  RIP	   results	   clearly	   show	   that	  Msl1-­‐Mof-­‐Msl3	   trimer	   or	   hexamer	   cannot	   bind	   roX	  RNA	  (corresponding	  to	  Msl1	  mut.	  12	  and	  13),	  which	  indicates	  an	  active	  role	  of	  Msl2	  in	  this	  binding.	  Interestingly	  Msl1	  mut.1	  also	  shows	  significant	  loss	  of	  roX	  RNA	  interaction	  implying	   that	   full	   integration	   happens	   only	   in	   the	   context	   of	   the	   whole	   complex.	   A	  recent	   technology,	   named	   CHIRP,	   has	   shown	   that	   roX2	   RNA	   exclusively	   follows	   the	  binding	  profile	  of	  Msl3	  166.	  It	  is	  tempting	  to	  speculate	  that	  roX2	  RNA	  is	  present	  only	  in	  ORF	   linked	   MSL	   complex	   and	   enables	   crosstalk	   between	   the	   two	   distant	   N-­‐terminal	  Msl1-­‐Msl2	  and	  C	  terminal	  Msl1-­‐Msl3-­‐Mof	  catalytic	  centers	  of	  the	  MSL	  complex.	  	  Although	  Mle	  is	  a	  major	  player	  in	  roX	  RNA	  shaping	  and	  we	  could	  not	  monitor	  its	  status	  with	  respect	  to	  our	  mutants.	  	  However	  Mle	  targeting	  to	  chromatin	  is	  RNAse	  sensitive	  in	  contrast	   to	  Msl1	   and	  Msl2	   44.	  Mle	   can	  not	   be	   immunoprecipitated	  with	  Msl1,	  Msl2	   or	  Msl3	   in	  SL-­‐2	  nuclear	  extracts	   16.	  Richter	  et.al	   also	  observed	   that	  Mle	   is	  not	  associated	  with	  Msl2	  although	  all	  other	  members	  of	  the	  MSL	  complex	  were	  co-­‐immunoprecipited.	  In	  fact	  Mle	  can	  only	  be	  IP’ed	  with	  MSL	  components	  under	  low	  ionic	  strength	  and	  RNAse	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friendly	  conditions	  and	  upon	  0.4	  M	  NaCl	  titration,	  the	  interaction	  is	  diminished	  26.	  In	  our	  experiments	   we	   also	   failed	   to	   see	   Mle	   being	   co-­‐IP’ed	   with	   Msl1	   under	   250	   mM	   salt	  concentrations.	   All	   these	   experiments	   strongly	   suggest	   that	   Mle	   bears	   no	   protein	  contact	  with	  the	  rest	  of	   the	  complex	  but	  only	   is	  bridged	  to	   it	  by	  RNA,	  presumably	  roX	  RNAs.	   Therefore	   RIP	   experiments	   with	   Msl1	   mutants	   are	   still	   relevant	   because	   we	  measure	  roX2	  RNA	  directly.	  	  
Sex	  independent	  binding	  of	  Msl1	  at	  promoters	  	  Our	  study	  reveals	  that	  Msl1	  binds	  Msl2	  at	  promoters	  in	  male	  cells.	  In	  mammals,	  MSL2	  ubiquitinates	   H2BK34	   triggering	   H3K4	   methylation	   and	   ultimately	   expression	   of	   the	  tested	   genes18.	   Since	   this	   crosstalk	  mainly	   happens	   at	   the	   promoters,	  we	  believe	   that	  Msl2	  in	  Drosophila	  might	  function	  similarly.	  Indeed,	  in	  vitro,	  Drosophila	  Msl2	  is	  capable	  of	   ubiquitinating	   Hela	   nucleosomes18.	   Interestingly,	   Kuroda	   and	   colleagues	   also	  observed	   an	   increase	   in	   RNAPII	   occupancy	   at	   autosomal	   promoters	   after	  Msl2	   RNAi,	  arguing	   for	   a	   role	   of	   Msl2	   on	   autosomes	   as	   well	   167.	   Furthermore,	   Msl2	   can	   also	  ubiquitinate	  other	  members	  of	  the	  complex,	  which	  we	  have	  shown	  at	  least	  for	  Msl1	   in	  
vitro,	  and	  may	  have	  a	  regulatory	  role	  on	  the	  assembly	  of	  the	  complex.	  The	  stabilization	  of	  Msl1	  mutants	  that	  cannot	  bind	  Msl2	  both	  in	  cell	  culture	  and	  in	  vivo	  models	  indicates	  a	  role	  of	  Msl2	  in	  controlling	  the	  amount	  of	  Msl1.	  The	  occurrence	  of	  Msl1	  at	  the	  promoters	  in	  both	  sexes	  and	  its	  independence	  from	  other	  members	   of	   the	   complex	   for	   this	   binding	   suggests	   the	   possibility	   of	   an	   evolutionary	  conserved	   function	   in	   higher	   eukaryotes.	   All	   complex	  members,	   except	   for	   Msl2	   and	  Msl1,	   have	   origins	   traceable	   to	   yeast	   17.	   The	   emergence	  of	   	   “Msl1	   like	   genes”,	   namely	  Msl1	  and	  Nsl1	  in	  Drosophila,	  both	  having	  a	  PEHE	  region	  to	  bind	  Mof	  through	  the	  same	  surface	   (Figure	   8),	   seemed	   to	   focus	   this	   ubiquitous	   acetyl-­‐transferase	   to	   promoter	  regions	  of	  a	  large	  portion	  of	  Drosophila	  genome.	  Indeed	  Mof	  binds	  to	  promoters	  in	  both	  sexes	  and	   is	   responsible	   for	   the	  promoter	   chromatin	  H4K16	  acetylation73.	   It	  was	  also	  observed	  that	  RNAi	  of	  Nsl1	  or	  Msl1	  does	  not	  completely	  diminish	  Mof	  occupancy	  at	  the	  promoter,	   probably	   because	   both	   proteins	   have	   complementary	   roles	   84,84.	   It	   will	   be	  interesting	   to	  delineate	  possible	   functional	   interplay	  of	  Msl1	  and	  Nsl1	  at	  promotes	  as	  well	  as	  the	  distribution	  of	  Mof	  between	  these	  two	  proteins.	  It	  is	  important	  to	  note	  that	  Msl1	  is	  not	  essential	  for	  female	  viability,	  possibly	  due	  to	  this	  redundancy	  between	  Msl1	  and	  Nsl1	  in	  terms	  of	  Mof	  recruitment	  to	  the	  promoters.	  Female	  viability	  decreases	  only	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when	   Msl1	   mutants	   that	   have	   intact	   PEHE	   region	   are	   expressed,	   probably	   causing	  mistargeting	   of	   Mof	   or	   diluting	   it	   away	   from	   promoters.	   In	   addition,	   no	   affect	   is	  observed	  upon	   expression	   of	  wild	   type	  Msl1	   or	  mut.10,	   strengthening	   the	   hypothesis	  that	  observed	  female	  phenotypes	  are	  due	  to	  Mof	  rather	  than	  Msl1.	  	  	  The	  distinguishing	  factor	  between	  the	  promoter	  complex	  and	  the	  dosage	  compensation	  complex	  could	  be	  Msl3,	  whose	  binding	  on	  the	  autosomal	  promoters	  was	  undetectable	  and	   X-­‐linked	   promoters	   was	   very	   low.	   It	   will	   be	   crucial	   to	   understand	   how	   Msl3	   is	  excluded	   from	   the	   promoters	   and	   which	   part	   of	   Msl1	   is	   responsible	   for	   promoter	  binding	  (Figure	  27).	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Figure	  27.	  Summary	  of	  the	  MSL	  complex	  chromatin	  interactions	  derived	  from	  this	  
work.	  	  The	  MSL	  complex	  binds	  to	  roX2	  high	  affinity	  site	  on	  male	  X	  chromosome	  in	  an	  Msl3-­‐Mof	  independent	   manner.	   RoX2	   HAS	   may	   represent	   one	   of	   the	   ‘’elementary	   high	   affinity	  sites’’.	  The	  MSL	  complex	  must	  be	  in	  the	  dimeric	  state	  for	  binding	  to	  open	  reading	  frames	  on	  X	  chromosome.	  Long,	  flexible	  Msl1	  linkers	  between	  the	  coiled	  coil	  and	  PEHE	  regions	  might	   enable	   the	   complex	   to	   interact	  with	   chromatin	   in	   various	   configurations.	  Msl1	  binds	   to	   male	   and	   female	   promoters	   in	   a	   dimerization/Msl	   proteins-­‐independent	  manner.	   In	   males	   and	   females,	   autosomal	   promoters	   are	   depleted	   of	   Msl3,	   however	  there	   is	   a	   slight	   enrichment	   on	   X-­‐linked	   promoters	   in	  males.	  We	   cannot	   rule	   out	   the	  existence	  of	  another	  protein	  that	  binds	  Msl1	  in	  a	  similar	  manner	  to	  Msl2	  on	  promoters	  in	  females.	  Color	  coding	  of	  proteins	  is	  similar	  to	  Figure	  17	  and	  26.	  
	  In	   summary,	  our	   study	  enhances	  our	  perspective	  on	   the	  architecture	  of	  MSL	  complex	  and	  how	  this	  configuration	  could	  help	  spreading	  of	  MSL	  complex	  on	  X	  chromosome.	  	  We	  show	   that	   Msl1	   plays	   a	   key	   structural	   role	   in	   the	   assembly	   and	   function	   of	   the	  MSL	  complex	  in	  Drosophila,	  where	  it	  acts	  as	  scaffold	  protein.	  Msl1	  dimerization	  is	  required	  for	  Msl2	  binding	  and	  roX2	  integration.	  Loss	  of	  either	  of	  these	  interactions	  has	  a	  severe	  consequence	  on	  X	  chromosome	  binding,	  which	  causes	  male	  lethality.	  We	  believe	  that	  a	  dimeric	   perspective	   of	   the	   MSL	   complex	   has	   a	   better	   explanatory	   power	   over	   the	  monomeric	  model.	  We	  showed	  the	  differences	  between	  high	  affinity	  sites	  and	  how	  they	  may	   form	   a	   gradient	   of	   affinities	   to	   help	   MSL	   spread	   more	   efficiently	   on	   the	   X	  chromosome.	   Our	   data	   also	   demonstrate	   for	   the	   first	   time	   dosage	   compensation	  complex	  independent	  function	  of	  Msl1	  on	  male	  and	  female	  promoters.	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MATERIALS	  AND	  METHODS	  
Cloning	  of	  Msl1	  mut.1-­‐8	  and	  Nsl1	  mutants	  for	  expression	  in	  Drosophila	  SL-­‐2	  cells	  
Drosophila	  Msl1-­‐Flag	  cDNA	  was	   initially	  cloned	  into	  a	  pFASTBac	  6His	  vector	  (a	  vector	  generated	   from	   pFASTBacTM1	   -­‐Invitrogen-­‐	   by	   introduction	   of	   a	   6His	   tag	   for	   the	  expression	   of	   N-­‐terminally	   tagged	   proteins).	   The	   various	   mutants	   of	   Msl1	   were	  generated	   in	   this	   vector	  by	  mutagenesis.	   For	   the	  expression	   in	  SL-­‐2	   cells,	   sub-­‐cloning	  was	  carried	  out	  through	  NotI-­‐XbaI	  restriction	  sites	  into	  the	  pAc5.1/V5-­‐His	  A.	  For	  stable	  cell	   line	   generation,	   we	   sub-­‐cloned	   all	   our	   constructs	   under	   Cu+2	   inducible	   MtnA	  promoter	   in	   pIBU1.	   Nsl1	  was	   initially	   cloned	   into	   SL-­‐2	   expression	   vector	   pBSactTAP,	  which	   is	  designed	   to	  express	  N-­‐terminally	  TAP	   tagged	  proteins.	  An	  oligo	   containing	  a	  Flag/HA	   tag	  was	   inserted	  downstream	  of	  N-­‐TAP.	  Mutagenesis	  was	   carried	  out	   in	   this	  vector.	  	  
Generation	  of	  3xFlag	  tagged	  piBU	  constructs	  pIBU	  vectors	   contain	   .Neomycin	  Resistance	   cassette	   expressed	  by	  Act5	  promoter	   and	  terminated	   by	   SV40	   teminator.	   PIBU1	   series	   contain	   MtnA	   promoter	   for	   Cupper	  inducible	   gene	   expression	   and	   pIBU2	   series	   have	   Act5c	   promoters	   for	   high	   levels	   of	  expression	   and	   generally	   used	   for	   transient	   transfections.	   3xFLAG	   and	   6	   His	   tag	  (DYKDHDDYKDHDDYKDDDDKHHHHHH)	   sequence	   was	   inserted	   into	   piBU2	   as	   a	   C	  terminal	   tag.	   Subcloning	   between	   pIBU1	   and	   2	   was	   done	   by	   PacI-­‐AscI	   rare	   cutters,	  which	  can	  swap	  the	  whole	  ORF	  in	  the	  multiple	  cloning	  site.	  	  
Transient	  transfections	  	  Msl1	  constructs	  for	  transient	  transfections	  are	  under	  short	  Actin	  5c	  promoter	  and	  have	  3xFlag-­‐6his	  C	  terminal	  tags.	  For	  dimerization	  experiments,	  2	  µg	  of	  each	  vector	  were	  co-­‐transfected	  to	  25	  million	  SL-­‐2	  and	  Kc	  cells	  using	  Effectene	  (Qiagen)	  reagent	  according	  to	  manufacturer’s	  suggestions.	  After	  48	  hours	  cells	  were	  harvested.	  For	  Msl2	  expression	  in	  Kc	  cells,	  Msl2	  constructs	  were	  cloned	  under	  MtnA	  promoter,	   together	  with	  C	  terminal	  3xFlag-­‐6his	  epitope.	  15	  million	  cells	  were	  transfected	  in	  10	  cm	  dish	  and	  after	  24	  hours,	  induced	  with	  250	  µM	  CuSO4.	  After	  24	  hours	  of	  induction,	  cells	  were	  harvested.	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Generation	  of	  Stable	  cells	  lines	  	  SL-­‐2	   cells	   were	   seeded	   on	   6	   well	   plates	   for	   80%	   confluency,	   corresponding	   to	   1-­‐2	  million	   cells.	   The	   cells	   were	   transfected	   with	   0.5	   µg	   of	   DNA	   by	   Qiagen	   Effectene	  Transfection	   Reagent.	   After	   two	   days,	   the	   cells	  were	   diluted	   to	   1:5	   and	   1:10.	   Twelve	  hours	  later,	  the	  medium	  was	  changed	  with	  the	  one	  that	  contains	  1	  mg/ml	  Geneticin.	  The	  cells	  were	  selected	  at	   least	   two	  weeks,	  until	   the	  WT	  cells	  were	  completely	  eliminated.	  For	   the	   subsequent	   amplification	   of	   the	   cells,	   0.5	  mg/ml	  Geneticin	   concentration	  was	  used.	  All	  stable	  lines	  were	  controlled	  by	  MtnB	  promoter	  to	  prevent	  the	  over-­‐expression	  of	  MSL1	  and	  its	  mutants	  during	  the	  selection	  period	  and	  for	  the	  induction,	  0.5	  µM	  CuSO4	  was	  used	  for	  12	  hours.	  	  
Flag	  immunoprecipitations	  Harvested	  cells	  were	  washed	  with	  cold	  PBS	  two	  times	  and	  resuspended	  in	  1	  ml	  HEMGT	  150	  buffer	  (25	  mM	  Hepes/KOH	  7.6,	  0.1	  mM	  EDTA,	  12.5	  mM	  MgCl2,	  10%	  Glycerol,	  0.2%	  Tween-­‐20,	  150	  mM	  KCl).	  After	  3	  times	  freeze	  thaw	  cycle	  in	  liq.	  N2	  and	  37°C	  waterbath,	  extract	  was	  centrifuged	  for	  30	  minutes	  in	  20000g.	  30	  μl	  bed	  volume	  of	  M2-­‐Flag	  agarose	  beads	  (Sigma)	  were	  incubated	  for	  3	  hours	  at	  4°C.	  The	  beads	  were	  washed	  for	  5	  times	  in	  HEMGT	  250	  and	  boiled	  with	  40	  μl	  of	  4X	  Laemmli	  Buffer.	  	  	  
Fractionation	  of	  SL-­‐2	  cells	  Wild-­‐type	  or	   transiently	   transfected	   cells	  were	  harvested	   and	  washed	  once	  with	  PBS.	  After	  determination	  of	   the	   volume	  of	   the	   cell	   pellet,	   the	   cells	  were	   re-­‐suspended	   in	  5	  PCV	  (pellet	  cell	  volume)	  of	  hypotonic	  buffer	  (10	  mM	  HEPES/KOH	  7.9,	  1,5	  mM	  MgCl2,	  10	  mM	  KCl,	  1	  mM	  PMSF	  and	  1X	  Protease	  Inhibitor	  cocktail	  solution)	  for	  15	  minutes	  at	  4°C.	  After	   incubation,	   the	   swollen	   cells	   were	   vortexed	   for	   30	   seconds	   in	   1%	   NP-­‐40.	   The	  supernatant	  was	  kept	  as	  cytoplasmic	  extract.	  The	  nuclei	  were	  pelleted	  with	  2000g	  for	  5	  minutes	  and	  washed	  with	  an	  isotonic	  solution	  (10	  mM	  HEPES/KOH	  7.6,	  2	  mM	  MgCl2,	  3	  mM	  CaCl2,	  300	  mM	  Sucrose,	  1	  mM	  PMSF	  and	  1X	  Protease	   Inhibitor	  cocktail	   solution).	  The	  washed	  nuclei	  were	  re-­‐suspended	  in	  5	  PCV	  of	  extraction	  buffer	  with	  150	  mM	  NaCl	  (20	  mM	  HEPES/KOH	  7.4,	  10%	  glycerol,	  150-­‐420	  mM	  NaCl,	  1	  mM	  MgCl2,	  0.1%	  Triton	  X-­‐100,	  1	  mM	  DTT,	  1X	  Protease	  Inhibitor	  cocktail	  solution)	  and	  rocked	  for	  2	  hours	  in	  the	  cold	   room.	   The	   extracted	   nuclei	   were	   centrifuged	   at	   22000g	   for	   15	   minutes.	   The	  supernatant	  was	  kept	   as	   the	  nucleoplasmic	   extract.	   The	  pellet	  was	   re-­‐suspended	   in	  5	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PCV	  of	  150	  mM	  salt	  extraction	  buffer	  and	  solubilized	  by	  Benzonase.	  Equal	  amounts	  of	  fractions	  were	  analyzed	  by	  western	  blot.	  	  
Immunofluorescence	  for	  SL-­‐2	  cells	  	  1	  million	  cells	  were	  harvested	  and	  washed	  with	  PBS.	  The	  cells	  were	  swollen	  in	  500	  µl	  0.5%	   sodium	   citrate	   for	   7	   minutes	   and	   loaded	   through	   a	   single	   chamber	   cytospin	  tunnel.	  The	  cells	  were	  spun	  for	  10	  minutes	  at	  900	  rpm.	  The	  slides	  were	  put	  in	  fixative	  solution	   (4%	   formaldehyde	   in	   PBS,	   0.1%	  Triton	  X-­‐100)	   for	   8	  minutes	   in	   a	   Coplin	   jar.	  After	  washing	  three	  times	  with	  PBS-­‐T,	  the	  cells	  were	  blocked	  with	  1%	  milk	  containing	  PBS-­‐T.	  Anti-­‐Flag	  mouse	  and	  anti-­‐MOF	  rabbit	  were	  used	   in	  1:100	  dilutions	   in	  1%	  milk	  containing	  PBS-­‐T	  overnight	  at	  4°C	  in	  a	  wet	  chamber.	  	  Secondary	  antibodies	  mouse-­‐488	  and	   rabbit	   TritC	   were	   used	   in	   1:200	   dilutions	   at	   37°C.	   	   After	   DAPI	   staining	   and	  mounting,	  the	  cells	  were	  mounted	  and	  watched	  at	  63X	  objective.	  	  
ChIP	  protocol	  from	  SL-­‐2	  cells	  SL-­‐2	  cells	  were	  harvested	  and	  washed	   twice	  with	  PBS.	  The	  cells	  were	  resuspended	   in	  Fixation	  buffer	  (50	  mM	  Hepes/NaOH	  pH	  8.0,	  1	  mM	  EDTA,	  0.5	  mM	  EGTA,	  100	  mM	  NaCl)	  and	   fixed	  with	   1.8%	  Formaldehyde	   (final	   concentration).	   The	   reaction	  was	   quenched	  with	   2.5	  M	   Glycine	   and	  washed	  with	   the	   following	   buffers	   for	   3	   times;	   Paro	   Rinse	   1	  (10mM	   Tris	   pH	   8.0,	   10mM	   EDTA,	   0.5mM	   EGTA,	   0.25%	   TritonX-­‐100),	   Paro	   Rinse	   2	  (10mM	  Tris	  pH	  8.0,	  200mM	  NaCl,	  1mM	  EDTA,	  0.5mM	  EGTA),	  and	  RIPA	  buffer	  (140mM	  NaCl,	   25mM	   HEPES	   pH	   7.5,	   1mM	   EDTA,	   1%	   TritonX-­‐100,	   0.1%	   SDS,	   0.1%	   DOC,	  supplemented	  with	  Protease	   Inhibitors).	  The	  cells	  were	  sonicated	   in	  RIPA	  buffer	  with	  Branson	   sonicator	   (Power	   output	   3%,	   Pulse	   duration	   40,	   30	   cycles	   in	   total	   and	   each	  cycle	  20	  seconds	  pulse	  and	  50	  seconds	  off).	  	  The	  fragmentation	  of	  the	  DNA	  was	  checked	  with	  agarose	  gels.	  	  The	  sonicated	  sample	  was	  centrifuged	  at	  14	  krpm	  for	  30	  minutes	  and	  the	   chromatin	   supernatant	  was	   cleared	  with	  blocked	  protein	  A-­‐Sepharose	  beads.	   The	  beads	  had	  been	  blocked	  with	  800	  µl	  RIPA,	  100	  µl	  salmone	  sperm	  DNA	  (10mg/ml)	  and	  100µl	   (100X	   NEB	   BSA)	   for	   1hr	   at	   4°C.	   For	   each	   immunoprecipitation,	   30	   µg	   DNA	  containing	  chromatin	  was	  incubated	  overnight	  with	  3	  µl	  antibody	  and	  collected	  with	  20	  
µl	   (bed	   volume)	   of	   blocked	   Protein	   A-­‐	   Sepharose	   Beads.	   For	   the	   Flag	   tag	   containing	  samples,	   the	   beads	   were	   bridged	   with	   rabbit	   anti-­‐mouse	   polyclonal	   antibody	   (from	  Active	  Motif).	  The	  beads	  were	  washed	  four	  times	  with	  RIPA	  buffer,	  one	  time	  with	  LiCl	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buffer	   (250mM	  LiCl,	  10mM	  Tris-­‐HCl	  pH	  8.0,	  1mM	  EDTA,	  0.5%	  NP-­‐40,	  0.5%	  DOC)	  and	  one	  time	  with	  TE	  buffer	  (10mM	  Tris-­‐HCl	  pH	  8.0,	  1mM	  EDTA).	  After	  resuspension	  in	  100	  ul	   of	   TE	   buffer,	   the	   precipitated	   chromatin	  was	   decrosslinked	   overnight	   at	   65°C.	   The	  sample	  was	  treated	  with	  1µl	  of	  10mg/ml	  RNAse	  A	  at	  37°C	  for	  30	  minutes	  and	  1.3µl	  of	  10mg/ml	  Proteinase	  K	  (plus	  5µl	  of	  10%	  SDS)	  for	  2	  hours.	  The	  sample	  was	  purified	  with	  MiniElute	  columns	  of	  Qiagen	  according	  to	  the	  manufacturer’s	  recommendations.	  	  
Chromatin	  Immunoprecipitaion	  in	  SL-­‐2	  cells	  with	  Chelex	  Method	  ChIP	  was	   carried	   out	   with	   a	   few	  modifications.	   After	   overnight	   IP,	   10%	   Inputs	  were	  taken,	   mixed	   with	   3	   volumes	   of	   100%	   ethanol,	   15	   μg	   GlycoBlue	   (Ambion)	   and	   was	  incubated	  at	  -­‐80°C	  during	  immunocollection	  by	  ProtA	  Sepharose	  beads	  (GE	  Healthcare).	  The	   beads	   were	   washed	   as	   before	   and	   finally	   after	   TE	   wash,	   the	   beads	   were	  resuspended	   in	  100	  μl	  10	  %	  Chelex	   solution.	   Input	   samples	  were	   centrifuged	  20000g	  for	  30	  minutes,	  washed	  with	  70%	  ethanol,	   vacuum	  dried	  at	  30°C	  and	   resuspended	   in	  100	   μl	   10%	   Chelex	   solution.	   All	   samples	  were	   decrosslinked	   at	   95°C	   for	   10	  minutes,	  cooled	  and	  incubated	  with	  20	  μg	  of	  Proteinase	  K	  for	  1	  hour	  at	  55°C.	  The	  samples	  were	  incubated	  at	  95C	  again	   for	  10	  minutes	  and	  centrifuged	  at	  20000g.	  Without	   taking	  any	  Chelex	   beads,	   supernatants	   were	   transferred	   to	   a	   new	   tube.	   The	   chelex	   modified	  protocol	   was	   adapted	   from	   157.	   Quantitative	   PCR	   was	   carried	   out	   with	   FastStart	  Universal	  SYBR	  Green	  Master	  (Roche).	  	  
RNA	  immunoprecipitation	  	  RIP	  was	  carried	  out	  essentially	  the	  same	  as	  158	  with	  25	  million	  SL-­‐2	  stable	  lines	  that	  had	  been	   induced	  with	  CuSO4	   for	  12	  hours.	  The	  cells	  were	   fixed	  with	  1%	  formaldehyde	  at	  room	  temperature	  for	  15	  minutes.	  Formaldehyde	  is	  quenched	  with	  200mM	  Glycine	  for	  5	  minutes	  at	  room	  temperature.	  The	  cells	  are	  pelleted	  by	  centrifugation	  at	  1000g	  for	  5	  minutes	  and	  washed	  twice	  with	  ice-­‐cold	  PBS.	  Then	  the	  cells	  are	  re-­‐suspended	  in	  500µL	  of	  FA	  lysis	  buffer	  (50mM	  HEPES/KOH	  7.6,	  140	  mM	  NaCl,	  1	  mM	  EDTA,	  1%	  (v/v)	  Triton	  X-­‐100,	   0.1%	   (w/v)	   sodium	  deoxycholate,	   40u/mL	  RNasin,	   1xProtease	   inhibitors)	   and	  spun	  at	  3000g	  for	  30	  seconds.	  Supernatant	  is	  discarded	  and	  the	  pellet	  is	  re-­‐suspended	  in	   600µL	   of	   FA	   lysis	   buffer	   and	   sonicated	   using	   a	   Branson	   sonifier	   (Power	   output:	   3,	  Duty	  cycle:	  40,	  10	  cycles.	  Each	  cycle:	  20	  seconds	  on,	  50	  seconds	  off).	  Sonicated	  extract	  is	  transferred	  into	  a	  new	  tube	  and	  centrifuged	  at	  maximum	  speed	  for	  10	  minutes	  at	  4˙C.	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Supernatant	   is	   transferred	  to	  a	  new	  tube	  and	  the	  centrifugation	   is	  repeated	  once.	  The	  extract	  is	  then	  pre-­‐cleared	  over	  50µL	  of	  Protein	  A	  sepharose	  beads	  for	  1	  hr	  at	  4˙C.	  Beads	  are	  removed	  by	  centrifuging	  at	  1000g	  for	  2	  minutes	  at	  4˙C.	  Supernatant	  is	  transferred	  into	   a	  new	   tube	  and	  made	   to	  25mM	  MgCl2	   and	  5mM	  CaCl2.	   3µL	  RNasin	   and	  6µL	  RQ1	  RNase-­‐free	   DNase	   (Promega)	   is	   added	   and	   the	   extract	   is	   incubated	   at	   37˙C	   for	   30	  minutes.	   The	   reaction	   is	   stopped	   by	   adding	   EDTA	   to	   20mM.	   Insoluble	   material	   is	  disposed	  of	  by	  centrifuging	  at	  maximum	  speed	  for	  10	  min	  at	  4˙C.	  Supernatant	  is	  either	  used	  immediately	  or	  snap-­‐frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80˙C	  until	  use.	  	  Extract	   coming	   from	  about	   a	  million	   cells	   is	   diluted	   to	  500µL	  with	  FA	   lysis	  buffer	   for	  each	  IP.	  50µL	  of	  this	  solution	  is	  saved	  as	  INPUT.	  3µL	  of	  anti-­‐FLAG	  (M2)	  or	  3µL	  of	  anti-­‐Mle	  antibody	  is	  added	  and	  the	  tubes	  are	  incubated	  in	  the	  cold	  room	  overnight	  with	  end-­‐over-­‐end	   rotation.	  The	  RIPs	  are	   centrifuged	  at	  maximum	  speed	   for	  10	  minutes	   at	  4˙C	  and	  the	  supernatants	  are	  transferred	  into	  a	  new	  tube	  that	  contains	  40µL	  of	  Protein	  A	  or	  G	  slurry.	  Incubation	  was	  for	  90	  minutes	  in	  the	  cold	  room.	  Then,	  the	  beads	  are	  pelleted	  by	   centrifugation	   at	   1000g	   for	  2	  minutes	   and	  washed	  once	  with	  FA	   lysis	   buffer,	   once	  with	  FA500	  buffer	  (50	  mM	  HEPES,	  pH	  7.5,	  500	  mM	  NaCl,	  1	  mM	  EDTA,	  1%	  (v/v)	  Triton	  X-­‐100,	  0.1%	  (w/v)	  sodium	  deoxycholate,	  1xProtease	  Inhibitors,	  40u/mL	  RNasin),	  once	  with	   LiCl	   buffer	   (10	  mM	  Tris·Cl,	   pH	  8,	   250	  mM	  LiCl,	   0.5%	   (v/v)	   Igepal	   CA	  630,	   0.1%	  (w/v)	   sodium	  deoxycholate	   1	  mM	  EDTA,	   1xProtease	   Inhibitors,	   40u/mL	  RNasin)	   and	  once	  with	  TE	  buffer	   (10	  mM	  Tris·Cl,	   pH	  8,	  1	  mM	  EDTA,	  100	  mM	  NaCl)	   for	  5	  minutes	  each	   in	   the	   cold	   room	  with	   end-­‐over-­‐end	   rotation.	   TE	   buffer	   is	   removed	   as	  much	   as	  possible	  and	  the	  immune	  complexes	  are	  eluted	  with	  75µL	  of	  RIP	  elution	  buffer	  (100	  mM	  Tris·Cl,	  pH	  8,	  10	  mM	  EDTA,	  1%	  (w/v)	  SDS,	  40U/mL	  RNasin)	  by	  incubation	  at	  37˙C	  for	  10	  minutes.	  The	  beads	  are	  pelleted	  by	   centrifugation	  at	  1000g	   for	  2	  minutes	  at	   room	  temperature,	  the	  supernatant	  is	  transferred	  into	  a	  new	  tube	  and	  the	  elution	  is	  repeated	  with	  another	  75µL	  of	  RIP	  elution	  buffer.	  Eluates	   are	   pooled,	   made	   to	   200mM	   NaCl	   and	   0.13µg/µL	   Proteinase	   K.	   Protease	  digestion	   was	   carried	   out	   by	   incubating	   the	   eluates	   at	   42˙C	   for	   1	   hour,	   followed	   by	  reversal	   of	   formaldehyde	   cross-­‐links	   by	   incubating	   at	   65˙C	   for	   1	   hour.	   Input	   samples	  saved	  before	  are	  processed	   in	  parallel.	  Onto	  each	  RIP,	  100µL	  nuclease-­‐free	  water	  and	  250µL	   acid-­‐phenol:	   chloroform	   is	   added.	   Phase	   separation	   is	   carried	   out	   in	  MaxTrak	  tubes	   (Qiagen)	   by	   centrifugation	   at	   10000g	   for	   3	  minutes	   at	   room	   temperature.	   The	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aqueous	   phase	   is	   transferred	   into	   a	   new	   tube	   and	   the	   RNA	   is	   precipitated	   by	   adding	  25µL	   of	   3M	   sodium	   acetate,	   20µg	   glycogen	   and	   625µL	   ice-­‐cold	   absolute	   ethanol	   and	  incubating	  the	  mixture	  at	  -­‐20˙C	  overnight.	  RIPs	  are	  centrifuged	  at	  maximum	  speed	  for	  30	  minutes	  are	  4˙C.	  Supernatant	  is	  discarded	  and	  the	  pellet	  is	  washed	  with	  ice-­‐cold	  70%	  ethanol.	  After	  a	  final	  centrifugation	  at	  maximum	  speed	  for	  5	  minutes	  at	  4˙C,	  supernatant	  is	   discarded	   and	   the	   pellet	   is	   air-­‐dried	   for	   5-­‐10	  minutes.	   90µL	   nuclease-­‐free	  water	   is	  used	   for	   re-­‐solubulizing	   the	   RNA	   pellet.	   10µL	   TURBO	   DNase	   buffer	   and	   1µL	   TURBO	  DNase	   (Ambion)	   is	   added	   and	   the	  mixture	   is	   incubated	   at	   37˙C	   for	   30	  minutes.	   10µL	  DNase	  inactivation	  reagent	  is	  pipetted	  to	  each	  tube	  and	  the	  tubes	  are	  incubated	  at	  room	  temperature	   for	   2	   minutes	   with	   occasional	   shaking.	   The	   tubes	   are	   centrifuged	   at	  10,000g	  for	  2	  minutes	  and	  the	  supernatants	  are	  transferred	  into	  fresh	  tubes.	  These	  RNA	  samples	  are	  either	  used	  immediately	  for	  reverse	  transcription-­‐qPCR	  or	  stored	  at	  -­‐80˙C	  until	   use.	   Reverse	   transcription	   and	   PCR	  were	   carried	   out	   in	   the	   same	   tube	   by	   using	  reverse	   transcriptase	   and	   RNasin	   in	   the	   SYBR	  mix,	   and	   adding	   a	   step	   of	   50˙C	   for	   30	  minutes	  before	  the	  start	  of	  PCR	  amplification.	  
Baculovirus	  mediated	  expression	  in	  Sf21	  cells	  50	   million	   exponentially	   grown	   Sf21	   cells	   were	   infected	   with	   1	   ml	   high	   titer	   virus	  stocks.	  After	  two	  days	  infection,	  the	  cells	  were	  harvested,	  washed	  once	  with	  PBS	  and	  re-­‐suspended	   in	   10	  ml	   of	   HEMGT	   150	   buffer.	  Whole	   cell	   extraction	   was	   carried	   out	   by	  three	  cycles	  of	  freeze-­‐thaw.	  For	  each	  Flag	  pull	  down,	  50	  μl	  Anti-­‐Flag	  M2	  Agarose	  beads	  were	   incubated	  with	   the	  extracts	   for	  2	  hours	  at	  4°C.	  The	  beads	  were	  washed	  5	   times	  with	  HEMGT	  500	  and	  once	  with	  HEMGT	  200	  buffer.	  The	  proteins	  were	  eluted	  with	  250	  ng/μl	  3XFlag	  peptide	  overnight	  at	  4°C.	  	  
In	  vitro	  reconstitution	  assay	  50	  million	  exponentially	  grown	  Sf21	  cells	  were	  infected	  with	  5	  ml	  high	  titer	  virus	  stock.	  After	   two	   days	   infection,	   the	   cells	   were	   harvested,	   washed	   once	   with	   PBS	   and	   re-­‐suspended	   in	   10	  ml	   of	   HEMGT	   150	   buffer.	  Whole	   cell	   extraction	   was	   carried	   out	   by	  three	  cycles	  of	  freeze-­‐thaw.	  For	  the	  dimeric	  or	  trimeric	  reconstitutions,	  equal	  amounts	  of	  extracts	  were	  mixed	  and	  incubated	  for	  2	  hours	  at	  4°C.	  	  For	  each	  Flag	  pull	  down,	  100	  μl	  Anti-­‐Flag	  M2	  Agarose	  beads	  were	  incubated	  with	  the	  extracts	  for	  2	  hours	  at	  4°C.	  The	  beads	   were	   washed	   twice	   with	   HEMGT	   500	   and	   once	   with	   HEMGT	   200	   buffer.	   The	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proteins	  were	  eluted	  with	  400	  ng/μl	  Flag	  peptide	  overnight	  at	  4°C.	  Eluted	  proteins	  were	  TCA	  precipitated	  and	  loaded	  on	  NuPAGE®	  Bis-­‐Tris	  4-­‐12%	  gradient	  gels.	  	  
In	  vitro	  Ubiquitination	  reactions	  hE1	  (100	  nM),	  hUbcH5b(250nM),	  5	  uM	  HA-­‐Ubiquitin	  and	  5mM	  ATP	  were	  used	   in	   the	  reactions.	   Proteins	   at	   100	   ug/ul	   were	   incubated	   up	   to	   30	   minutes	   at	   30°C	   at	   slow	  shaking	  at	  a	  termoshaker.	  Negative	  controls	  were	  carried	  out	  without	  ATP.	  	  
Fly	  culture	  and	  rearing	  conditions	  Unless	  otherwise	  specified,	  flies	  (Drosophila	  melanogaster)	  were	  reared	  on	  standard	  fly	  medium	   at	   25°C	   and	   70%	   relative	   humidity	   and	   12	   hrs	   dark/12	   hrs	   light	   cycle.	   All	  transgenic	   lines	   carrying	   mutant	   versions	   of	   msl1	   were	   generated	   through	   phiC31	  integrase-­‐mediated	  germ-­‐line	  transformation	  using	  y1	  M{vas-­‐int.Dm}ZH-­‐2A	  w*;	  PBac{y+-­‐
attP-­‐3B}VK00033	   (Bloomington	   stock	   #24871).	   The	   following	   stocks	   were	   obtained	  from	  the	  Bloomington	  stock	  centre	  or	  were	  kindly	  donated:	  y1	  w*;	  P{tubP-­‐GAL4}LL7/TM3,	  
Sb1	  	  (Bloomington	  stock	  #5138),	  msl1L60/CyO	  (Mitzi	  Kuroda),	  msl1γ269	  cn1	  bw1/CyO	  (John	  Lucchesi),	   w*;	   In(2LR)noc4LScorv9R,	   b1/CyO,	   P{ActGFP}JMR1	   (Bloomington	   stock	   #4533)	  
Eip75BÎ”51/TM6B,	  P{Ubi-­‐GFP.S65T}PAD2,	  Tb1	  (Bloomington	  stock	  #23652).	  All	  lines	  used	  in	  this	  study	  were	  generated	  by	  standard	  genetic	  crosses	  from	  the	  above	  listed	  stocks.	  In	  order	  to	  obtain	  flies	  ectopically	  expressing	  mutant	  msl1	  in	  a	  wild	  type	  background	  y1	  w*;	  
P{tubP-­‐GAL4}LL7/	   TM6B,	   P{Ubi-­‐GFP.S65T}PAD2,	   Tb1	   virgin	   females	   were	   crossed	   with	  males	  homozygous	   for	   the	  appropriate	  UAS-­‐msl1*	   transgenic	   insertion.	  For	  analysis	   in	  
msl1	   null	   mutant	   background	   y1	   w*;	   msl1L60/CyO,	   P{ActGFP}JMR1;	   P{tubP-­‐GAL4}LL7/	  
TM6B,	  Tb1	  virgin	  females	  were	  crossed	  with	  y1	  w*;	  msl1γ269	  cn1	  bw1/CyO,	  P{ActGFP}JMR1;	  
P{UAS-­‐msl1*}65B2	  males.	  
Preparation	  of	  larval	  protein	  extracts	  for	  Western	  blot	  analysis	  To	   extract	   proteins	   for	   immunoblotting,	   50	   second-­‐instar	   larvae	   of	   the	   appropriate	  genotype	  were	  collected	  in	  1.5ml	  Eppendorf	  tubes	  on	  ice	  and	  washed	  with	  1ml	  ice-­‐cold	  1	   x	   PBS	   buffer.	   The	   larvae	   were	   homogenized	   in	   100	   µl	   2x	   ROTH	   lysis	   buffer	   with	  freshly	   added	   1:1000	   antifoam	   A	   (Sigma,	   A5633)	   and	   protease	   inhibitor	   cocktail	  (Roche)	  at	  4⁰C.	  Homogenates	  were	  sonicated	  for	  10	  sec	   in	  a	  Branson	  250	  sonicator	  at	  40	   pulse	   intensity	   1,	   boiled	   for	   10	   min	   at	   95°C	   and	   sonicated	   again.	   After	   5	   min	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centrifugation	  at	  16000g	  in	  a	  table-­‐top	  centrifuge	  at	  4°C	  supernatants	  were	  transferred	  to	  fresh	  Eppendorf	  tubes	  and	  either	  immediately	  used	  for	  SDS-­‐PAGE	  or	  stored	  at	  -­‐20°C.	  
Primers	  
CHIP	  PRIMERS	   FORWARD	   REVERSE	  
roX2	  3'	  	   ACG	  GTG	  CTG	  GCT	  TAG	  AGA	  GA	   GGC	  GGA	  AAT	  GTA	  TTT	  GCA	  GT	  
Su(wa)	   TGTGTTGTCAGGGATCCAAA	   TTCGAGTTGATGCGAACAAG	  
1B4	  	   ATCTCGCTGTTATCGGTTGC	   TCAAGTTGATCGTGGAGCAG	  1C4	  	   AAAGAGCACCAACCGATCAC	   AAAGACATTTGGTTGTGGGC	  
1C5	  	   ATATTTTGATCGAGGTGGCG	   TCTGGCACATCTTTGAGCAC	  
2A1	   CTGATCGTCGTAAAAACGCA	   TAAAAGGCTGCCACAGCTTC	  
2A4	   CGTAGAGCAGTCTGCCATTG	   CAATCGCGGTTTTATGACCT	  
2B1	   GAAGCACGTGATATTGGGCT	   GCACTACATCAGCACAGCGT	  
2B7	   GACAGGGAGATTAATGGGCA	   CTTGTCCGGTCGATTTTTGT	  
2B14	   GCGACTATATAGGACCGCCA	   TCCAGAAGTCCGTGTTCCAT	  
2C4	   TCGCCATCTCTGTCTGTCTG	   TACTTCCGTTTCCGCTCACT	  
2C8	   TGAAACGTGTCATCTCGCTC	   TGACTTCGTTAGGGAATGGC	  
2F1	   GCTAAGTTTGGATTGCCCTG	   CTGCATATAGGGTTTGCCGT	  
3A1	   TGGTTGTCCACCAAAGTGAA	   CAGGCAACCCATCTCTCTCT	  
rpl22	  promoter	  	   CAA	  TCC	  AAT	  GCG	  CAG	  TTA	  TG	   AAG	  GCC	  TTG	  TTC	  GCA	  TAT	  TG	  
rpl22	  middle	  	   TAG	  CGG	  TAA	  GCT	  GGG	  CTA	  AA	   GTC	  GCT	  CTG	  ATG	  GCA	  GTG	  TA	  
rpl22	  end	  	   GGC	  TAG	  CCC	  GAA	  GTT	  TTC	  TT	   AGC	  TGA	  TCC	  CTT	  CAG	  TGG	  AA	  
Ucp4a	  promoter	  	   CAAGTTGTCGCGAGTTGAAA	   CAATTGCTTCGCTCTAGCTG	  
Ucp4a	  middle	  	   CGCAAGGAGTTCACACAGAA	   CTCCATTTGGATTTGCACCT	  Ucp4a	  end	   TTCATGTTACCCCGCCTTTA	   CTCCTGACATTTGGGCATTC	  
klp3a	  promoter	   GAGGTGCCGGTGTAGAAAGA	   CACAAATCGTCCAACCACAT	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klp3a	  middle	   CATTCCCATTCGGAGGAGTA	   GCAGCTCCTGTTTGAGATCC	  
klp3a	  end	   TTGATGTTGGCTGTCGAAAA	   TTGAATTCATTCCTGGGTCA	  
CG4406	  promoter	  	   CTGCTCGATAGCACGCAGT	   TATCGACGGTCACACTGCTC	  
CG4406	  middle	   CCTGGAACTTGAGGAATCCA	   GGCAGCAATGTGCTCATCTA	  
CG4406	  end	   AGCTCGGAAGGAAACTGTGA	   GTGACCAAAAAGCCCTTCAA	  
CG6506	  promoter	   GCCGATGTTTACCGACAATC	   CATGGTTGGTTATCGGGACT	  
CG6506	  middle	   ATCCGTGCCTAATGATACCG	   ACGGTTGGTGTGAACCAAAT	  
CG6506	  end	   ACAGTCAGCTCCCAGCAGAT	   AAAGTGGCGTGAAAGTTGCT	  
CG3473	  upstream	  	   ACTCGGTTCAGATCCTGTGG	   GGCCAGTGGGCTTGTAATAA	  ODSH	   AAGATCCGCTAAGCGATGAA	   GCCAGGAGTTGAAGTTGGTC	  
sec5	  promoter	  	   GCT	  GCT	  CAG	  CAA	  GGA	  GAC	  TT	   CGG	  ACG	  AGC	  ATA	  AAA	  AGA	  GC	  
sec5	  middle	  	   CCA	  GGA	  AAA	  GGC	  AAA	  GAA	  CA	   TCG	  CAG	  AAG	  TTA	  ACC	  CGA	  TT	  
sec5	  end	  	   ATC	  AAC	  GGC	  TTC	  ATC	  TTT	  CG	   GCG	  TTT	  TCT	  TCC	  ATT	  TTC	  CA	  
cycb	  promoter	   CAGTGGCGCTCGAGAATAAT	   TATCGCACGTATCGCATCTC	  
cycb	  middle	   CATCTTGTGGGACACCTCCT	   AGCCCATTCACAAGGATCAC	  
cycb	  end	   TCAGAGACATTTTTGGGAAACA	   TCGCACATTCATACAAAAACAA	  
Nc73EF	  promoter	   CGATATCTGGCACAAAACGA	   GCGTTAGTGGTGGGACTGTT	  
Nc73EF	  middle	   CAATCGGGTCTGGTAATGCT	   GGAAGTAGTCGGGATCGTCA	  
Nc73EF	  end	   TGTTTCAAACCAAGCAAAGC	   TGCGCTCCATAAAGGGTATC	  
NAT1	  promoter	   CCACACCATGGATTGTGAAA	   TGCAGCAATCGATAACCTGT	  
NAT1	  middle	   AATCATACGCACTCCGTTCC	   CGATCATTGTTGCGCATATC	  
NAT1	  end	   CTGTGCCGTTGGTTCAAGTA	   GTCGGAAATCTCCTCCTTCC	  
CG11815	  promoter	   GGCATACATTTCGGATTGCT	   TTGCACGATAATCAGCCGTA	  
CG11815	  middle	   GCTTTCCAGCTTCTTCATGG	   TCGATTGGACGGAGGACTAC	  
CG11815	  end	   TTTTGTTGTCATCGCCTTCA	   CATGAGCGAGGATGAACTGA	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LNK	  promoter	   TTCCCACCATTTTGCTTACC	   CACAGAAAACCCGATTACCG	  
LNK	  middle	  	   TTCGGAGAAGGGTCAGTGTC	   TTCCAGTGGTATCGGGTTGT	  
LNK	  end	   CATTTGGGCTTTGGGTTTTA	   TTCGTTACCTTATTTCAAACGAA	  
rpl6	  promoter	   CGACTTGGCCACCTTTTTAG	   TGGTCACACCGCTCTAGACA	  
rpl6	  middle	   TTTGTGCTCGCTGAAGTTTG	   GAAGAGCAAGGCCTCCTACC	  
rpl6	  end	   CGCGCTTGTACAGTGTTTTT	   GAGGGGATGGATTTGGTTCT	  
rlip	  promoter	   CATGACACAGTAGCGCCATC	   CCGCTGCTATCCAACACTG	  
rlip	  middle	   TGCAGGATCACCTGAAGTGT	   TGTACAACCGCTTGAAGTGC	  
rlip	  end	   CGGATTCCTCATGCCTAAAG	   ATTTCGGTGGGTCAAGTCTG	  
RIP	  PRIMERS	   FORWARD	   REVERSE	  
roX2	  (a)	   TCGCAATGCAAACTGAAGTC	   AGGCGCGTAAAACGTTACC	  
Rox2	  	  (b)	   GAAACGTTCTCCGAAGCAAA	   GCGGAAATCGTTACTCTTGC	  
7SK	  	   GATAACCCGTCGTCATCCAG	   AGTAATTCTGCCTGGCGTTG	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  1.	  Chromosome	  Res.	  2009;17(5):603-­‐19.	  	  	  	  X	  chromosomal	  regulation	  in	  flies:	  when	  less	  is	  more.	  	  	  	  
Hallacli	  E,	  Akhtar	  A.	  	  	  	  In	   Drosophila,	   dosage	   compensation	   of	   the	   single	   male	   X	   chromosome	   involves	  upregulation	   of	   expression	   of	   X	   linked	   genes.	   Dosage	   compensation	   complex	   or	   the	  	  male	   specific	   lethal	   (MSL)	   complex	   is	   intimately	   involved	   in	   this	   regulation.	   The	  MSL	  complex	  members	   decorate	   the	  male	   X	   chromosome	  by	   binding	   on	   hundreds	   of	   sites	  along	   the	   X	   chromosome.	   Recent	   genome	  wide	   analysis	   has	   brought	   new	   light	   into	   X	  chromosomal	   regulation.	   It	   is	   becoming	   increasingly	   clear	   that	   although	   the	   X	  chromosome	   achieves	   male	   specific	   regulation	   via	   the	   MSL	   complex	   members,	   a	  number	   of	   general	   factors	   also	   impinge	   on	   this	   regulation.	   Future	   studies	   integrating	  these	  aspects	  promise	  to	  shed	  more	  light	  into	  this	  epigenetic	  phenomenon.	  	  
 2.	  Nat	  Struct	  Mol	  Biol.	  2011	  Feb;18(2):142-­‐9.	  Epub	  2011	  Jan	  9.	  	  	  	  Structural	  basis	  for	  MOF	  and	  MSL3	  recruitment	  into	  the	  dosage	  compensation	  complex	  by	  MSL1.	  	  	  	  Kadlec	  J*,	  Hallacli	  E,*	  Lipp	  M,	  Holz	  H,	  Sanchez-­‐Weatherby	  J,	  Cusack	  S,	  Akhtar	  A.	  	  	  The	   male-­‐specific	   lethal	   (MSL)	   complex	   is	   required	   for	   dosage	   compensation	   in	  Drosophila	   melanogaster,	   and	   analogous	   complexes	   exist	   in	   mammals.	   We	   report	  structures	  of	  binary	  complexes	  of	  mammalian	  MSL3	  and	  the	  histone	  acetyltransferase	  (HAT)	   MOF	   with	   consecutive	   segments	   of	   MSL1.	   MSL1	   interacts	   with	   MSL3	   as	   an	  extended	   chain	   forming	   an	   extensive	   hydrophobic	   interface,	   whereas	   the	   MSL1-­‐MOF	  interface	  involves	  electrostatic	  interactions	  between	  the	  HAT	  domain	  and	  a	  long	  helix	  of	  MSL1.	  This	  structure	  provides	  insights	  into	  the	  catalytic	  mechanism	  of	  MOF	  and	  enables	  us	  to	  show	  analogous	  interactions	  of	  MOF	  with	  NSL1.	  In	  Drosophila,	  selective	  disruption	  of	  Msl1	   interactions	  with	  Msl3	   or	  Mof	   severely	   affects	  Msl1	   targeting	   to	   the	   body	   of	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dosage-­‐compensated	   genes	   and	   several	   high-­‐affinity	   sites,	  without	   affecting	  promoter	  binding.	  We	  propose	  that	  Msl1	  acts	  as	  a	  scaffold	  for	  MSL	  complex	  assembly	  to	  achieve	  specific	  targeting	  to	  the	  X	  chromosome.	  	  	  *	  Joint	  first	  authors	  This	   paper	   contains	   my	   work	   related	   to	   the	   PEHE	   domain	   of	   Msl1	   and	   qualitative	  differences	  in	  the	  High	  affinity	  sites.	  	  3	  Dev	  Cell.	  2012	  Mar	  13;22(3):610-­‐24.	  	  	  	  The	   MOF	   Chromobarrel	   Domain	   Controls	   Genome-­‐wide	   H4K16	   Acetylation	   and	  Spreading	  	  of	  the	  MSL	  Complex.	  	  	  	  Conrad	   T,	   Cavalli	   FM,	  Holz	  H,	  Hallacli	   E,	   Kind	   J,	   Ilik	   I,	   Vaquerizas	   JM,	   Luscombe	  NM,	  Akhtar	  A.	  	  	  	  The	  histone	  H4	  lysine	  16	  (H4K16)-­‐specific	  acetyltransferase	  MOF	  is	  part	  of	  two	  distinct	  complexes	   involved	   in	   X	   chromosome	   dosage	   compensation	   and	   autosomal	  transcription	  regulation.	  Here	  we	  show	  that	  the	  MOF	  chromobarrel	  domain	  is	  essential	  for	  H4K16	  acetylation	  throughout	  the	  Drosophila	  genome	  and	  is	  required	  for	  spreading	  of	  the	  male-­‐specific	  lethal	  (MSL)	  complex	  on	  the	  X	  chromosome.	  The	  MOF	  chromobarrel	  domain	  directly	   interacts	  with	  nucleic	   acids	   and	  potentiates	  MOF's	   enzymatic	   activity	  after	  chromatin	  binding,	  making	  it	  a	  unique	  example	  of	  a	  chromo-­‐like	  domain	  directly	  controlling	   acetylation	   activity	   in	  vivo.	   We	   also	   show	   that	   the	   Drosophila-­‐specific	   N	  terminus	   of	   MOF	   has	   evolved	   to	   perform	   sex-­‐specific	   functions.	   It	   modulates	  nucleosome	   binding	   and	   HAT	   activity	   and	   controls	   MSL	   complex	   assembly,	   thus	  regulating	   MOF	   function	   in	   dosage	   compensation.	   We	   propose	   that	   MOF	   has	   been	  especially	   tailored	   to	   achieve	   tight	   regulation	   of	   its	   enzymatic	   activity	   and	   enable	   its	  dual	  role	  on	  X	  and	  autosomes.	  	  For	   this	   paper,	   I	   made	   stable	   SL-­‐2	   cell	   lines	   expressing	   different	   Mof	   mutants	   and	  checked	  their	  interactions	  with	  the	  rest	  of	  the	  complex	  by	  immunoprecipitation.	  I	  also	  investigated	  interaction	  of	  Mof	  mutants	  with	  roX2	  RNA.	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WORK	  IN	  SUBMISSION	  	  MSL1	  mediated	  dimerization	  of	  the	  dosage	  compensation	  complex	  is	  essential	  for	  male	  X-­‐chromosome	  regulation	  in	  Drosophila	  	  
Erinc	   Hallacli,	  Michael	   Lipp,	   Plamen	   Georgiev,	   Clare	   Spielman,	   Stephen	   Cusack	   Asifa	  Akhtar	  and	  Jan	  Kadlec	  	  	  The	  male	   specific	   lethal	   (MSL)	   complex	   regulates	  dosage	   compensation	  of	   the	  male	  X	  chromosome	  in	  Drosophila.	  Here,	  we	  report	  the	  crystal	  structure	  of	  its	  MSL1-­‐MSL2	  core,	  where	  two	  MSL2	  subunits	  bind	  to	  a	  dimer	  formed	  by	  two	  molecules	  of	  MSL1.	  Analysis	  of	  structure-­‐based	  mutants	  revealed	  that	  MSL2	  can	  only	  interact	  with	  the	  MSL1	  dimer,	  but	  MSL1	  dimerization	  occurs	  independent	  of	  MSL2.	  We	  show	  that	  MSL1	  is	  a	  substrate	  for	   MSL2	   E3	   ubiquitin	   ligase	   activity.	   ChIP	   experiments	   revealed	   that	   MSL1	  dimerization	   is	   essential	   for	   targeting	   and	   spreading	   of	   the	  MSL	   complex	   on	  X-­‐linked	  genes,	  however	  MSL1	  binding	  to	  promoters	  of	  male	  and	  female	  cells	  is	  independent	  of	  the	   dimer	   status	   and	   other	   MSL	   proteins.	   Finally,	   we	   show	   that	   loss	   of	   MSL1	  dimerization	   leads	  to	  male	  specific	   lethality	   in	   transgenic	   flies.	  We	  propose	  that	  MSL1	  mediated	   dimerization	   of	   the	   entire	   MSL	   complex	   is	   required	   for	   MSL2	   binding,	   X	  chromosome	  recognition	  and	  spreading	  along	  the	  X	  chromosome.	  	  This	   body	   of	   work	   includes	   the	   data	   related	   to	   interaction	   of	   Msl1	   and	   Msl2	   and	  dimerization	  of	  Msl1.	  
